Datasets:

Modalities:
Text
Formats:
parquet
Libraries:
Datasets
pandas
License:
LionelLow commited on
Commit
31bf53b
·
verified ·
1 Parent(s): 561171b

Uploading Coursework Dataset

Browse files
PLOD_CW_2025_Test.conll ADDED
The diff for this file is too large to render. See raw diff
 
PLOD_CW_2025_Test.parquet ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:7254c666fd5e2a2524e8a27fadc433da0ddfed269d3202fcb05e6f8624b2704b
3
+ size 55506
PLOD_CW_2025_Train.conll ADDED
The diff for this file is too large to render. See raw diff
 
PLOD_CW_2025_Train.parquet ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:47bb3ca03d7eab8d42be0d45823ae7a79e066f8cc22c81f144d78672d4e877a8
3
+ size 343318
PLOD_CW_2025_Val.conll ADDED
@@ -0,0 +1,6154 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ Multi ADJ B-LF
2
+ - PUNCT I-LF
3
+ locus ADJ I-LF
4
+ sequence NOUN I-LF
5
+ typing NOUN I-LF
6
+ ( PUNCT B-O
7
+ MLST NOUN B-AC
8
+ ) PUNCT B-O
9
+ was AUX B-O
10
+ performed VERB B-O
11
+ by ADP B-O
12
+ PCR NOUN B-AC
13
+ - PUNCT B-O
14
+ sequencing NOUN B-O
15
+ of ADP B-O
16
+ a DET B-O
17
+ set NOUN B-O
18
+ of ADP B-O
19
+ pneumococcal ADJ B-O
20
+ housekeeping NOUN B-O
21
+ genes NOUN B-O
22
+ , PUNCT B-O
23
+ including VERB B-O
24
+ ardE NOUN B-O
25
+ , PUNCT B-O
26
+ gdh NOUN B-O
27
+ , PUNCT B-O
28
+ gki NOUN B-O
29
+ , PUNCT B-O
30
+ recP NOUN B-O
31
+ , PUNCT B-O
32
+ spi NOUN B-O
33
+ , PUNCT B-O
34
+ xpt NOUN B-O
35
+ , PUNCT B-O
36
+ and CCONJ B-O
37
+ ddl NOUN B-O
38
+ [ PUNCT B-O
39
+ 17 NUM B-O
40
+ ] PUNCT B-O
41
+ . PUNCT B-O
42
+
43
+ The DET B-O
44
+ investigated VERB B-O
45
+ traits NOUN B-O
46
+ were AUX B-O
47
+ heading NOUN B-LF
48
+ date NOUN I-LF
49
+ ( PUNCT B-O
50
+ HD PROPN B-AC
51
+ ) PUNCT B-O
52
+ , PUNCT B-O
53
+ plant NOUN B-LF
54
+ height NOUN I-LF
55
+ ( PUNCT B-O
56
+ PH PROPN B-AC
57
+ ) PUNCT B-O
58
+ , PUNCT B-O
59
+ GY PROPN B-AC
60
+ , PUNCT B-O
61
+ thousand NUM B-LF
62
+ grain NOUN I-LF
63
+ weight NOUN I-LF
64
+ ( PUNCT B-O
65
+ TGW PROPN B-AC
66
+ ) PUNCT B-O
67
+ , PUNCT B-O
68
+ weight NOUN B-O
69
+ of ADP B-O
70
+ straw NOUN B-O
71
+ – PUNCT B-O
72
+ referred VERB B-O
73
+ to ADP B-O
74
+ as ADP B-O
75
+ straw NOUN B-LF
76
+ yield NOUN I-LF
77
+ ( PUNCT B-O
78
+ SY PROPN B-AC
79
+ ) PUNCT B-O
80
+ , PUNCT B-O
81
+ spike NOUN B-LF
82
+ number NOUN I-LF
83
+ per ADP I-LF
84
+ meter NOUN I-LF
85
+ ( PUNCT B-O
86
+ SN PROPN B-AC
87
+ ) PUNCT B-O
88
+ , PUNCT B-O
89
+ grain NOUN B-LF
90
+ number NOUN I-LF
91
+ per ADP I-LF
92
+ spike NOUN I-LF
93
+ ( PUNCT B-O
94
+ GN PROPN B-AC
95
+ ) PUNCT B-O
96
+ , PUNCT B-O
97
+ harvest NOUN B-LF
98
+ index NOUN I-LF
99
+ ( PUNCT B-O
100
+ HI PROPN B-AC
101
+ ) PUNCT B-O
102
+ , PUNCT B-O
103
+ N NOUN B-LF
104
+ harvest NOUN I-LF
105
+ index NOUN I-LF
106
+ ( PUNCT B-O
107
+ NHI PROPN B-AC
108
+ ) PUNCT B-O
109
+ , PUNCT B-O
110
+ GPC PROPN B-AC
111
+ , PUNCT B-O
112
+ NUE PROPN B-AC
113
+ , PUNCT B-O
114
+ NUpE PROPN B-AC
115
+ , PUNCT B-O
116
+ NUtE PROPN B-AC
117
+ , PUNCT B-O
118
+ amount NOUN B-O
119
+ of ADP B-O
120
+ N NOUN B-O
121
+ taken VERB B-O
122
+ up ADP B-O
123
+ by ADP B-O
124
+ the DET B-O
125
+ whole ADJ B-O
126
+ plant NOUN B-O
127
+ ( PUNCT B-O
128
+ NUpfull PROPN B-AC
129
+ ) PUNCT B-O
130
+ , PUNCT B-O
131
+ amount NOUN B-O
132
+ of ADP B-O
133
+ the DET B-O
134
+ N NOUN B-O
135
+ harvested VERB B-O
136
+ in ADP B-O
137
+ grain NOUN B-O
138
+ ( PUNCT B-O
139
+ NUpgrain PROPN B-AC
140
+ ) PUNCT B-O
141
+ , PUNCT B-O
142
+ grain NOUN B-LF
143
+ N NOUN I-LF
144
+ accumulation NOUN I-LF
145
+ efficiency NOUN I-LF
146
+ ( PUNCT B-O
147
+ GNACE PROPN B-AC
148
+ ) PUNCT B-O
149
+ . PUNCT B-O
150
+ GY PROPN B-AC
151
+ , PUNCT B-O
152
+ HD PROPN B-AC
153
+ and CCONJ B-O
154
+ PH PROPN B-AC
155
+ were AUX B-O
156
+ scored VERB B-O
157
+ on ADP B-O
158
+ a DET B-O
159
+ per ADP B-O
160
+ plot NOUN B-O
161
+ basis NOUN B-O
162
+ , PUNCT B-O
163
+ while SCONJ B-O
164
+ GN PROPN B-AC
165
+ , PUNCT B-O
166
+ SN PROPN B-AC
167
+ , PUNCT B-O
168
+ TGW PROPN B-AC
169
+ and CCONJ B-O
170
+ SY PROPN B-AC
171
+ were AUX B-O
172
+ evaluated VERB B-O
173
+ from ADP B-O
174
+ above ADP B-O
175
+ - PUNCT B-O
176
+ ground NOUN B-O
177
+ biomass NOUN B-O
178
+ samples NOUN B-O
179
+ collected VERB B-O
180
+ from ADP B-O
181
+ a DET B-O
182
+ representative ADJ B-O
183
+ row NOUN B-O
184
+ of ADP B-O
185
+ each DET B-O
186
+ plot NOUN B-O
187
+ , PUNCT B-O
188
+ whose DET B-O
189
+ length NOUN B-O
190
+ was AUX B-O
191
+ one NUM B-O
192
+ meter NOUN B-O
193
+ . PUNCT B-O
194
+
195
+ AVR PROPN B-AC
196
+ - PUNCT B-O
197
+ Aortic ADJ B-LF
198
+ valve NOUN I-LF
199
+ replacement NOUN I-LF
200
+ , PUNCT B-O
201
+ TAVI PROPN B-AC
202
+ – PUNCT B-O
203
+ transcutaneous ADJ B-O
204
+ aortic ADJ B-O
205
+ valve NOUN B-O
206
+ implantation NOUN B-O
207
+
208
+ After ADP B-O
209
+ amelogenin NOUN B-O
210
+ , PUNCT B-O
211
+ ameloblastin NOUN B-LF
212
+ ( PUNCT B-O
213
+ AMBN PROPN B-AC
214
+ ) PUNCT B-O
215
+ is AUX B-O
216
+ the DET B-O
217
+ second ADV B-O
218
+ most ADV B-O
219
+ abundant ADJ B-O
220
+ enamel NOUN B-O
221
+ matrix NOUN B-O
222
+ protein NOUN B-O
223
+ . PUNCT B-O
224
+
225
+ To PART B-O
226
+ address VERB B-O
227
+ the DET B-O
228
+ association NOUN B-O
229
+ between ADP B-O
230
+ a DET B-O
231
+ history NOUN B-O
232
+ of ADP B-O
233
+ tuberculosis NOUN B-LF
234
+ ( PUNCT B-O
235
+ TB PROPN B-AC
236
+ ) PUNCT B-O
237
+ or CCONJ B-O
238
+ nontuberculous ADJ B-O
239
+ mycobacterial ADJ B-O
240
+ ( PUNCT B-O
241
+ NTM PROPN B-AC
242
+ ) PUNCT B-O
243
+ infection NOUN B-O
244
+ and CCONJ B-O
245
+ the DET B-O
246
+ risk NOUN B-O
247
+ of ADP B-O
248
+ newly ADV B-O
249
+ diagnosed VERB B-O
250
+ Sjögren PROPN B-LF
251
+ ’s PART I-LF
252
+ syndrome NOUN I-LF
253
+ ( PUNCT B-O
254
+ SS PROPN B-AC
255
+ ) PUNCT B-O
256
+ . PUNCT B-O
257
+
258
+ As SCONJ B-O
259
+ SIRS PROPN B-AC
260
+ caused VERB B-O
261
+ by ADP B-O
262
+ tissue NOUN B-O
263
+ damage NOUN B-O
264
+ increases VERB B-O
265
+ the DET B-O
266
+ release NOUN B-O
267
+ of ADP B-O
268
+ damage NOUN B-LF
269
+ - PUNCT I-LF
270
+ associated VERB I-LF
271
+ molecular ADJ I-LF
272
+ patterns NOUN I-LF
273
+ ( PUNCT B-O
274
+ DAMPs PROPN B-AC
275
+ ) PUNCT B-O
276
+ , PUNCT B-O
277
+ SIRS PROPN B-AC
278
+ becomes VERB B-O
279
+ more ADV B-O
280
+ severe ADJ B-O
281
+ and CCONJ B-O
282
+ the DET B-O
283
+ multiple ADJ B-O
284
+ organ NOUN B-O
285
+ failure NOUN B-O
286
+ of ADP B-O
287
+ the DET B-O
288
+ patient NOUN B-O
289
+ worsens VERB B-O
290
+ . PUNCT B-O
291
+
292
+ EV PROPN B-AC
293
+ , PUNCT B-O
294
+ extracellular ADJ B-LF
295
+ vesicle NOUN I-LF
296
+ ; PUNCT B-O
297
+ NSC PROPN B-AC
298
+ , PUNCT B-O
299
+ neural ADJ B-LF
300
+ stem NOUN I-LF
301
+ cell NOUN I-LF
302
+ ; PUNCT B-O
303
+ WB PROPN B-AC
304
+ , PUNCT B-O
305
+ western ADJ B-LF
306
+ blot NOUN I-LF
307
+ . PUNCT B-O
308
+
309
+ The DET B-O
310
+ same ADJ B-O
311
+ experiment NOUN B-O
312
+ was AUX B-O
313
+ also ADV B-O
314
+ conducted VERB B-O
315
+ in ADP B-O
316
+ the DET B-O
317
+ 2011 NUM B-O
318
+ DS PROPN B-AC
319
+ , PUNCT B-O
320
+ 2011 NUM B-O
321
+ WS PROPN B-AC
322
+ and CCONJ B-O
323
+ 2012 NUM B-O
324
+ WS PROPN B-AC
325
+ but CCONJ B-O
326
+ only ADV B-O
327
+ phenology NOUN B-O
328
+ and CCONJ B-O
329
+ final ADJ B-O
330
+ crop NOUN B-O
331
+ aboveground ADJ B-LF
332
+ dry ADJ I-LF
333
+ weight NOUN I-LF
334
+ ( PUNCT B-O
335
+ agdw NOUN B-AC
336
+ ) PUNCT B-O
337
+ are AUX B-O
338
+ reported VERB B-O
339
+ here ADV B-O
340
+ . PUNCT B-O
341
+
342
+ Of ADP B-O
343
+ these PRON B-O
344
+ , PUNCT B-O
345
+ Nucleolar ADJ B-LF
346
+ and CCONJ I-LF
347
+ spindle NOUN I-LF
348
+ - PUNCT I-LF
349
+ associated VERB I-LF
350
+ protein NOUN I-LF
351
+ 1 NUM I-LF
352
+ ( PUNCT B-O
353
+ NUSAP1 PROPN B-AC
354
+ ) PUNCT B-O
355
+ was AUX B-O
356
+ detected VERB B-O
357
+ as ADP B-O
358
+ a DET B-O
359
+ significantly ADV B-O
360
+ upregulated VERB B-O
361
+ gene NOUN B-O
362
+ . PUNCT B-O
363
+
364
+ Mitochondrial ADJ B-O
365
+ fusion NOUN B-O
366
+ / SYM B-O
367
+ fission NOUN B-O
368
+ is AUX B-O
369
+ primarily ADV B-O
370
+ regulated VERB B-O
371
+ by ADP B-O
372
+ dynamin NOUN B-O
373
+ - PUNCT B-O
374
+ like ADJ B-O
375
+ GTPase PROPN B-O
376
+ , PUNCT B-O
377
+ optic ADJ B-LF
378
+ atrophy NOUN I-LF
379
+ 1 NUM I-LF
380
+ ( PUNCT B-O
381
+ Opa1 PROPN B-AC
382
+ ) PUNCT B-O
383
+ and CCONJ B-O
384
+ dynamin NOUN B-LF
385
+ - PUNCT I-LF
386
+ related VERB I-LF
387
+ protein NOUN I-LF
388
+ 1 NUM I-LF
389
+ ( PUNCT B-O
390
+ Drp1 PROPN B-AC
391
+ , PUNCT B-O
392
+ mitofusin NOUN B-O
393
+ 1/2 NUM B-O
394
+ ( PUNCT B-O
395
+ Mfn1/2 NOUN B-O
396
+ ) PUNCT B-O
397
+ [ PUNCT B-O
398
+ 40–42 NUM B-O
399
+ ] PUNCT B-O
400
+ . PUNCT B-O
401
+
402
+ We PRON B-O
403
+ carried VERB B-O
404
+ out ADP B-O
405
+ a DET B-O
406
+ series NOUN B-O
407
+ of ADP B-O
408
+ experimental ADJ B-O
409
+ studies NOUN B-O
410
+ in ADP B-O
411
+ order NOUN B-O
412
+ to PART B-O
413
+ obtain VERB B-O
414
+ behavioural ADJ B-O
415
+ data NOUN B-O
416
+ from ADP B-O
417
+ rats NOUN B-O
418
+ given VERB B-O
419
+ low ADJ B-O
420
+ , PUNCT B-O
421
+ medium ADJ B-O
422
+ , PUNCT B-O
423
+ and CCONJ B-O
424
+ high ADJ B-O
425
+ doses NOUN B-O
426
+ of ADP B-O
427
+ peptide NOUN B-LF
428
+ YY3 PROPN I-LF
429
+ - PUNCT I-LF
430
+ 36 NUM I-LF
431
+ ( PUNCT B-O
432
+ PYY3 PROPN B-AC
433
+ - PUNCT B-AC
434
+ 36 NUM B-AC
435
+ ) PUNCT B-O
436
+ in ADP B-O
437
+ the DET B-O
438
+ light ADJ B-O
439
+ and CCONJ B-O
440
+ dark ADJ B-O
441
+ period NOUN B-O
442
+ , PUNCT B-O
443
+ as ADP B-O
444
+ well ADV B-O
445
+ as ADP B-O
446
+ rats NOUN B-O
447
+ given VERB B-O
448
+ low ADJ B-O
449
+ and CCONJ B-O
450
+ high ADJ B-O
451
+ doses NOUN B-O
452
+ of ADP B-O
453
+ lithium NOUN B-O
454
+ chloride NOUN B-O
455
+ ( PUNCT B-O
456
+ LiCl PROPN B-O
457
+ ) PUNCT B-O
458
+ in ADP B-O
459
+ the DET B-O
460
+ light ADJ B-O
461
+ period NOUN B-O
462
+ and CCONJ B-O
463
+ rats NOUN B-O
464
+ given VERB B-O
465
+ low ADJ B-O
466
+ , PUNCT B-O
467
+ medium ADJ B-O
468
+ , PUNCT B-O
469
+ and CCONJ B-O
470
+ high ADJ B-O
471
+ doses NOUN B-O
472
+ of ADP B-O
473
+ glucagon NOUN B-LF
474
+ - PUNCT I-LF
475
+ like ADJ I-LF
476
+ peptide NOUN I-LF
477
+ 1 NUM I-LF
478
+ ( PUNCT B-O
479
+ GLP-1 PROPN B-AC
480
+ ) PUNCT B-O
481
+ and CCONJ B-O
482
+ leptin NOUN B-O
483
+ in ADP B-O
484
+ the DET B-O
485
+ dark ADJ B-O
486
+ period NOUN B-O
487
+ ( PUNCT B-O
488
+ details NOUN B-O
489
+ and CCONJ B-O
490
+ doses NOUN B-O
491
+ in ADP B-O
492
+ Table PROPN B-O
493
+ 2 NUM B-O
494
+ and CCONJ B-O
495
+ Materials NOUN B-O
496
+ and CCONJ B-O
497
+ Methods NOUN B-O
498
+ ) PUNCT B-O
499
+ . PUNCT B-O
500
+
501
+ Olfactory ADJ B-LF
502
+ sensory ADJ I-LF
503
+ neurons NOUN I-LF
504
+ ( PUNCT B-O
505
+ OSNs PROPN B-AC
506
+ ) PUNCT B-O
507
+ in ADP B-O
508
+ most ADJ B-O
509
+ vertebrates NOUN B-O
510
+ and CCONJ B-O
511
+ insects NOUN B-O
512
+ are AUX B-O
513
+ specified VERB B-O
514
+ to PART B-O
515
+ express VERB B-O
516
+ a DET B-O
517
+ single ADJ B-O
518
+ odorant NOUN B-LF
519
+ receptor NOUN I-LF
520
+ ( PUNCT B-O
521
+ OR PROPN B-AC
522
+ ) PUNCT B-O
523
+ from ADP B-O
524
+ a DET B-O
525
+ large ADJ B-O
526
+ repertoire NOUN B-O
527
+ of ADP B-O
528
+ OR PROPN B-AC
529
+ genes NOUN B-O
530
+ in ADP B-O
531
+ the DET B-O
532
+ genome NOUN B-O
533
+ [ X B-O
534
+ 1–4 NUM B-O
535
+ ] PUNCT B-O
536
+ . PUNCT B-O
537
+
538
+ Combined ADJ B-LF
539
+ hepatocellular ADJ I-LF
540
+ - PUNCT I-LF
541
+ cholangiocarcinoma NOUN I-LF
542
+ ( PUNCT B-O
543
+ cHCC NOUN B-AC
544
+ - PUNCT B-AC
545
+ CC NOUN B-AC
546
+ ) PUNCT B-O
547
+ accounts VERB B-O
548
+ for ADP B-O
549
+ 0.4%–14.2 NUM B-O
550
+ % NOUN B-O
551
+ of ADP B-O
552
+ primary ADJ B-O
553
+ liver NOUN B-O
554
+ malignancies NOUN B-O
555
+ [ PUNCT B-O
556
+ 1 NUM B-O
557
+ , PUNCT B-O
558
+ 2 NUM B-O
559
+ ] PUNCT B-O
560
+ , PUNCT B-O
561
+ and CCONJ B-O
562
+ contains VERB B-O
563
+ pathological ADJ B-O
564
+ components NOUN B-O
565
+ of ADP B-O
566
+ both CCONJ B-O
567
+ hepatocellular ADJ B-LF
568
+ carcinoma NOUN I-LF
569
+ ( PUNCT B-O
570
+ HCC PROPN B-AC
571
+ ) PUNCT B-O
572
+ and CCONJ B-O
573
+ cholangiocarcinoma NOUN B-LF
574
+ ( PUNCT B-O
575
+ CC NOUN B-AC
576
+ ) PUNCT B-O
577
+ [ PUNCT B-O
578
+ 3 NUM B-O
579
+ ] PUNCT B-O
580
+ . PUNCT B-O
581
+
582
+ “ PUNCT B-O
583
+ Post PROPN B-O
584
+ - ADJ B-O
585
+ Tax ADJ B-O
586
+ : PUNCT B-O
587
+ Behavior NOUN B-O
588
+ Only ADV B-O
589
+ ” PUNCT B-O
590
+ refers VERB B-O
591
+ to ADP B-O
592
+ estimates NOUN B-O
593
+ of ADP B-O
594
+ beverage NOUN B-O
595
+ intake NOUN B-O
596
+ using VERB B-O
597
+ only ADV B-O
598
+ the DET B-O
599
+ pre ADJ B-O
600
+ - ADJ B-O
601
+ tax ADJ B-O
602
+ food NOUN B-LF
603
+ composition NOUN I-LF
604
+ table NOUN I-LF
605
+ ( PUNCT B-O
606
+ FCT PROPN B-AC
607
+ ) PUNCT B-O
608
+ , PUNCT B-O
609
+ which PRON B-O
610
+ keeps VERB B-O
611
+ nutrient NOUN B-O
612
+ content NOUN B-O
613
+ constant ADJ B-O
614
+ . PUNCT B-O
615
+ “ PUNCT B-O
616
+ Post PROPN B-O
617
+ - ADJ B-O
618
+ Tax ADJ B-O
619
+ : PUNCT B-O
620
+ Reformulation NOUN B-O
621
+ Included VERB B-O
622
+ ” PUNCT B-O
623
+ refers VERB B-O
624
+ to ADP B-O
625
+ estimates NOUN B-O
626
+ of ADP B-O
627
+ beverage NOUN B-O
628
+ intake NOUN B-O
629
+ using VERB B-O
630
+ the DET B-O
631
+ post ADJ B-O
632
+ - ADJ B-O
633
+ tax ADJ B-O
634
+ FCT PROPN B-AC
635
+ , PUNCT B-O
636
+ which PRON B-O
637
+ accounts VERB B-O
638
+ for ADP B-O
639
+ reformulation NOUN B-O
640
+ changes NOUN B-O
641
+ in ADP B-O
642
+ the DET B-O
643
+ nutrient NOUN B-O
644
+ content NOUN B-O
645
+ of ADP B-O
646
+ beverages NOUN B-O
647
+ . PUNCT B-O
648
+
649
+ b X B-O
650
+ GH NOUN B-AC
651
+ : PUNCT B-O
652
+ growth NOUN B-LF
653
+ hormone NOUN I-LF
654
+
655
+ IES PROPN B-AC
656
+ , PUNCT B-O
657
+ internal ADJ B-LF
658
+ eliminated VERB I-LF
659
+ sequence NOUN I-LF
660
+ . PUNCT B-O
661
+
662
+ Compared VERB B-O
663
+ to ADP B-O
664
+ the DET B-O
665
+ X NOUN B-O
666
+ - PUNCT B-O
667
+ ray NOUN B-O
668
+ crystal NOUN B-O
669
+ structure NOUN B-O
670
+ of ADP B-O
671
+ the DET B-O
672
+ template NOUN B-O
673
+ ( PUNCT B-O
674
+ PDB NOUN B-O
675
+ code NOUN B-O
676
+ 4F13 NUM B-O
677
+ ) PUNCT B-O
678
+ [ PUNCT B-O
679
+ 32 NUM B-O
680
+ ] PUNCT B-O
681
+ , PUNCT B-O
682
+ the DET B-O
683
+ geometrical ADJ B-O
684
+ root NOUN B-LF
685
+ - PUNCT I-LF
686
+ mean NOUN I-LF
687
+ square ADJ I-LF
688
+ deviation NOUN I-LF
689
+ ( PUNCT B-O
690
+ RMSD NOUN B-AC
691
+ ) PUNCT B-O
692
+ for ADP B-O
693
+ the DET B-O
694
+ Cα PROPN B-O
695
+ atoms NOUN B-O
696
+ of ADP B-O
697
+ the DET B-O
698
+ modeled VERB B-O
699
+ AlgL PROPN B-AC
700
+ structure NOUN B-O
701
+ was AUX B-O
702
+ very ADV B-O
703
+ low ADJ B-O
704
+ ( PUNCT B-O
705
+ 1.03 NUM B-O
706
+ Å NOUN B-O
707
+ ) PUNCT B-O
708
+ , PUNCT B-O
709
+ suggesting VERB B-O
710
+ the DET B-O
711
+ high ADJ B-O
712
+ fidelity NOUN B-O
713
+ of ADP B-O
714
+ the DET B-O
715
+ modeled VERB B-O
716
+ structure NOUN B-O
717
+ . PUNCT B-O
718
+
719
+ CI PROPN B-AC
720
+ , PUNCT B-O
721
+ confidence NOUN B-LF
722
+ interval NOUN I-LF
723
+ ; PUNCT B-O
724
+ non ADJ B-O
725
+ - ADJ B-O
726
+ UHCS ADJ B-AC
727
+ , PUNCT B-O
728
+ non ADJ B-O
729
+ - ADJ B-O
730
+ universal ADJ B-LF
731
+ health NOUN I-LF
732
+ care NOUN I-LF
733
+ system NOUN I-LF
734
+ ; PUNCT B-O
735
+ NR PROPN B-O
736
+ , PUNCT B-O
737
+ not PART B-O
738
+ reported VERB B-O
739
+ ; PUNCT B-O
740
+ OR PROPN B-AC
741
+ , PUNCT B-O
742
+ odds NOUN B-LF
743
+ ratio NOUN I-LF
744
+ ; PUNCT B-O
745
+ SEER PROPN B-AC
746
+ , PUNCT B-O
747
+ National PROPN B-LF
748
+ Cancer PROPN I-LF
749
+ Institute PROPN I-LF
750
+ 's PART I-LF
751
+ Surveillance PROPN I-LF
752
+ , PUNCT I-LF
753
+ Epidemiology PROPN I-LF
754
+ and CCONJ I-LF
755
+ End PROPN I-LF
756
+ Results PROPN I-LF
757
+ database NOUN B-O
758
+ ; PUNCT B-O
759
+ SEP PROPN B-AC
760
+ , PUNCT B-O
761
+ socioeconomic ADJ B-LF
762
+ position NOUN I-LF
763
+ . PUNCT B-O
764
+
765
+ Past ADJ B-O
766
+ studies NOUN B-O
767
+ have AUX B-O
768
+ found VERB B-O
769
+ an DET B-O
770
+ association NOUN B-O
771
+ between ADP B-O
772
+ low ADJ B-O
773
+ levels NOUN B-O
774
+ of ADP B-O
775
+ hemoglobin NOUN B-LF
776
+ A1c NOUN I-LF
777
+ ( PUNCT B-O
778
+ HbA1c NOUN B-AC
779
+ , PUNCT B-O
780
+ a DET B-O
781
+ marker NOUN B-O
782
+ of ADP B-O
783
+ average ADJ B-O
784
+ blood NOUN B-O
785
+ sugar NOUN B-O
786
+ levels NOUN B-O
787
+ over ADP B-O
788
+ the DET B-O
789
+ past ADJ B-O
790
+ 2–3 NUM B-O
791
+ months NOUN B-O
792
+ ; PUNCT B-O
793
+ a DET B-O
794
+ low ADJ B-O
795
+ HbA1c NOUN B-AC
796
+ percentage NOUN B-O
797
+ indicates VERB B-O
798
+ good ADJ B-O
799
+ glycemic ADJ B-O
800
+ control NOUN B-O
801
+ ) PUNCT B-O
802
+ and CCONJ B-O
803
+ a DET B-O
804
+ high ADJ B-O
805
+ risk NOUN B-O
806
+ of ADP B-O
807
+ severe ADJ B-O
808
+ hypoglycemia NOUN B-O
809
+ . PUNCT B-O
810
+
811
+ Abbreviations NOUN B-O
812
+ : NOUN B-O
813
+ mPAP PROPN B-AC
814
+ = VERB B-O
815
+ mean ADJ B-LF
816
+ pulmonary ADJ I-LF
817
+ artery NOUN I-LF
818
+ pressure NOUN I-LF
819
+ ; PUNCT B-O
820
+ PA PROPN B-AC
821
+ : NOUN B-AC
822
+ A NOUN B-AC
823
+ = VERB B-O
824
+ pulmonary ADJ B-LF
825
+ artery NOUN I-LF
826
+ to ADP B-O
827
+ ascending ADJ B-O
828
+ aorta NOUN B-O
829
+ diameter NOUN B-O
830
+ ratio NOUN B-O
831
+ ; PUNCT B-O
832
+ PH NOUN B-AC
833
+ = VERB B-O
834
+ pulmonary ADJ B-LF
835
+ hypertension NOUN I-LF
836
+ . PUNCT B-O
837
+
838
+ PUD PROPN B-AC
839
+ ; PUNCT B-O
840
+ Peptic ADJ B-LF
841
+ Ulcer NOUN I-LF
842
+ Disease NOUN I-LF
843
+
844
+ Specifically ADV B-O
845
+ , PUNCT B-O
846
+ administration NOUN B-O
847
+ of ADP B-O
848
+ the DET B-O
849
+ TB PROPN B-AC
850
+ vaccine NOUN B-O
851
+ bacillus NOUN B-LF
852
+ Calmette PROPN I-LF
853
+ – PUNCT I-LF
854
+ Guérin PROPN I-LF
855
+ ( PUNCT B-O
856
+ BCG PROPN B-AC
857
+ ) PUNCT B-O
858
+ or CCONJ B-O
859
+ measles NOUN B-O
860
+ vaccines NOUN B-O
861
+ in ADP B-O
862
+ children NOUN B-O
863
+ reduces VERB B-O
864
+ overall ADJ B-O
865
+ mortality NOUN B-O
866
+ by ADP B-O
867
+ more ADJ B-O
868
+ than ADP B-O
869
+ what PRON B-O
870
+ would AUX B-O
871
+ be AUX B-O
872
+ expected VERB B-O
873
+ by ADP B-O
874
+ prevention NOUN B-O
875
+ of ADP B-O
876
+ these DET B-O
877
+ 2 NUM B-O
878
+ diseases NOUN B-O
879
+ alone ADV B-O
880
+ [ PUNCT B-O
881
+ 12 NUM B-O
882
+ ] PUNCT B-O
883
+ . PUNCT B-O
884
+
885
+ To PART B-O
886
+ test VERB B-O
887
+ this DET B-O
888
+ hypothesis NOUN B-O
889
+ , PUNCT B-O
890
+ we PRON B-O
891
+ predicted VERB B-O
892
+ errors NOUN B-O
893
+ in ADP B-O
894
+ the DET B-O
895
+ reported VERB B-O
896
+ diameter NOUN B-O
897
+ size NOUN B-O
898
+ of ADP B-O
899
+ the DET B-O
900
+ retro ADJ B-O
901
+ - ADJ B-O
902
+ cued VERB B-O
903
+ circle NOUN B-O
904
+ as ADP B-O
905
+ a DET B-O
906
+ function NOUN B-O
907
+ of ADP B-O
908
+ the DET B-O
909
+ competitor(s NOUN B-LF
910
+ ) PUNCT I-LF
911
+ relative ADJ I-LF
912
+ size NOUN I-LF
913
+ ( PUNCT B-O
914
+ ΔC NOUN B-AC
915
+ ) PUNCT B-O
916
+ and CCONJ B-O
917
+ of ADP B-O
918
+ the DET B-O
919
+ ΔS NOUN B-AC
920
+ — PUNCT B-O
921
+ i.e. X B-O
922
+ , PUNCT B-O
923
+ the DET B-O
924
+ difference NOUN B-O
925
+ between ADP B-O
926
+ the DET B-O
927
+ previous ADJ B-O
928
+ and CCONJ B-O
929
+ the DET B-O
930
+ current ADJ B-O
931
+ target NOUN B-O
932
+ circle NOUN B-O
933
+ ’s PART B-O
934
+ size NOUN B-O
935
+ . PUNCT B-O
936
+
937
+ The DET B-O
938
+ second ADJ B-O
939
+ group NOUN B-O
940
+ “ PUNCT B-O
941
+ Complete PROPN B-LF
942
+ Granulation PROPN I-LF
943
+ Bed PROPN I-LF
944
+ ” PUNCT B-O
945
+ ( PUNCT B-O
946
+ CGB PROPN B-AC
947
+ ) PUNCT B-O
948
+ included VERB B-O
949
+ wounds NOUN B-O
950
+ with ADP B-O
951
+ a DET B-O
952
+ complete ADJ B-LF
953
+ granulation NOUN I-LF
954
+ bed NOUN I-LF
955
+ , PUNCT B-O
956
+ or CCONJ B-O
957
+ only ADV B-O
958
+ minor ADJ B-O
959
+ clefts NOUN B-O
960
+ or CCONJ B-O
961
+ defects NOUN B-O
962
+ of ADP B-O
963
+ less ADJ B-O
964
+ than ADP B-O
965
+ 0.5 NUM B-O
966
+ cm NOUN B-O
967
+ depth NOUN B-O
968
+ . PUNCT B-O
969
+
970
+ IFOF PROPN B-AC
971
+ , PUNCT B-O
972
+ inferior ADJ B-LF
973
+ fronto ADJ I-LF
974
+ - PUNCT I-LF
975
+ occipital ADJ I-LF
976
+ fascicle NOUN I-LF
977
+ ; PUNCT B-O
978
+ ILF PROPN B-AC
979
+ , PUNCT B-O
980
+ inferior ADJ B-LF
981
+ longitudinal ADJ I-LF
982
+ fascicle NOUN I-LF
983
+ ; PUNCT B-O
984
+ ILFlat PROPN B-AC
985
+ , PUNCT B-O
986
+ inferior ADJ B-LF
987
+ longitudinal ADJ I-LF
988
+ fascicle NOUN I-LF
989
+ lateral ADJ B-O
990
+ ; PUNCT B-O
991
+ ILFmed PROPN B-AC
992
+ , PUNCT B-O
993
+ inferior ADJ B-LF
994
+ longitudinal ADJ I-LF
995
+ fascicle NOUN I-LF
996
+ medial ADJ B-O
997
+ ; PUNCT B-O
998
+ KL PROPN B-AC
999
+ , PUNCT B-O
1000
+ Kullback PROPN B-LF
1001
+ – PUNCT I-LF
1002
+ Liebler PROPN I-LF
1003
+ ; PUNCT B-O
1004
+ MdLF PROPN B-AC
1005
+ , PUNCT B-O
1006
+ middle ADJ B-LF
1007
+ longitudinal ADJ I-LF
1008
+ fascicle NOUN I-LF
1009
+ ; PUNCT B-O
1010
+ PRIME PROPN B-O
1011
+ - PUNCT B-O
1012
+ DE PROPN B-O
1013
+ , PUNCT B-O
1014
+ Primate PROPN B-O
1015
+ Data PROPN B-O
1016
+ Exchange PROPN B-O
1017
+ . PUNCT B-O
1018
+
1019
+ Abbreviations NOUN B-O
1020
+ : PUNCT B-O
1021
+ BP PROPN B-AC
1022
+ , PUNCT B-O
1023
+ blood NOUN B-LF
1024
+ pressure NOUN I-LF
1025
+ ; PUNCT B-O
1026
+ sBP NOUN B-AC
1027
+ , PUNCT B-O
1028
+ systolic ADJ B-LF
1029
+ blood NOUN I-LF
1030
+ pressure NOUN I-LF
1031
+ . PUNCT B-O
1032
+
1033
+ Integrated VERB B-O
1034
+ muscle NOUN B-O
1035
+ protein NOUN B-O
1036
+ balance NOUN B-O
1037
+ has AUX B-O
1038
+ been AUX B-O
1039
+ calculated VERB B-O
1040
+ for ADP B-O
1041
+ the DET B-O
1042
+ following VERB B-O
1043
+ periods NOUN B-O
1044
+ of ADP B-O
1045
+ time NOUN B-O
1046
+ : PUNCT B-O
1047
+ post ADJ B-LF
1048
+ absorptive ADJ I-LF
1049
+ period NOUN B-O
1050
+ ( PUNCT B-O
1051
+ PA NOUN B-AC
1052
+ ) PUNCT B-O
1053
+ ( PUNCT B-O
1054
+ 0–150min NUM B-O
1055
+ ) PUNCT B-O
1056
+ , PUNCT B-O
1057
+ early ADJ B-O
1058
+ post ADJ B-LF
1059
+ prandial ADJ I-LF
1060
+ period NOUN B-O
1061
+ ( PUNCT B-O
1062
+ PP NOUN B-AC
1063
+ ) PUNCT B-O
1064
+ ( PUNCT B-O
1065
+ 150–300min NUM B-O
1066
+ ) PUNCT B-O
1067
+ and CCONJ B-O
1068
+ late ADJ B-O
1069
+ post ADJ B-LF
1070
+ prandial ADJ I-LF
1071
+ period NOUN B-O
1072
+ ( PUNCT B-O
1073
+ PP NOUN B-AC
1074
+ ) PUNCT B-O
1075
+ ( PUNCT B-O
1076
+ 300–550min NUM B-O
1077
+ ) PUNCT B-O
1078
+ . PUNCT B-O
1079
+
1080
+ Multiple ADJ B-O
1081
+ sources NOUN B-O
1082
+ were AUX B-O
1083
+ used VERB B-O
1084
+ , PUNCT B-O
1085
+ integrating VERB B-O
1086
+ the DET B-O
1087
+ hospital NOUN B-LF
1088
+ discharge NOUN I-LF
1089
+ register NOUN I-LF
1090
+ ( PUNCT B-O
1091
+ HDR PROPN B-AC
1092
+ ) PUNCT B-O
1093
+ , PUNCT B-O
1094
+ clinical ADJ B-O
1095
+ charts NOUN B-O
1096
+ , PUNCT B-O
1097
+ spirometry NOUN B-O
1098
+ and CCONJ B-O
1099
+ the DET B-O
1100
+ cause NOUN B-LF
1101
+ - PUNCT I-LF
1102
+ specific ADJ I-LF
1103
+ mortality NOUN I-LF
1104
+ register NOUN I-LF
1105
+ ( PUNCT B-O
1106
+ CMR PROPN B-AC
1107
+ ) PUNCT B-O
1108
+ in ADP B-O
1109
+ a DET B-O
1110
+ longitudinal ADJ B-O
1111
+ algorithm NOUN B-O
1112
+ , PUNCT B-O
1113
+ to PART B-O
1114
+ reduce VERB B-O
1115
+ underestimation NOUN B-O
1116
+ of ADP B-O
1117
+ COPD PROPN B-AC
1118
+ prevalence NOUN B-O
1119
+ . PUNCT B-O
1120
+
1121
+ Unadjusted ADJ B-O
1122
+ prevalence NOUN B-LF
1123
+ risk NOUN I-LF
1124
+ ratios NOUN I-LF
1125
+ ( PUNCT B-O
1126
+ PRRs NOUN B-AC
1127
+ ) PUNCT B-O
1128
+ and CCONJ B-O
1129
+ adjusted VERB B-O
1130
+ PRRs NOUN B-AC
1131
+ ( PUNCT B-O
1132
+ adjPRRs NOUN B-AC
1133
+ ) PUNCT B-O
1134
+ of ADP B-O
1135
+ HIV PROPN B-O
1136
+ shedding NOUN B-O
1137
+ were AUX B-O
1138
+ estimated VERB B-O
1139
+ using VERB B-O
1140
+ modified VERB B-O
1141
+ Poisson PROPN B-O
1142
+ regression NOUN B-O
1143
+ with ADP B-O
1144
+ robust ADJ B-O
1145
+ variance NOUN B-O
1146
+ . PUNCT B-O
1147
+
1148
+ The DET B-O
1149
+ myocardial ADJ B-O
1150
+ extracellular ADJ B-LF
1151
+ matrix NOUN I-LF
1152
+ ( PUNCT B-O
1153
+ ECM PROPN B-AC
1154
+ ) PUNCT B-O
1155
+ is AUX B-O
1156
+ a DET B-O
1157
+ critical ADJ B-O
1158
+ component NOUN B-O
1159
+ in ADP B-O
1160
+ normal ADJ B-O
1161
+ and CCONJ B-O
1162
+ pathophysiological ADJ B-O
1163
+ conditions NOUN B-O
1164
+ of ADP B-O
1165
+ the DET B-O
1166
+ heart NOUN B-O
1167
+ , PUNCT B-O
1168
+ and CCONJ B-O
1169
+ is AUX B-O
1170
+ mainly ADV B-O
1171
+ regulated VERB B-O
1172
+ by ADP B-O
1173
+ cardiac ADJ B-O
1174
+ fibroblasts NOUN B-O
1175
+ [ PUNCT B-O
1176
+ 1 NUM B-O
1177
+ ] PUNCT B-O
1178
+ . PUNCT B-O
1179
+
1180
+ Furthermore ADV B-O
1181
+ , PUNCT B-O
1182
+ the DET B-O
1183
+ complete ADJ B-O
1184
+ lack NOUN B-O
1185
+ of ADP B-O
1186
+ access NOUN B-O
1187
+ to ADP B-O
1188
+ health NOUN B-O
1189
+ care NOUN B-O
1190
+ , PUNCT B-O
1191
+ absence NOUN B-O
1192
+ of ADP B-O
1193
+ skilled ADJ B-O
1194
+ delivery NOUN B-O
1195
+ services NOUN B-O
1196
+ , PUNCT B-O
1197
+ or CCONJ B-O
1198
+ delayed VERB B-O
1199
+ entry NOUN B-O
1200
+ into ADP B-O
1201
+ antenatal ADJ B-LF
1202
+ care NOUN I-LF
1203
+ ( PUNCT B-O
1204
+ ANC PROPN B-AC
1205
+ ) PUNCT B-O
1206
+ deprive VERB B-O
1207
+ both CCONJ B-O
1208
+ the DET B-O
1209
+ teenage ADJ B-O
1210
+ mother NOUN B-O
1211
+ and CCONJ B-O
1212
+ her PRON B-O
1213
+ offspring NOUN B-O
1214
+ of ADP B-O
1215
+ basic ADJ B-O
1216
+ health NOUN B-O
1217
+ care NOUN B-O
1218
+ services NOUN B-O
1219
+ [ PUNCT B-O
1220
+ 4 NUM B-O
1221
+ ] PUNCT B-O
1222
+ . PUNCT B-O
1223
+
1224
+ This DET B-O
1225
+ antiviral ADJ B-O
1226
+ response NOUN B-O
1227
+ is AUX B-O
1228
+ triggered VERB B-O
1229
+ by ADP B-O
1230
+ virus NOUN B-O
1231
+ - PUNCT B-O
1232
+ specific ADJ B-O
1233
+ double ADJ B-LF
1234
+ - PUNCT I-LF
1235
+ stranded ADJ I-LF
1236
+ RNA NOUN I-LF
1237
+ molecules NOUN B-O
1238
+ ( PUNCT B-O
1239
+ dsRNAs NOUN B-AC
1240
+ ) PUNCT B-O
1241
+ that PRON B-O
1242
+ are AUX B-O
1243
+ produced VERB B-O
1244
+ during ADP B-O
1245
+ infection NOUN B-O
1246
+ . PUNCT B-O
1247
+
1248
+ The DET B-O
1249
+ receiver NOUN B-LF
1250
+ operating NOUN I-LF
1251
+ characteristic NOUN I-LF
1252
+ ( PUNCT B-O
1253
+ ROC PROPN B-AC
1254
+ ) PUNCT B-O
1255
+ curves NOUN B-O
1256
+ show VERB B-O
1257
+ the DET B-O
1258
+ discrimination NOUN B-O
1259
+ of ADP B-O
1260
+ the DET B-O
1261
+ model NOUN B-O
1262
+ after ADP B-O
1263
+ including VERB B-O
1264
+ empirically ADV B-O
1265
+ diagnosed VERB B-O
1266
+ TB PROPN B-AC
1267
+ patients NOUN B-O
1268
+ in ADP B-O
1269
+ the DET B-O
1270
+ study NOUN B-O
1271
+ population NOUN B-O
1272
+ . PUNCT B-O
1273
+
1274
+ Furthermore ADV B-O
1275
+ , PUNCT B-O
1276
+ in ADP B-O
1277
+ patients NOUN B-O
1278
+ with ADP B-O
1279
+ HCV PROPN B-AC
1280
+ - ADJ B-O
1281
+ related VERB B-O
1282
+ cirrhosis NOUN B-O
1283
+ , PUNCT B-O
1284
+ the DET B-O
1285
+ primary ADJ B-O
1286
+ necro ADJ B-O
1287
+ - ADJ B-O
1288
+ inflammatory ADJ B-O
1289
+ stimulus NOUN B-O
1290
+ ( PUNCT B-O
1291
+ i.e. X B-O
1292
+ the DET B-O
1293
+ hepatitis PROPN B-LF
1294
+ C PROPN I-LF
1295
+ virus NOUN I-LF
1296
+ ) PUNCT B-O
1297
+ is AUX B-O
1298
+ still ADV B-O
1299
+ present ADJ B-O
1300
+ , PUNCT B-O
1301
+ whereas SCONJ B-O
1302
+ in ADP B-O
1303
+ ALD PROPN B-AC
1304
+ or CCONJ B-O
1305
+ NAFLD PROPN B-AC
1306
+ - ADJ B-O
1307
+ related VERB B-O
1308
+ cirrhosis NOUN B-O
1309
+ , PUNCT B-O
1310
+ the DET B-O
1311
+ primary ADJ B-O
1312
+ necro ADJ B-O
1313
+ - ADJ B-O
1314
+ inflammatory ADJ B-O
1315
+ stimulus NOUN B-O
1316
+ ( PUNCT B-O
1317
+ i.e. X B-O
1318
+ alcohol NOUN B-O
1319
+ use NOUN B-O
1320
+ in ADP B-O
1321
+ ALD PROPN B-AC
1322
+ or CCONJ B-O
1323
+ a DET B-O
1324
+ hypothesized VERB B-O
1325
+ lipotoxic ADJ B-O
1326
+ molecule NOUN B-O
1327
+ in ADP B-O
1328
+ NAFLD PROPN B-AC
1329
+ ) PUNCT B-O
1330
+ may AUX B-O
1331
+ or CCONJ B-O
1332
+ may AUX B-O
1333
+ not PART B-O
1334
+ still ADV B-O
1335
+ be AUX B-O
1336
+ present ADJ B-O
1337
+ after ADP B-O
1338
+ the DET B-O
1339
+ development NOUN B-O
1340
+ of ADP B-O
1341
+ cirrhosis NOUN B-O
1342
+ . PUNCT B-O
1343
+
1344
+ PF PROPN B-AC
1345
+ : PUNCT B-O
1346
+ Processed VERB B-LF
1347
+ foods NOUN I-LF
1348
+ , PUNCT B-O
1349
+ EAR PROPN B-AC
1350
+ : PUNCT B-O
1351
+ Estimated VERB B-LF
1352
+ average ADJ I-LF
1353
+ requirement NOUN I-LF
1354
+ , PUNCT B-O
1355
+ RNI PROPN B-AC
1356
+ : PUNCT B-O
1357
+ Recommended VERB B-LF
1358
+ nutrient NOUN I-LF
1359
+ intake NOUN I-LF
1360
+ , PUNCT B-O
1361
+ UL PROPN B-AC
1362
+ : PUNCT B-O
1363
+ Tolerable ADJ B-LF
1364
+ upper ADJ I-LF
1365
+ intake NOUN I-LF
1366
+ limit NOUN I-LF
1367
+ ; PUNCT B-O
1368
+ for ADP B-O
1369
+ iodine NOUN B-O
1370
+ . PUNCT B-O
1371
+
1372
+ To PART B-O
1373
+ measure VERB B-O
1374
+ the DET B-O
1375
+ social ADJ B-O
1376
+ deprivation NOUN B-O
1377
+ of ADP B-O
1378
+ the DET B-O
1379
+ area NOUN B-O
1380
+ of ADP B-O
1381
+ residence NOUN B-O
1382
+ we PRON B-O
1383
+ used VERB B-O
1384
+ the DET B-O
1385
+ Welsh PROPN B-LF
1386
+ Index PROPN I-LF
1387
+ of ADP I-LF
1388
+ Multiple PROPN I-LF
1389
+ Deprivation PROPN I-LF
1390
+ ( PUNCT B-O
1391
+ WIMD PROPN B-AC
1392
+ ) PUNCT B-O
1393
+ 2005 NUM B-O
1394
+ at ADP B-O
1395
+ lower ADJ B-LF
1396
+ super ADJ I-LF
1397
+ output NOUN I-LF
1398
+ area NOUN I-LF
1399
+ ( PUNCT B-O
1400
+ LSOA PROPN B-AC
1401
+ ) PUNCT B-O
1402
+ level NOUN B-O
1403
+ , PUNCT B-O
1404
+ equivalent ADJ B-O
1405
+ to ADP B-O
1406
+ a DET B-O
1407
+ postcode NOUN B-O
1408
+ area NOUN B-O
1409
+ with ADP B-O
1410
+ a DET B-O
1411
+ minimum NOUN B-O
1412
+ of ADP B-O
1413
+ 1000 NUM B-O
1414
+ houses NOUN B-O
1415
+ and CCONJ B-O
1416
+ mean ADJ B-O
1417
+ 1500 NUM B-O
1418
+ houses NOUN B-O
1419
+ [ PUNCT B-O
1420
+ 29 NUM B-O
1421
+ ] PUNCT B-O
1422
+ . PUNCT B-O
1423
+
1424
+ Arp2/3 NOUN B-AC
1425
+ , PUNCT B-O
1426
+ actin NOUN B-LF
1427
+ - PUNCT I-LF
1428
+ related VERB I-LF
1429
+ protein NOUN I-LF
1430
+ 2/3 NUM I-LF
1431
+ ; PUNCT B-O
1432
+ CK-666 NOUN B-AC
1433
+ , PUNCT B-O
1434
+ Arp2/3 NOUN B-LF
1435
+ complex NOUN I-LF
1436
+ inhibitor NOUN I-LF
1437
+ I NUM I-LF
1438
+ ; PUNCT B-O
1439
+ WASp PROPN B-AC
1440
+ , PUNCT B-O
1441
+ Wiskott PROPN B-LF
1442
+ – PUNCT I-LF
1443
+ Aldrich PROPN I-LF
1444
+ syndrome PROPN I-LF
1445
+ protein NOUN I-LF
1446
+ . PUNCT B-O
1447
+
1448
+ GA PROPN B-AC
1449
+ = PUNCT B-O
1450
+ general ADJ B-LF
1451
+ anaesthesia NOUN I-LF
1452
+ ; PUNCT B-O
1453
+ MACCE PROPN B-AC
1454
+ = PUNCT B-O
1455
+ major ADJ B-O
1456
+ cardiac ADJ B-O
1457
+ and CCONJ B-O
1458
+ cerebrovascular ADJ B-O
1459
+ events NOUN B-O
1460
+
1461
+ In ADP B-O
1462
+ response NOUN B-O
1463
+ to PART B-O
1464
+ these DET B-O
1465
+ concerns NOUN B-O
1466
+ , PUNCT B-O
1467
+ in ADP B-O
1468
+ 2011 NUM B-O
1469
+ , PUNCT B-O
1470
+ an DET B-O
1471
+ Indian ADJ B-O
1472
+ parliamentary ADJ B-O
1473
+ standing NOUN B-O
1474
+ committee NOUN B-O
1475
+ closely ADV B-O
1476
+ examined VERB B-O
1477
+ the DET B-O
1478
+ Indian ADJ B-O
1479
+ national ADJ B-O
1480
+ drug NOUN B-O
1481
+ regulator NOUN B-O
1482
+ — PUNCT B-O
1483
+ the DET B-O
1484
+ Central PROPN B-O
1485
+ Drugs PROPN B-O
1486
+ Standard PROPN B-O
1487
+ Control PROPN B-O
1488
+ Organization PROPN B-O
1489
+ ( PUNCT B-O
1490
+ CDSCO PROPN B-AC
1491
+ ) PUNCT B-O
1492
+ . PUNCT B-O
1493
+ The DET B-O
1494
+ committee NOUN B-O
1495
+ ’s PART B-O
1496
+ report NOUN B-O
1497
+ , PUNCT B-O
1498
+ released VERB B-O
1499
+ in ADP B-O
1500
+ 2012 NUM B-O
1501
+ , PUNCT B-O
1502
+ highlighted VERB B-O
1503
+ multiple ADJ B-O
1504
+ deficiencies NOUN B-O
1505
+ in ADP B-O
1506
+ the DET B-O
1507
+ approval NOUN B-O
1508
+ processes NOUN B-O
1509
+ of ADP B-O
1510
+ the DET B-O
1511
+ CDSCO PROPN B-AC
1512
+ , PUNCT B-O
1513
+ including VERB B-O
1514
+ a DET B-O
1515
+ failure NOUN B-O
1516
+ to PART B-O
1517
+ test VERB B-O
1518
+ the DET B-O
1519
+ efficacy NOUN B-O
1520
+ and CCONJ B-O
1521
+ safety NOUN B-O
1522
+ of ADP B-O
1523
+ many ADJ B-O
1524
+ of ADP B-O
1525
+ the DET B-O
1526
+ FDCs NOUN B-AC
1527
+ available ADJ B-O
1528
+ in ADP B-O
1529
+ India PROPN B-O
1530
+ , PUNCT B-O
1531
+ but CCONJ B-O
1532
+ provided VERB B-O
1533
+ no DET B-O
1534
+ systematic ADJ B-O
1535
+ evidence NOUN B-O
1536
+ to PART B-O
1537
+ support VERB B-O
1538
+ its PRON B-O
1539
+ concerns NOUN B-O
1540
+ about ADP B-O
1541
+ FDCs NOUN B-AC
1542
+ . PUNCT B-O
1543
+ Here ADV B-O
1544
+ , PUNCT B-O
1545
+ the DET B-O
1546
+ researchers NOUN B-O
1547
+ undertake VERB B-O
1548
+ a DET B-O
1549
+ time NOUN B-O
1550
+ - ADJ B-O
1551
+ trend NOUN B-O
1552
+ analysis NOUN B-O
1553
+ of ADP B-O
1554
+ the DET B-O
1555
+ sales NOUN B-O
1556
+ volumes NOUN B-O
1557
+ of ADP B-O
1558
+ oral ADJ B-O
1559
+ FDCs NOUN B-AC
1560
+ for ADP B-O
1561
+ pain NOUN B-O
1562
+ relief NOUN B-O
1563
+ ( PUNCT B-O
1564
+ analgesia NOUN B-O
1565
+ ; PUNCT B-O
1566
+ formulations NOUN B-O
1567
+ of ADP B-O
1568
+ non ADJ B-LF
1569
+ - ADJ I-LF
1570
+ steroidal ADJ I-LF
1571
+ anti ADJ I-LF
1572
+ - ADJ I-LF
1573
+ inflammatory ADJ I-LF
1574
+ drugs NOUN I-LF
1575
+ , PUNCT B-O
1576
+ NSAIDs PROPN B-AC
1577
+ ) PUNCT B-O
1578
+ , PUNCT B-O
1579
+ diabetes NOUN B-O
1580
+ ( PUNCT B-O
1581
+ metformin NOUN B-O
1582
+ formulations NOUN B-O
1583
+ ) PUNCT B-O
1584
+ , PUNCT B-O
1585
+ depression NOUN B-O
1586
+ / SYM B-O
1587
+ anxiety NOUN B-O
1588
+ ( PUNCT B-O
1589
+ anti ADJ B-O
1590
+ - ADJ B-O
1591
+ depressant ADJ B-O
1592
+ / SYM B-O
1593
+ benzodiazepine NOUN B-O
1594
+ formulations NOUN B-O
1595
+ ) PUNCT B-O
1596
+ , PUNCT B-O
1597
+ and CCONJ B-O
1598
+ psychosis NOUN B-O
1599
+ ( PUNCT B-O
1600
+ anti ADJ B-O
1601
+ - ADJ B-O
1602
+ psychotic ADJ B-O
1603
+ formulations NOUN B-O
1604
+ ) PUNCT B-O
1605
+ in ADP B-O
1606
+ India PROPN B-O
1607
+ between ADP B-O
1608
+ 2007 NUM B-O
1609
+ and CCONJ B-O
1610
+ 2012 NUM B-O
1611
+ . PUNCT B-O
1612
+
1613
+ QEESI PROPN B-AC
1614
+ consisted VERB B-O
1615
+ of ADP B-O
1616
+ five NUM B-O
1617
+ subscales NOUN B-O
1618
+ , PUNCT B-O
1619
+ each PRON B-O
1620
+ with ADP B-O
1621
+ 10 NUM B-O
1622
+ items NOUN B-O
1623
+ , PUNCT B-O
1624
+ which PRON B-O
1625
+ in ADP B-O
1626
+ total NOUN B-O
1627
+ consisted VERB B-O
1628
+ of ADP B-O
1629
+ 50 NUM B-O
1630
+ items NOUN B-O
1631
+ : PUNCT B-O
1632
+ Q1 NOUN B-AC
1633
+ Chemical NOUN B-LF
1634
+ Intolerances NOUN I-LF
1635
+ , PUNCT B-O
1636
+ Q2 PROPN B-AC
1637
+ Other ADJ B-LF
1638
+ Intolerances NOUN I-LF
1639
+ , PUNCT B-O
1640
+ Q3 PROPN B-AC
1641
+ Symptom NOUN B-LF
1642
+ Severity PROPN I-LF
1643
+ , PUNCT B-O
1644
+ Q4 PROPN B-O
1645
+ Masking NOUN B-O
1646
+ Index PROPN B-O
1647
+ , PUNCT B-O
1648
+ and CCONJ B-O
1649
+ Q5 PROPN B-AC
1650
+ Life NOUN B-LF
1651
+ Impacts NOUN I-LF
1652
+ . PUNCT B-O
1653
+
1654
+ DD PROPN B-AC
1655
+ , PUNCT B-O
1656
+ constant ADJ B-LF
1657
+ darkness NOUN I-LF
1658
+ ; PUNCT B-O
1659
+ GI PROPN B-AC
1660
+ , PUNCT B-O
1661
+ GIGANTEA PROPN B-LF
1662
+ ; PUNCT B-O
1663
+ LUC PROPN B-AC
1664
+ , PUNCT B-O
1665
+ LUCIFERASE PROPN B-LF
1666
+ . PUNCT B-O
1667
+
1668
+ After ADP B-O
1669
+ 28 NUM B-O
1670
+ days NOUN B-O
1671
+ of ADP B-O
1672
+ treatment NOUN B-O
1673
+ , PUNCT B-O
1674
+ both CCONJ B-O
1675
+ the DET B-O
1676
+ low ADJ B-O
1677
+ ( PUNCT B-O
1678
+ 15 NUM B-O
1679
+ mg NOUN B-O
1680
+ / SYM B-O
1681
+ kg NOUN B-O
1682
+ b.w NOUN B-O
1683
+ . PUNCT B-O
1684
+ ) PUNCT B-O
1685
+ and CCONJ B-O
1686
+ medium ADJ B-O
1687
+ dose NOUN B-O
1688
+ ( PUNCT B-O
1689
+ 75 NUM B-O
1690
+ mg NOUN B-O
1691
+ / SYM B-O
1692
+ kg NOUN B-O
1693
+ b.w NOUN B-O
1694
+ . PUNCT B-O
1695
+ ) PUNCT B-O
1696
+ of ADP B-O
1697
+ SSJ PROPN B-AC
1698
+ prevented VERB B-O
1699
+ BW NOUN B-AC
1700
+ gain NOUN B-O
1701
+ but CCONJ B-O
1702
+ is AUX B-O
1703
+ more ADV B-O
1704
+ significant ADJ B-O
1705
+ with ADP B-O
1706
+ the DET B-O
1707
+ one NUM B-O
1708
+ dose NOUN B-O
1709
+ , PUNCT B-O
1710
+ leading VERB B-O
1711
+ to ADP B-O
1712
+ a DET B-O
1713
+ loss NOUN B-O
1714
+ of ADP B-O
1715
+ almost ADV B-O
1716
+ 5 NUM B-O
1717
+ g NOUN B-O
1718
+ in ADP B-O
1719
+ body NOUN B-LF
1720
+ weight NOUN I-LF
1721
+ ( PUNCT B-O
1722
+ P<0.01 NUM B-O
1723
+ ) PUNCT B-O
1724
+ compared VERB B-O
1725
+ to ADP B-O
1726
+ an DET B-O
1727
+ average NOUN B-O
1728
+ of ADP B-O
1729
+ 14.7 NUM B-O
1730
+ g NOUN B-O
1731
+ gained VERB B-O
1732
+ by ADP B-O
1733
+ the DET B-O
1734
+ HFD PROPN B-AC
1735
+ group NOUN B-O
1736
+ . PUNCT B-O
1737
+
1738
+ A DET B-O
1739
+ new ADJ B-O
1740
+ recently ADV B-O
1741
+ introduced VERB B-O
1742
+ anthropometric ADJ B-O
1743
+ measure NOUN B-O
1744
+ , PUNCT B-O
1745
+ named VERB B-O
1746
+ body NOUN B-LF
1747
+ shape NOUN I-LF
1748
+ index NOUN I-LF
1749
+ ( PUNCT B-O
1750
+ ABSI PROPN B-AC
1751
+ ) PUNCT B-O
1752
+ , PUNCT B-O
1753
+ appears VERB B-O
1754
+ to PART B-O
1755
+ be AUX B-O
1756
+ a DET B-O
1757
+ substantial ADJ B-O
1758
+ risk NOUN B-O
1759
+ factor NOUN B-O
1760
+ for ADP B-O
1761
+ premature ADJ B-O
1762
+ mortality NOUN B-O
1763
+ in ADP B-O
1764
+ the DET B-O
1765
+ general ADJ B-O
1766
+ population NOUN B-O
1767
+ [ PUNCT B-O
1768
+ 8 NUM B-O
1769
+ ] PUNCT B-O
1770
+ . PUNCT B-O
1771
+
1772
+ OPC PROPN B-AC
1773
+ , PUNCT B-O
1774
+ oligodendrocyte NOUN B-LF
1775
+ precursor NOUN I-LF
1776
+ cell NOUN I-LF
1777
+ ; PUNCT B-O
1778
+ UMAP PROPN B-AC
1779
+ , PUNCT B-O
1780
+ Uniform PROPN B-LF
1781
+ Manifold PROPN I-LF
1782
+ Approximation PROPN I-LF
1783
+ and CCONJ I-LF
1784
+ Projection PROPN I-LF
1785
+ . PUNCT B-O
1786
+
1787
+ Electrophysiological ADJ B-O
1788
+ methods NOUN B-O
1789
+ , PUNCT B-O
1790
+ like ADP B-O
1791
+ intracranially ADV B-O
1792
+ recorded VERB B-O
1793
+ electroencephalography NOUN B-LF
1794
+ ( PUNCT B-O
1795
+ EEG NOUN B-AC
1796
+ ) PUNCT B-O
1797
+ or CCONJ B-O
1798
+ EEG NOUN B-AC
1799
+ / SYM B-O
1800
+ magnetoencephalography NOUN B-LF
1801
+ ( PUNCT B-O
1802
+ MEG PROPN B-AC
1803
+ ) PUNCT B-O
1804
+ , PUNCT B-O
1805
+ are AUX B-O
1806
+ particularly ADV B-O
1807
+ promising ADJ B-O
1808
+ to PART B-O
1809
+ offer VERB B-O
1810
+ a DET B-O
1811
+ mechanistic ADJ B-O
1812
+ understanding NOUN B-O
1813
+ of ADP B-O
1814
+ memory NOUN B-O
1815
+ formation NOUN B-O
1816
+ processes NOUN B-O
1817
+ . PUNCT B-O
1818
+
1819
+ Patient NOUN B-O
1820
+ ( PUNCT B-O
1821
+ P NOUN B-O
1822
+ ) PUNCT B-O
1823
+ , PUNCT B-O
1824
+ Deletion NOUN B-LF
1825
+ of ADP I-LF
1826
+ exon NOUN I-LF
1827
+ 3 NUM I-LF
1828
+ of ADP B-O
1829
+ IL10RB PROPN B-O
1830
+ ( PUNCT B-O
1831
+ delE3 NOUN B-AC
1832
+ ) PUNCT B-O
1833
+ , PUNCT B-O
1834
+ duplication NOUN B-O
1835
+ of ADP B-O
1836
+ exon NOUN B-O
1837
+ 6 NUM B-O
1838
+ ( PUNCT B-O
1839
+ duplE6 NOUN B-O
1840
+ ) PUNCT B-O
1841
+ , PUNCT B-O
1842
+ and CCONJ B-O
1843
+ wild ADJ B-O
1844
+ type NOUN B-O
1845
+ allele NOUN B-O
1846
+ ( PUNCT B-O
1847
+ WT NOUN B-O
1848
+ ) PUNCT B-O
1849
+ . PUNCT B-O
1850
+ Allele PROPN B-O
1851
+ 1 NUM B-O
1852
+ ; PUNCT B-O
1853
+ maternal ADJ B-O
1854
+ allele NOUN B-O
1855
+ , PUNCT B-O
1856
+ Allele PROPN B-O
1857
+ 2 NUM B-O
1858
+ , PUNCT B-O
1859
+ paternal ADJ B-O
1860
+ allele NOUN B-O
1861
+ ( PUNCT B-O
1862
+ see VERB B-O
1863
+ S2 PROPN B-O
1864
+ Fig PROPN B-O
1865
+ ) PUNCT B-O
1866
+ . PUNCT B-O
1867
+
1868
+ Abbreviations NOUN B-O
1869
+ : PUNCT B-O
1870
+ HOMA PROPN B-AC
1871
+ - PUNCT B-AC
1872
+ IR PROPN B-AC
1873
+ , PUNCT B-O
1874
+ HOMA PROPN B-O
1875
+ Insulin PROPN B-LF
1876
+ Resistance PROPN I-LF
1877
+ Index PROPN B-O
1878
+ ; PUNCT B-O
1879
+ ESS PROPN B-AC
1880
+ , PUNCT B-O
1881
+ Epworth PROPN B-LF
1882
+ Sleepiness PROPN I-LF
1883
+ Scale PROPN I-LF
1884
+ ; PUNCT B-O
1885
+ MSLT PROPN B-AC
1886
+ , PUNCT B-O
1887
+ multiple ADJ B-O
1888
+ sleep NOUN B-O
1889
+ latency NOUN B-O
1890
+ test NOUN B-O
1891
+ ; PUNCT B-O
1892
+ TST PROPN B-AC
1893
+ , PUNCT B-O
1894
+ total ADJ B-LF
1895
+ sleep NOUN I-LF
1896
+ time NOUN I-LF
1897
+ ; PUNCT B-O
1898
+ SOL PROPN B-AC
1899
+ , PUNCT B-O
1900
+ sleep NOUN B-LF
1901
+ onset NOUN I-LF
1902
+ latency NOUN I-LF
1903
+ ; PUNCT B-O
1904
+ WASO PROPN B-AC
1905
+ , PUNCT B-O
1906
+ waking VERB B-LF
1907
+ after ADP I-LF
1908
+ sleep NOUN I-LF
1909
+ onset NOUN I-LF
1910
+ ; PUNCT B-O
1911
+ REM PROPN B-AC
1912
+ , PUNCT B-O
1913
+ rapid ADJ B-LF
1914
+ eyes NOUN I-LF
1915
+ movement NOUN I-LF
1916
+ ; PUNCT B-O
1917
+ AHI PROPN B-AC
1918
+ , PUNCT B-O
1919
+ apnea NOUN B-O
1920
+ - PUNCT B-O
1921
+ hypopnea NOUN B-O
1922
+ index NOUN B-O
1923
+ . PUNCT B-O
1924
+
1925
+ In ADP B-O
1926
+ this DET B-O
1927
+ study NOUN B-O
1928
+ , PUNCT B-O
1929
+ the DET B-LF
1930
+ peel NOUN I-LF
1931
+ of ADP I-LF
1932
+ green ADJ I-LF
1933
+ fruit NOUN I-LF
1934
+ ( PUNCT B-O
1935
+ GFP PROPN B-AC
1936
+ ) PUNCT B-O
1937
+ , PUNCT B-O
1938
+ the DET B-LF
1939
+ sarcocarp NOUN I-LF
1940
+ of ADP I-LF
1941
+ green ADJ I-LF
1942
+ fruit NOUN I-LF
1943
+ ( PUNCT B-O
1944
+ GFS PROPN B-AC
1945
+ ) PUNCT B-O
1946
+ , PUNCT B-O
1947
+ the DET B-LF
1948
+ peel NOUN I-LF
1949
+ of ADP I-LF
1950
+ red ADJ I-LF
1951
+ fruit NOUN I-LF
1952
+ ( PUNCT B-O
1953
+ FP PROPN B-AC
1954
+ ) PUNCT B-O
1955
+ and CCONJ B-O
1956
+ the DET B-LF
1957
+ sarcocarp NOUN I-LF
1958
+ of ADP I-LF
1959
+ red ADJ I-LF
1960
+ fruit NOUN I-LF
1961
+ ( PUNCT B-O
1962
+ FS PROPN B-AC
1963
+ ) PUNCT B-O
1964
+ of ADP B-O
1965
+ G. PROPN B-O
1966
+ jasminoides NOUN B-O
1967
+ were AUX B-O
1968
+ used VERB B-O
1969
+ for ADP B-O
1970
+ transcriptome NOUN B-O
1971
+ sequencing NOUN B-O
1972
+ . PUNCT B-O
1973
+
1974
+ Studies NOUN B-O
1975
+ show VERB B-O
1976
+ that SCONJ B-O
1977
+ in ADP B-O
1978
+ chronic ADJ B-O
1979
+ liver NOUN B-O
1980
+ disease NOUN B-O
1981
+ , PUNCT B-O
1982
+ proinflammatory ADJ B-O
1983
+ cytokines NOUN B-O
1984
+ such ADJ B-O
1985
+ as ADP B-O
1986
+ TNF PROPN B-AC
1987
+ - PUNCT B-AC
1988
+ α NOUN B-AC
1989
+ , PUNCT B-O
1990
+ IL-1β NOUN B-O
1991
+ and CCONJ B-O
1992
+ PDGF PROPN B-AC
1993
+ ( PUNCT B-O
1994
+ platelet NOUN B-LF
1995
+ - PUNCT I-LF
1996
+ derived VERB I-LF
1997
+ growth NOUN I-LF
1998
+ factor NOUN I-LF
1999
+ ) PUNCT B-O
2000
+ stimulate VERB B-O
2001
+ the DET B-O
2002
+ secretion NOUN B-O
2003
+ of ADP B-O
2004
+ SDF-1 NOUN B-AC
2005
+ by ADP B-O
2006
+ hepatocytes NOUN B-O
2007
+ in ADP B-O
2008
+ the DET B-O
2009
+ tissue NOUN B-O
2010
+ [ PUNCT B-O
2011
+ 20,21 NUM B-O
2012
+ ] PUNCT B-O
2013
+ . PUNCT B-O
2014
+
2015
+ Atomic ADJ B-O
2016
+ coordinates NOUN B-O
2017
+ and CCONJ B-O
2018
+ structure NOUN B-O
2019
+ factors NOUN B-O
2020
+ were AUX B-O
2021
+ deposited VERB B-O
2022
+ in ADP B-O
2023
+ the DET B-O
2024
+ Protein PROPN B-LF
2025
+ Data PROPN I-LF
2026
+ Bank PROPN I-LF
2027
+ under ADP B-O
2028
+ PDB PROPN B-AC
2029
+ i NOUN B-O
2030
+ d NOUN B-O
2031
+ code NOUN B-O
2032
+ 5HSA NOUN B-O
2033
+ . PUNCT B-O
2034
+
2035
+ The DET B-O
2036
+ RNA NOUN B-O
2037
+ mimic NOUN B-O
2038
+ we PRON B-O
2039
+ utilized VERB B-O
2040
+ comprises VERB B-O
2041
+ the DET B-O
2042
+ ITS1 PROPN B-O
2043
+ sequence NOUN B-O
2044
+ , PUNCT B-O
2045
+ which PRON B-O
2046
+ forms VERB B-O
2047
+ the DET B-O
2048
+ main ADJ B-O
2049
+ binding VERB B-O
2050
+ site NOUN B-O
2051
+ between ADP B-O
2052
+ Rrp5 NOUN B-O
2053
+ and CCONJ B-O
2054
+ preribosomes NOUN B-O
2055
+ ( PUNCT B-O
2056
+ S1B PROPN B-O
2057
+ Fig PROPN B-O
2058
+ , PUNCT B-O
2059
+ [ NUM B-O
2060
+ 12,13 NUM B-O
2061
+ ] PUNCT B-O
2062
+ ) PUNCT B-O
2063
+ . PUNCT B-O
2064
+ 3 NUM B-AC
2065
+ - PUNCT B-AC
2066
+ D NOUN B-AC
2067
+ reconstruction NOUN B-O
2068
+ of ADP B-O
2069
+ the DET B-O
2070
+ density NOUN B-O
2071
+ observed VERB B-O
2072
+ for ADP B-O
2073
+ the DET B-O
2074
+ complex NOUN B-O
2075
+ between ADP B-O
2076
+ Rrp5 NOUN B-O
2077
+ and CCONJ B-O
2078
+ RNA NOUN B-O
2079
+ ( PUNCT B-O
2080
+ Rrp5•RNA NOUN B-AC
2081
+ ) PUNCT B-O
2082
+ ( PUNCT B-O
2083
+ EM PROPN B-AC
2084
+ Database PROPN B-O
2085
+ code NOUN B-O
2086
+ 6655 NUM B-O
2087
+ ) PUNCT B-O
2088
+ shows VERB B-O
2089
+ an DET B-O
2090
+ elongated ADJ B-O
2091
+ molecule NOUN B-O
2092
+ with ADP B-O
2093
+ a DET B-O
2094
+ round ADJ B-O
2095
+ , PUNCT B-O
2096
+ hollow ADJ B-O
2097
+ fist NOUN B-O
2098
+ - PUNCT B-O
2099
+ like ADJ B-O
2100
+ base NOUN B-O
2101
+ and CCONJ B-O
2102
+ a DET B-O
2103
+ slender ADJ B-O
2104
+ thumb NOUN B-O
2105
+ - PUNCT B-O
2106
+ like ADJ B-O
2107
+ projection NOUN B-O
2108
+ ( PUNCT B-O
2109
+ Fig PROPN B-O
2110
+ 4B NUM B-O
2111
+ ) PUNCT B-O
2112
+ . PUNCT B-O
2113
+ 2 NUM B-AC
2114
+ - PUNCT B-AC
2115
+ D NOUN B-AC
2116
+ alignment NOUN B-O
2117
+ and CCONJ B-O
2118
+ classification NOUN B-O
2119
+ and CCONJ B-O
2120
+ 3 NUM B-AC
2121
+ - PUNCT B-AC
2122
+ D NOUN B-AC
2123
+ analysis NOUN B-O
2124
+ by ADP B-O
2125
+ random ADJ B-LF
2126
+ conical ADJ I-LF
2127
+ tilt NOUN I-LF
2128
+ ( PUNCT B-O
2129
+ RCT PROPN B-AC
2130
+ ) PUNCT B-O
2131
+ confirm VERB B-O
2132
+ this DET B-O
2133
+ assessment NOUN B-O
2134
+ ( PUNCT B-O
2135
+ S5 PROPN B-O
2136
+ Fig PROPN B-O
2137
+ ) PUNCT B-O
2138
+ . PUNCT B-O
2139
+
2140
+ At ADP B-O
2141
+ 24 NUM B-O
2142
+ hpi NOUN B-AC
2143
+ , PUNCT B-O
2144
+ we PRON B-O
2145
+ euthanized VERB B-O
2146
+ embryos NOUN B-O
2147
+ and CCONJ B-O
2148
+ determined VERB B-O
2149
+ bacterial ADJ B-O
2150
+ burden NOUN B-O
2151
+ ( PUNCT B-O
2152
+ colony NOUN B-LF
2153
+ - PUNCT I-LF
2154
+ forming VERB I-LF
2155
+ units NOUN I-LF
2156
+ [ PUNCT B-O
2157
+ CFU PROPN B-AC
2158
+ ] PUNCT B-O
2159
+ ) PUNCT B-O
2160
+ in ADP B-O
2161
+ whole ADJ B-O
2162
+ fish NOUN B-O
2163
+ . PUNCT B-O
2164
+
2165
+ In ADP B-O
2166
+ our PRON B-O
2167
+ expedition NOUN B-O
2168
+ to ADP B-O
2169
+ characterize VERB B-O
2170
+ membrane NOUN B-O
2171
+ biogenesis NOUN B-O
2172
+ in ADP B-O
2173
+ T. PROPN B-O
2174
+ gondii PROPN B-O
2175
+ , PUNCT B-O
2176
+ we PRON B-O
2177
+ fractionated VERB B-O
2178
+ the DET B-O
2179
+ parasite NOUN B-O
2180
+ lipids NOUN B-O
2181
+ by ADP B-O
2182
+ high ADJ B-O
2183
+ - PUNCT B-O
2184
+ performance NOUN B-O
2185
+ liquid NOUN B-O
2186
+ chromatography NOUN B-O
2187
+ ( PUNCT B-O
2188
+ HPLC PROPN B-AC
2189
+ ) PUNCT B-O
2190
+ and CCONJ B-O
2191
+ observed VERB B-O
2192
+ a DET B-O
2193
+ major ADJ B-O
2194
+ lipid NOUN B-O
2195
+ peak NOUN B-O
2196
+ X1 NUM B-O
2197
+ eluting VERB B-O
2198
+ next ADV B-O
2199
+ to ADP B-O
2200
+ PtdSer PROPN B-AC
2201
+ ( PUNCT B-O
2202
+ Fig PROPN B-O
2203
+ 1A NUM B-O
2204
+ ) PUNCT B-O
2205
+ . PUNCT B-O
2206
+ Other ADJ B-O
2207
+ major ADJ B-O
2208
+ lipids NOUN B-O
2209
+ were AUX B-O
2210
+ PtdCho PROPN B-AC
2211
+ , PUNCT B-O
2212
+ PtdEtn PROPN B-AC
2213
+ , PUNCT B-O
2214
+ PtdIns PROPN B-AC
2215
+ , PUNCT B-O
2216
+ PtdSer PROPN B-AC
2217
+ , PUNCT B-O
2218
+ and CCONJ B-O
2219
+ phosphoethanolamine NOUN B-LF
2220
+ - PUNCT I-LF
2221
+ ceramide NOUN I-LF
2222
+ ( PUNCT B-O
2223
+ PEtn PROPN B-AC
2224
+ - PUNCT B-AC
2225
+ Cer PROPN B-AC
2226
+ ) PUNCT B-O
2227
+ , PUNCT B-O
2228
+ confirming VERB B-O
2229
+ previous ADJ B-O
2230
+ reports NOUN B-O
2231
+ [ X B-O
2232
+ 5,7 NUM B-O
2233
+ ] PUNCT B-O
2234
+ . PUNCT B-O
2235
+
2236
+ The DET B-O
2237
+ first ADJ B-O
2238
+ layer NOUN B-O
2239
+ line NOUN B-O
2240
+ indicates VERB B-O
2241
+ the DET B-O
2242
+ 111 NUM B-O
2243
+ - PUNCT B-O
2244
+ Å NOUN B-O
2245
+ helical ADJ B-O
2246
+ pitch NOUN B-O
2247
+ of ADP B-O
2248
+ the DET B-O
2249
+ WT PROPN B-AC
2250
+ - PUNCT B-AC
2251
+ M1 PROPN B-AC
2252
+ oligomer NOUN B-O
2253
+ . PUNCT B-O
2254
+ ( PUNCT B-O
2255
+ C NOUN B-O
2256
+ ) PUNCT B-O
2257
+ 2D ADJ B-O
2258
+ class NOUN B-O
2259
+ averages NOUN B-O
2260
+ that PRON B-O
2261
+ focus VERB B-O
2262
+ on ADP B-O
2263
+ the DET B-O
2264
+ center NOUN B-O
2265
+ of ADP B-O
2266
+ the DET B-O
2267
+ helical ADJ B-O
2268
+ segments NOUN B-O
2269
+ show VERB B-O
2270
+ large ADJ B-O
2271
+ heterogeneity NOUN B-O
2272
+ of ADP B-O
2273
+ additional ADJ B-O
2274
+ density NOUN B-O
2275
+ on ADP B-O
2276
+ either DET B-O
2277
+ side NOUN B-O
2278
+ of ADP B-O
2279
+ the DET B-O
2280
+ outer ADJ B-O
2281
+ layer NOUN B-O
2282
+ of ADP B-O
2283
+ the DET B-O
2284
+ filament NOUN B-O
2285
+ . PUNCT B-O
2286
+ cryo ADJ B-AC
2287
+ - PUNCT B-AC
2288
+ EM PROPN B-AC
2289
+ , PUNCT B-O
2290
+ cryo ADJ B-LF
2291
+ - PUNCT I-LF
2292
+ electron NOUN I-LF
2293
+ microscopy NOUN I-LF
2294
+ ; PUNCT B-O
2295
+ M1 PROPN B-AC
2296
+ , PUNCT B-O
2297
+ matrix NOUN B-LF
2298
+ protein NOUN I-LF
2299
+ 1 NUM I-LF
2300
+ ; PUNCT B-O
2301
+ WT PROPN B-AC
2302
+ - PUNCT B-AC
2303
+ M1 PROPN B-AC
2304
+ , PUNCT B-O
2305
+ full ADJ B-LF
2306
+ - PUNCT I-LF
2307
+ length NOUN I-LF
2308
+ PR8 PROPN I-LF
2309
+ M1 PROPN I-LF
2310
+ . PUNCT B-O
2311
+
2312
+ HP PROPN B-AC
2313
+ , PUNCT B-O
2314
+ hippocampus NOUN B-LF
2315
+ ; PUNCT B-O
2316
+ LEC PROPN B-AC
2317
+ , PUNCT B-O
2318
+ lateral ADJ B-LF
2319
+ entorhinal ADJ I-LF
2320
+ cortex NOUN I-LF
2321
+ ; PUNCT B-O
2322
+ MTC PROPN B-AC
2323
+ , PUNCT B-O
2324
+ mitral ADJ B-LF
2325
+ and CCONJ I-LF
2326
+ tufted ADJ I-LF
2327
+ cell NOUN I-LF
2328
+ ; PUNCT B-O
2329
+ OB PROPN B-AC
2330
+ , PUNCT B-O
2331
+ olfactory ADJ B-LF
2332
+ bulb NOUN I-LF
2333
+ ; PUNCT B-O
2334
+ PFC PROPN B-AC
2335
+ , PUNCT B-O
2336
+ prefrontal ADJ B-LF
2337
+ cortex NOUN I-LF
2338
+ ; PUNCT B-O
2339
+ RR NOUN B-AC
2340
+ , PUNCT B-O
2341
+ respiration NOUN B-LF
2342
+ - PUNCT I-LF
2343
+ related VERB I-LF
2344
+ rhythm NOUN I-LF
2345
+ . PUNCT B-O
2346
+
2347
+ The DET B-O
2348
+ histone NOUN B-LF
2349
+ deacetylase NOUN I-LF
2350
+ 1 NUM I-LF
2351
+ ( PUNCT B-O
2352
+ HDAC1 NOUN B-AC
2353
+ ) PUNCT B-O
2354
+ was AUX B-O
2355
+ used VERB B-O
2356
+ as ADP B-O
2357
+ a DET B-O
2358
+ loading NOUN B-O
2359
+ control NOUN B-O
2360
+ . PUNCT B-O
2361
+
2362
+ In ADP B-O
2363
+ the DET B-O
2364
+ models NOUN B-O
2365
+ presented VERB B-O
2366
+ here ADV B-O
2367
+ , PUNCT B-O
2368
+ weight NOUN B-LF
2369
+ - PUNCT I-LF
2370
+ for ADP I-LF
2371
+ - PUNCT I-LF
2372
+ length NOUN I-LF
2373
+ - PUNCT I-LF
2374
+ z NOUN I-LF
2375
+ - PUNCT I-LF
2376
+ scores NOUN I-LF
2377
+ ( PUNCT B-O
2378
+ WLZs NOUN B-AC
2379
+ ) PUNCT B-O
2380
+ were AUX B-O
2381
+ used VERB B-O
2382
+ . PUNCT B-O
2383
+
2384
+ In ADP B-O
2385
+ order NOUN B-O
2386
+ to PART B-O
2387
+ identify VERB B-O
2388
+ essential ADJ B-O
2389
+ genes NOUN B-O
2390
+ on ADP B-O
2391
+ the DET B-O
2392
+ X NOUN B-O
2393
+ chromosome NOUN B-O
2394
+ that PRON B-O
2395
+ are AUX B-O
2396
+ involved ADJ B-O
2397
+ in ADP B-O
2398
+ neuronal ADJ B-O
2399
+ homeostasis NOUN B-O
2400
+ , PUNCT B-O
2401
+ we PRON B-O
2402
+ performed VERB B-O
2403
+ a DET B-O
2404
+ forward ADJ B-O
2405
+ genetic ADJ B-O
2406
+ screen NOUN B-O
2407
+ using VERB B-O
2408
+ ethyl NOUN B-LF
2409
+ methanesulfonate NOUN I-LF
2410
+ ( PUNCT B-O
2411
+ EMS PROPN B-AC
2412
+ ) PUNCT B-O
2413
+ . PUNCT B-O
2414
+ We PRON B-O
2415
+ used VERB B-O
2416
+ the DET B-O
2417
+ FLP PROPN B-O
2418
+ / SYM B-O
2419
+ FRT PROPN B-O
2420
+ system NOUN B-O
2421
+ to PART B-O
2422
+ induce VERB B-O
2423
+ homozygous ADJ B-O
2424
+ mutant ADJ B-O
2425
+ clones NOUN B-O
2426
+ in ADP B-O
2427
+ the DET B-O
2428
+ photoreceptor NOUN B-O
2429
+ neurons NOUN B-O
2430
+ of ADP B-O
2431
+ the DET B-O
2432
+ otherwise ADV B-O
2433
+ heterozygous ADJ B-O
2434
+ flies NOUN B-O
2435
+ and CCONJ B-O
2436
+ performed VERB B-O
2437
+ electroretinograms NOUN B-LF
2438
+ ( PUNCT B-O
2439
+ ERGs PROPN B-AC
2440
+ ) PUNCT B-O
2441
+ on ADP B-O
2442
+ 3- NUM B-O
2443
+ and CCONJ B-O
2444
+ 33 NUM B-O
2445
+ - PUNCT B-O
2446
+ days NOUN B-O
2447
+ - PUNCT B-O
2448
+ old ADJ B-O
2449
+ flies NOUN B-O
2450
+ . PUNCT B-O
2451
+
2452
+ Secondary ADJ B-O
2453
+ results NOUN B-O
2454
+ included VERB B-O
2455
+ spherical ADJ B-LF
2456
+ equivalent NOUN I-LF
2457
+ ( PUNCT B-O
2458
+ SE PROPN B-AC
2459
+ ) PUNCT B-O
2460
+ and CCONJ B-O
2461
+ CCT PROPN B-AC
2462
+ . PUNCT B-O
2463
+ Finally ADV B-O
2464
+ , PUNCT B-O
2465
+ ECD PROPN B-AC
2466
+ and CCONJ B-O
2467
+ IOP PROPN B-O
2468
+ were AUX B-O
2469
+ set VERB B-O
2470
+ as ADP B-O
2471
+ the DET B-O
2472
+ last ADJ B-O
2473
+ observation NOUN B-O
2474
+ indicator NOUN B-O
2475
+ to PART B-O
2476
+ evaluate VERB B-O
2477
+ the DET B-O
2478
+ safety NOUN B-O
2479
+ of ADP B-O
2480
+ surgery NOUN B-O
2481
+ . PUNCT B-O
2482
+
2483
+ HILIC PROPN B-AC
2484
+ - PUNCT B-AC
2485
+ MS2 PROPN B-AC
2486
+ of ADP B-O
2487
+ stereo ADV B-O
2488
+ - PUNCT B-O
2489
+ controlled VERB B-O
2490
+ β NOUN B-AC
2491
+ - PUNCT B-AC
2492
+ GlcCer PROPN B-AC
2493
+ and CCONJ B-O
2494
+ an DET B-O
2495
+ α NOUN B-O
2496
+ / SYM B-O
2497
+ β NOUN B-AC
2498
+ - PUNCT B-AC
2499
+ GlcCer PROPN B-AC
2500
+ mixture NOUN B-O
2501
+ . PUNCT B-O
2502
+ α NOUN B-O
2503
+ / SYM B-O
2504
+ β NOUN B-AC
2505
+ - PUNCT B-AC
2506
+ GlcCer PROPN B-AC
2507
+ , PUNCT B-O
2508
+ α NOUN B-O
2509
+ / SYM B-O
2510
+ β NOUN B-LF
2511
+ - PUNCT I-LF
2512
+ glucosylceramide NOUN I-LF
2513
+ ; PUNCT B-O
2514
+ HILIC PROPN B-AC
2515
+ - PUNCT B-AC
2516
+ MS2 PROPN B-AC
2517
+ , PUNCT B-O
2518
+ hydrophilic ADJ B-LF
2519
+ interaction NOUN I-LF
2520
+ liquid NOUN I-LF
2521
+ chromatography NOUN I-LF
2522
+ - PUNCT I-LF
2523
+ tandem NOUN I-LF
2524
+ mass NOUN I-LF
2525
+ spectrometry NOUN I-LF
2526
+ . PUNCT B-O
2527
+
2528
+ COTS PROPN B-AC
2529
+ , PUNCT B-O
2530
+ crown NOUN B-LF
2531
+ - PUNCT I-LF
2532
+ of ADP I-LF
2533
+ - PUNCT I-LF
2534
+ thorns NOUN I-LF
2535
+ starfish NOUN I-LF
2536
+ ; PUNCT B-O
2537
+ GBR PROPN B-AC
2538
+ , PUNCT B-O
2539
+ Great PROPN B-LF
2540
+ Barrier PROPN I-LF
2541
+ Reef PROPN I-LF
2542
+ ; PUNCT B-O
2543
+ NCJ PROPN B-O
2544
+ , PUNCT B-O
2545
+ North PROPN B-O
2546
+ Caledonian PROPN B-O
2547
+ Jet PROPN B-O
2548
+ ; PUNCT B-O
2549
+ SCJ PROPN B-O
2550
+ , PUNCT B-O
2551
+ South PROPN B-O
2552
+ Caledonian PROPN B-O
2553
+ Jet PROPN B-O
2554
+ . PUNCT B-O
2555
+
2556
+ We PRON B-O
2557
+ mechanistically ADV B-O
2558
+ studied VERB B-O
2559
+ tTreg NOUN B-AC
2560
+ cell NOUN B-O
2561
+ generation NOUN B-O
2562
+ in ADP B-O
2563
+ the DET B-O
2564
+ atrophied ADJ B-O
2565
+ thymus NOUN B-O
2566
+ by ADP B-O
2567
+ utilizing VERB B-O
2568
+ both CCONJ B-O
2569
+ postnatal ADJ B-O
2570
+ TEC NOUN B-AC
2571
+ - PUNCT B-O
2572
+ defective ADJ B-O
2573
+ ( PUNCT B-O
2574
+ resulting VERB B-O
2575
+ from ADP B-O
2576
+ FoxN1 PROPN B-AC
2577
+ - PUNCT B-O
2578
+ floxed VERB B-O
2579
+ conditional ADJ B-LF
2580
+ knockout NOUN I-LF
2581
+ [ X B-O
2582
+ cKO NOUN B-AC
2583
+ ] PUNCT B-O
2584
+ ) PUNCT B-O
2585
+ and CCONJ B-O
2586
+ naturally ADV B-O
2587
+ aged VERB B-O
2588
+ mouse NOUN B-O
2589
+ models NOUN B-O
2590
+ . PUNCT B-O
2591
+
2592
+ A DET B-O
2593
+ switch NOUN B-O
2594
+ of ADP B-O
2595
+ this DET B-O
2596
+ balance NOUN B-O
2597
+ to ADP B-O
2598
+ the DET B-O
2599
+ benefit NOUN B-O
2600
+ of ADP B-O
2601
+ augmented VERB B-O
2602
+ responses NOUN B-O
2603
+ toward ADP B-O
2604
+ TGFβ NOUN B-AC
2605
+ is AUX B-O
2606
+ a DET B-O
2607
+ hallmark NOUN B-O
2608
+ of ADP B-O
2609
+ endothelial ADJ B-LF
2610
+ cell NOUN I-LF
2611
+ ( PUNCT B-O
2612
+ EC PROPN B-AC
2613
+ ) PUNCT B-O
2614
+ dysfunction NOUN B-O
2615
+ and CCONJ B-O
2616
+ precondition NOUN B-O
2617
+ to ADP B-O
2618
+ several ADJ B-O
2619
+ vascular ADJ B-O
2620
+ diseases NOUN B-O
2621
+ , PUNCT B-O
2622
+ including VERB B-O
2623
+ cerebral ADJ B-LF
2624
+ cavernous ADJ I-LF
2625
+ malformation NOUN I-LF
2626
+ ( PUNCT B-O
2627
+ CCM PROPN B-AC
2628
+ ) PUNCT B-O
2629
+ [ PUNCT B-O
2630
+ 2 NUM B-O
2631
+ ] PUNCT B-O
2632
+ , PUNCT B-O
2633
+ hereditary ADJ B-LF
2634
+ hemorrhagic ADJ I-LF
2635
+ telangiectasia NOUN I-LF
2636
+ ( PUNCT B-O
2637
+ HHT PROPN B-AC
2638
+ ) PUNCT B-O
2639
+ [ PUNCT B-O
2640
+ 3 NUM B-O
2641
+ ] PUNCT B-O
2642
+ , PUNCT B-O
2643
+ and CCONJ B-O
2644
+ pulmonary ADJ B-LF
2645
+ arterial ADJ I-LF
2646
+ hypertension NOUN I-LF
2647
+ ( PUNCT B-O
2648
+ PAH PROPN B-AC
2649
+ ) PUNCT B-O
2650
+ . PUNCT B-O
2651
+ Understanding VERB B-O
2652
+ the DET B-O
2653
+ cellular ADJ B-O
2654
+ context NOUN B-O
2655
+ in ADP B-O
2656
+ which PRON B-O
2657
+ this DET B-O
2658
+ imbalance NOUN B-O
2659
+ takes VERB B-O
2660
+ place NOUN B-O
2661
+ is AUX B-O
2662
+ key ADJ B-O
2663
+ to ADP B-O
2664
+ tackling VERB B-O
2665
+ augmented VERB B-O
2666
+ TGFβ NOUN B-AC
2667
+ signaling NOUN B-O
2668
+ [ PUNCT B-O
2669
+ 4 NUM B-O
2670
+ ] PUNCT B-O
2671
+ . PUNCT B-O
2672
+
2673
+ ACE2 PROPN B-AC
2674
+ , PUNCT B-O
2675
+ angiotensin NOUN B-LF
2676
+ - PUNCT I-LF
2677
+ converting VERB I-LF
2678
+ enzyme NOUN I-LF
2679
+ 2 NUM I-LF
2680
+ ; PUNCT B-O
2681
+ RBD PROPN B-AC
2682
+ , PUNCT B-O
2683
+ receptor NOUN B-LF
2684
+ binding VERB I-LF
2685
+ domain NOUN I-LF
2686
+ ; PUNCT B-O
2687
+ SARS PROPN B-AC
2688
+ - PUNCT B-AC
2689
+ CoV-2 PROPN B-AC
2690
+ , PUNCT B-O
2691
+ SARS PROPN B-LF
2692
+ Coronavirus PROPN I-LF
2693
+ 2 NUM I-LF
2694
+ . PUNCT B-O
2695
+
2696
+ CIDRZ PROPN B-AC
2697
+ , PUNCT B-O
2698
+ Centre PROPN B-LF
2699
+ for ADP I-LF
2700
+ Infectious PROPN I-LF
2701
+ Disease PROPN I-LF
2702
+ Research PROPN I-LF
2703
+ in ADP I-LF
2704
+ Zambia PROPN I-LF
2705
+ ; PUNCT B-O
2706
+ LTFU PROPN B-O
2707
+ , PUNCT B-O
2708
+ lost VERB B-O
2709
+ to ADP B-O
2710
+ follow NOUN B-O
2711
+ - PUNCT B-O
2712
+ up NOUN B-O
2713
+ ; PUNCT B-O
2714
+ PPS PROPN B-O
2715
+ , PUNCT B-O
2716
+ probability NOUN B-O
2717
+ proportional ADJ B-O
2718
+ to ADP B-O
2719
+ size NOUN B-O
2720
+ ; PUNCT B-O
2721
+ SRS PROPN B-O
2722
+ , PUNCT B-O
2723
+ simple ADJ B-O
2724
+ random ADJ B-O
2725
+ sample NOUN B-O
2726
+ . PUNCT B-O
2727
+
2728
+ Thoracolumbar ADJ B-LF
2729
+ interfascial ADJ I-LF
2730
+ block NOUN I-LF
2731
+ ( PUNCT B-O
2732
+ TLIP NOUN B-AC
2733
+ block NOUN B-AC
2734
+ ) PUNCT B-O
2735
+ is AUX B-O
2736
+ a DET B-O
2737
+ novel ADJ B-O
2738
+ regional ADJ B-O
2739
+ anesthesia NOUN B-O
2740
+ technique NOUN B-O
2741
+ first ADV B-O
2742
+ described VERB B-O
2743
+ by ADP B-O
2744
+ Hand PROPN B-O
2745
+ et NOUN B-O
2746
+ al NOUN B-O
2747
+ . PUNCT B-O
2748
+ in ADP B-O
2749
+ 2015 NUM B-O
2750
+ [ PUNCT B-O
2751
+ 7 NUM B-O
2752
+ ] PUNCT B-O
2753
+ , PUNCT B-O
2754
+ which PRON B-O
2755
+ is AUX B-O
2756
+ an DET B-O
2757
+ interfascial ADJ B-O
2758
+ plane NOUN B-O
2759
+ block NOUN B-O
2760
+ applied VERB B-O
2761
+ at ADP B-O
2762
+ the DET B-O
2763
+ L3 NOUN B-O
2764
+ vertebral ADJ B-O
2765
+ level NOUN B-O
2766
+ in ADP B-O
2767
+ spine NOUN B-O
2768
+ surgery NOUN B-O
2769
+ . PUNCT B-O
2770
+
2771
+ Abbreviations NOUN B-O
2772
+ : PUNCT B-O
2773
+ ACE PROPN B-AC
2774
+ , PUNCT B-O
2775
+ adverse ADJ B-LF
2776
+ childhood NOUN I-LF
2777
+ experience NOUN I-LF
2778
+ ; PUNCT B-O
2779
+ CI PROPN B-AC
2780
+ , PUNCT B-O
2781
+ confidence NOUN B-LF
2782
+ interval NOUN I-LF
2783
+ ; PUNCT B-O
2784
+ CSE PROPN B-O
2785
+ , PUNCT B-O
2786
+ Certificate PROPN B-O
2787
+ of ADP B-O
2788
+ Secondary PROPN B-O
2789
+ Education PROPN B-O
2790
+ ; PUNCT B-O
2791
+ GCSE PROPN B-AC
2792
+ , PUNCT B-O
2793
+ General PROPN B-LF
2794
+ Certificate PROPN I-LF
2795
+ of ADP I-LF
2796
+ Secondary PROPN I-LF
2797
+ Education PROPN I-LF
2798
+ ; PUNCT B-O
2799
+ PAF PROPN B-O
2800
+ , PUNCT B-O
2801
+ population NOUN B-O
2802
+ attributable ADJ B-O
2803
+ fraction NOUN B-O
2804
+ ; PUNCT B-O
2805
+ RD PROPN B-AC
2806
+ , PUNCT B-O
2807
+ risk NOUN B-LF
2808
+ difference NOUN I-LF
2809
+ . PUNCT B-O
2810
+
2811
+ BMI NOUN B-AC
2812
+ = VERB B-O
2813
+ body NOUN B-LF
2814
+ mass NOUN I-LF
2815
+ index NOUN I-LF
2816
+ ; PUNCT B-O
2817
+ MET PROPN B-AC
2818
+ = VERB B-O
2819
+ metabolic ADJ B-LF
2820
+ equivalent NOUN I-LF
2821
+
2822
+ Isolates NOUN B-O
2823
+ were AUX B-O
2824
+ cultured VERB B-O
2825
+ from ADP B-O
2826
+ sputum NOUN B-O
2827
+ or CCONJ B-O
2828
+ bronchoalveolar ADJ B-LF
2829
+ lavage NOUN I-LF
2830
+ ( PUNCT B-O
2831
+ BAL NOUN B-AC
2832
+ ) PUNCT B-O
2833
+ from ADP B-O
2834
+ patients NOUN B-O
2835
+ with ADP B-O
2836
+ CF PROPN B-AC
2837
+ after ADP B-O
2838
+ obtaining VERB B-O
2839
+ informed ADJ B-O
2840
+ consent NOUN B-O
2841
+ . PUNCT B-O
2842
+
2843
+ Reviewer ADJ B-O
2844
+ comment NOUN B-O
2845
+ : PUNCT B-O
2846
+ 13 X B-O
2847
+ . X B-O
2848
+ “ PUNCT B-O
2849
+ Table NOUN B-O
2850
+ 4 NUM B-O
2851
+ : PUNCT B-O
2852
+ Bivariate ADJ B-O
2853
+ and CCONJ B-O
2854
+ Multivariate ADJ B-O
2855
+ analysis NOUN B-O
2856
+ on ADP B-O
2857
+ treatment NOUN B-O
2858
+ outcome NOUN B-O
2859
+ of ADP B-O
2860
+ SAM PROPN B-AC
2861
+ and CCONJ B-O
2862
+ associated VERB B-O
2863
+ factors NOUN B-O
2864
+ ” PUNCT B-O
2865
+ shall AUX B-O
2866
+ be AUX B-O
2867
+ re VERB B-O
2868
+ - VERB B-O
2869
+ written VERB B-O
2870
+ as ADP B-O
2871
+ “ PUNCT B-O
2872
+ Table NOUN B-O
2873
+ 4 NUM B-O
2874
+ : PUNCT B-O
2875
+ Treatment NOUN B-O
2876
+ outcome NOUN B-O
2877
+ of ADP B-O
2878
+ severe ADJ B-LF
2879
+ acute ADJ I-LF
2880
+ malnutrition NOUN I-LF
2881
+ and CCONJ B-O
2882
+ associated VERB B-O
2883
+ factors NOUN B-O
2884
+ in ADP B-O
2885
+ ------ PUNCT B-O
2886
+ Woreda PROPN B-O
2887
+ , PUNCT B-O
2888
+ Northern PROPN B-O
2889
+ Wollo PROPN B-O
2890
+ , PUNCT B-O
2891
+ Ethiopia PROPN B-O
2892
+ ---month NOUN B-O
2893
+ , PUNCT B-O
2894
+ ----year NOUN B-O
2895
+ to ADP B-O
2896
+ -----month NOUN B-O
2897
+ , PUNCT B-O
2898
+ ----year NOUN B-O
2899
+ ” PUNCT B-O
2900
+
2901
+ Dual ADJ B-LF
2902
+ - PUNCT I-LF
2903
+ specificity NOUN I-LF
2904
+ tyrosine NOUN I-LF
2905
+ - PUNCT I-LF
2906
+ phosphorylation NOUN I-LF
2907
+ - PUNCT I-LF
2908
+ regulated VERB I-LF
2909
+ kinase NOUN I-LF
2910
+ 2 NUM I-LF
2911
+ ( PUNCT B-O
2912
+ DYRK2 PROPN B-AC
2913
+ ) PUNCT B-O
2914
+ is AUX B-O
2915
+ a DET B-O
2916
+ member NOUN B-O
2917
+ of ADP B-O
2918
+ dual ADJ B-O
2919
+ - PUNCT B-O
2920
+ specificity NOUN B-O
2921
+ kinase NOUN B-O
2922
+ family NOUN B-O
2923
+ , PUNCT B-O
2924
+ which PRON B-O
2925
+ could AUX B-O
2926
+ phosphorylate VERB B-O
2927
+ both CCONJ B-O
2928
+ Ser PROPN B-O
2929
+ / SYM B-O
2930
+ Thr PROPN B-O
2931
+ and CCONJ B-O
2932
+ Tyr PROPN B-O
2933
+ substrates NOUN B-O
2934
+ . PUNCT B-O
2935
+
2936
+ Damage NOUN B-LF
2937
+ - PUNCT I-LF
2938
+ associated VERB I-LF
2939
+ molecular ADJ I-LF
2940
+ patterns NOUN I-LF
2941
+ ( PUNCT B-O
2942
+ DAMPs PROPN B-AC
2943
+ ) PUNCT B-O
2944
+ are AUX B-O
2945
+ released VERB B-O
2946
+ into ADP B-O
2947
+ the DET B-O
2948
+ extracellular ADJ B-O
2949
+ space NOUN B-O
2950
+ by ADP B-O
2951
+ tissue NOUN B-O
2952
+ damage NOUN B-O
2953
+ that PRON B-O
2954
+ triggers VERB B-O
2955
+ an DET B-O
2956
+ inflammatory ADJ B-O
2957
+ response NOUN B-O
2958
+ without ADP B-O
2959
+ infection NOUN B-O
2960
+ . PUNCT B-O
2961
+
2962
+ Other ADJ B-O
2963
+ outcomes NOUN B-O
2964
+ included VERB B-O
2965
+ weight NOUN B-O
2966
+ gain NOUN B-O
2967
+ velocity NOUN B-O
2968
+ after ADP B-O
2969
+ two NUM B-O
2970
+ weeks NOUN B-O
2971
+ , PUNCT B-O
2972
+ length NOUN B-LF
2973
+ of ADP I-LF
2974
+ stay NOUN I-LF
2975
+ ( PUNCT B-O
2976
+ LoS PROPN B-AC
2977
+ ) PUNCT B-O
2978
+ , PUNCT B-O
2979
+ discharge NOUN B-O
2980
+ anthropometrics NOUN B-O
2981
+ , PUNCT B-O
2982
+ linear ADJ B-O
2983
+ and CCONJ B-O
2984
+ MUAC PROPN B-AC
2985
+ growth NOUN B-O
2986
+ , PUNCT B-O
2987
+ treatment NOUN B-O
2988
+ outcome NOUN B-O
2989
+ , PUNCT B-O
2990
+ morbidity NOUN B-O
2991
+ , PUNCT B-O
2992
+ and CCONJ B-O
2993
+ relapses NOUN B-O
2994
+ . PUNCT B-O
2995
+
2996
+ PRISMA PROPN B-AC
2997
+ , PUNCT B-O
2998
+ Preferred ADJ B-LF
2999
+ Reporting NOUN I-LF
3000
+ Items NOUN I-LF
3001
+ for ADP I-LF
3002
+ Systematic ADJ I-LF
3003
+ Reviews NOUN I-LF
3004
+ and CCONJ I-LF
3005
+ Meta NOUN I-LF
3006
+ - NOUN I-LF
3007
+ Analyses NOUN I-LF
3008
+ . PUNCT B-O
3009
+
3010
+ Although SCONJ B-O
3011
+ the DET B-O
3012
+ phosphorylation NOUN B-O
3013
+ of ADP B-O
3014
+ eIF2α NOUN B-AC
3015
+ leads VERB B-O
3016
+ to ADP B-O
3017
+ attenuation NOUN B-O
3018
+ of ADP B-O
3019
+ the DET B-O
3020
+ translation NOUN B-O
3021
+ of ADP B-O
3022
+ most ADJ B-O
3023
+ transcripts NOUN B-O
3024
+ , PUNCT B-O
3025
+ it PRON B-O
3026
+ also ADV B-O
3027
+ increases VERB B-O
3028
+ the DET B-O
3029
+ translation NOUN B-O
3030
+ of ADP B-O
3031
+ specific ADJ B-O
3032
+ mRNAs NOUN B-O
3033
+ such ADJ B-O
3034
+ as ADP B-O
3035
+ activating VERB B-LF
3036
+ transcription NOUN I-LF
3037
+ factor NOUN I-LF
3038
+ 4 NUM I-LF
3039
+ ( PUNCT B-O
3040
+ ATF4 PROPN B-AC
3041
+ ) PUNCT B-O
3042
+ [ X B-O
3043
+ 41 NUM B-O
3044
+ ] X B-O
3045
+ as ADP B-O
3046
+ part NOUN B-O
3047
+ of ADP B-O
3048
+ the DET B-O
3049
+ stress NOUN B-O
3050
+ response NOUN B-O
3051
+ . PUNCT B-O
3052
+
3053
+ Bradykinin NOUN B-LF
3054
+ ( PUNCT B-O
3055
+ BK)-related PROPN B-AC
3056
+ peptides NOUN B-O
3057
+ , PUNCT B-O
3058
+ derived VERB B-O
3059
+ from ADP B-O
3060
+ the DET B-O
3061
+ selective ADJ B-O
3062
+ cleavage NOUN B-O
3063
+ of ADP B-O
3064
+ circulating VERB B-O
3065
+ kininogens NOUN B-O
3066
+ , PUNCT B-O
3067
+ stimulate VERB B-O
3068
+ two NUM B-O
3069
+ related ADJ B-O
3070
+ G PROPN B-O
3071
+ protein NOUN B-O
3072
+ coupled VERB B-O
3073
+ receptors NOUN B-O
3074
+ : PUNCT B-O
3075
+ the DET B-O
3076
+ widely ADV B-O
3077
+ expressed VERB B-O
3078
+ BK PROPN B-AC
3079
+ B2 PROPN B-LF
3080
+ receptor NOUN I-LF
3081
+ ( PUNCT B-O
3082
+ B2R NOUN B-AC
3083
+ ) PUNCT B-O
3084
+ and CCONJ B-O
3085
+ the DET B-O
3086
+ strongly ADV B-O
3087
+ regulated VERB B-O
3088
+ B1 PROPN B-LF
3089
+ receptor NOUN I-LF
3090
+ ( PUNCT B-O
3091
+ B1R NOUN B-AC
3092
+ ) PUNCT B-O
3093
+ [ PUNCT B-O
3094
+ 1 NUM B-O
3095
+ ] PUNCT B-O
3096
+ . PUNCT B-O
3097
+
3098
+ • PUNCT B-O
3099
+ LC PROPN B-AC
3100
+ is AUX B-O
3101
+ not PART B-O
3102
+ a DET B-O
3103
+ common ADJ B-O
3104
+ abbreviation NOUN B-O
3105
+ ; PUNCT B-O
3106
+ I PRON B-O
3107
+ suggest VERB B-O
3108
+ to PART B-O
3109
+ write VERB B-O
3110
+ liver NOUN B-LF
3111
+ cirrhosis NOUN I-LF
3112
+ in ADP B-O
3113
+ full ADJ B-O
3114
+ throughout ADP B-O
3115
+ . PUNCT B-O
3116
+
3117
+ AAA PROPN B-AC
3118
+ , PUNCT B-O
3119
+ abdominal ADJ B-LF
3120
+ aortic ADJ I-LF
3121
+ aneurysm NOUN I-LF
3122
+ ; PUNCT B-O
3123
+ Ang PROPN B-AC
3124
+ II NUM B-AC
3125
+ , PUNCT B-O
3126
+ angiotensin NOUN B-LF
3127
+ II NUM I-LF
3128
+ ; PUNCT B-O
3129
+ Drp1 PROPN B-AC
3130
+ , PUNCT B-O
3131
+ dynamin NOUN B-LF
3132
+ - PUNCT I-LF
3133
+ related VERB I-LF
3134
+ protein NOUN I-LF
3135
+ 1 NUM I-LF
3136
+ ; PUNCT B-O
3137
+ Mdivi-1 PROPN B-AC
3138
+ , PUNCT B-O
3139
+ mitochondrial ADJ B-LF
3140
+ division NOUN I-LF
3141
+ inhibitor NOUN I-LF
3142
+ 1 NUM I-LF
3143
+ ; PUNCT B-O
3144
+ Mfn1 PROPN B-AC
3145
+ , PUNCT B-O
3146
+ mitofusin NOUN B-LF
3147
+ 1 NUM I-LF
3148
+ ; PUNCT B-O
3149
+ MTG PROPN B-AC
3150
+ , PUNCT B-O
3151
+ MitoTracker PROPN B-LF
3152
+ Green PROPN I-LF
3153
+ ; PUNCT B-O
3154
+ mtROS PROPN B-AC
3155
+ , PUNCT B-O
3156
+ mitochondrial ADJ B-LF
3157
+ ROS NOUN I-LF
3158
+ ; PUNCT B-O
3159
+ si PROPN B-O
3160
+ - PUNCT B-O
3161
+ Drp1 PROPN B-AC
3162
+ , PUNCT B-O
3163
+ short ADJ B-O
3164
+ interfering VERB B-O
3165
+ RNA NOUN B-O
3166
+ targeting VERB B-O
3167
+ Drp1 PROPN B-AC
3168
+ ; PUNCT B-O
3169
+ si PROPN B-O
3170
+ - PUNCT B-O
3171
+ NC PROPN B-O
3172
+ , PUNCT B-O
3173
+ short ADJ B-O
3174
+ interfering VERB B-O
3175
+ RNA NOUN B-O
3176
+ control NOUN B-O
3177
+ ; PUNCT B-O
3178
+ VSMC PROPN B-AC
3179
+ , PUNCT B-O
3180
+ vascular ADJ B-LF
3181
+ smooth ADJ I-LF
3182
+ muscle NOUN I-LF
3183
+ cell NOUN I-LF
3184
+ . PUNCT B-O
3185
+
3186
+ Stimulus NOUN B-LF
3187
+ - PUNCT I-LF
3188
+ specific ADJ I-LF
3189
+ adaptation NOUN I-LF
3190
+ ( PUNCT B-O
3191
+ SSA PROPN B-AC
3192
+ ) PUNCT B-O
3193
+ in ADP B-O
3194
+ single ADJ B-O
3195
+ neurons NOUN B-O
3196
+ of ADP B-O
3197
+ the DET B-O
3198
+ auditory ADJ B-O
3199
+ cortex NOUN B-O
3200
+ was AUX B-O
3201
+ suggested VERB B-O
3202
+ to PART B-O
3203
+ be AUX B-O
3204
+ a DET B-O
3205
+ potential ADJ B-O
3206
+ neural ADJ B-O
3207
+ correlate NOUN B-O
3208
+ of ADP B-O
3209
+ the DET B-O
3210
+ mismatch NOUN B-LF
3211
+ negativity NOUN I-LF
3212
+ ( PUNCT B-O
3213
+ MMN PROPN B-AC
3214
+ ) PUNCT B-O
3215
+ , PUNCT B-O
3216
+ a DET B-O
3217
+ widely ADV B-O
3218
+ studied ADJ B-O
3219
+ component NOUN B-O
3220
+ of ADP B-O
3221
+ the DET B-O
3222
+ auditory ADJ B-O
3223
+ event NOUN B-LF
3224
+ - PUNCT I-LF
3225
+ related VERB I-LF
3226
+ potentials NOUN I-LF
3227
+ ( PUNCT B-O
3228
+ ERP PROPN B-AC
3229
+ ) PUNCT B-O
3230
+ that PRON B-O
3231
+ is AUX B-O
3232
+ elicited VERB B-O
3233
+ by ADP B-O
3234
+ changes NOUN B-O
3235
+ in ADP B-O
3236
+ the DET B-O
3237
+ auditory ADJ B-O
3238
+ environment NOUN B-O
3239
+ . PUNCT B-O
3240
+
3241
+ One NUM B-O
3242
+ identified VERB B-O
3243
+ candidate NOUN B-O
3244
+ for ADP B-O
3245
+ asparagine NOUN B-O
3246
+ hydroxylation NOUN B-O
3247
+ was AUX B-O
3248
+ the DET B-O
3249
+ deubiquitinase NOUN B-LF
3250
+ ( PUNCT B-O
3251
+ DUB PROPN B-AC
3252
+ ) PUNCT B-O
3253
+ ovarian ADJ B-LF
3254
+ tumor NOUN I-LF
3255
+ domain NOUN I-LF
3256
+ containing VERB I-LF
3257
+ ubiquitin NOUN I-LF
3258
+ aldehyde NOUN I-LF
3259
+ binding VERB I-LF
3260
+ protein NOUN I-LF
3261
+ 1 NUM I-LF
3262
+ ( PUNCT B-O
3263
+ OTUB1 PROPN B-AC
3264
+ ) PUNCT B-O
3265
+ ( PUNCT B-O
3266
+ Uniprot PROPN B-O
3267
+ accession NOUN B-O
3268
+ number NOUN B-O
3269
+ : PUNCT B-O
3270
+ Q96FW1 PROPN B-O
3271
+ ) PUNCT B-O
3272
+ [ PUNCT B-O
3273
+ 19 NUM B-O
3274
+ ] PUNCT B-O
3275
+ . PUNCT B-O
3276
+
3277
+ These DET B-O
3278
+ visits NOUN B-O
3279
+ are AUX B-O
3280
+ augmented VERB B-O
3281
+ by ADP B-O
3282
+ visits NOUN B-O
3283
+ from ADP B-O
3284
+ the DET B-O
3285
+ volunteer NOUN B-O
3286
+ community NOUN B-O
3287
+ health NOUN B-O
3288
+ workers NOUN B-O
3289
+ ( PUNCT B-O
3290
+ Shasthya PROPN B-LF
3291
+ Shebika PROPN I-LF
3292
+ [ PUNCT B-O
3293
+ SSs PROPN B-AC
3294
+ ] PUNCT B-O
3295
+ ) PUNCT B-O
3296
+ , PUNCT B-O
3297
+ a DET B-O
3298
+ cadre NOUN B-O
3299
+ chosen VERB B-O
3300
+ from ADP B-O
3301
+ and CCONJ B-O
3302
+ by ADP B-O
3303
+ their PRON B-O
3304
+ communities NOUN B-O
3305
+ who PRON B-O
3306
+ receive VERB B-O
3307
+ a DET B-O
3308
+ 15 NUM B-O
3309
+ - PUNCT B-O
3310
+ day NOUN B-O
3311
+ training NOUN B-O
3312
+ course NOUN B-O
3313
+ followed VERB B-O
3314
+ by ADP B-O
3315
+ monthly ADJ B-O
3316
+ refresher NOUN B-O
3317
+ training NOUN B-O
3318
+ and CCONJ B-O
3319
+ ad X B-O
3320
+ hoc X B-O
3321
+ 3 NUM B-O
3322
+ - PUNCT B-O
3323
+ day NOUN B-O
3324
+ intensive ADJ B-O
3325
+ training NOUN B-O
3326
+ for ADP B-O
3327
+ new ADJ B-O
3328
+ content NOUN B-O
3329
+ areas NOUN B-O
3330
+ . PUNCT B-O
3331
+
3332
+ CI PROPN B-AC
3333
+ , PUNCT B-O
3334
+ confidence NOUN B-LF
3335
+ interval NOUN I-LF
3336
+ ; PUNCT B-O
3337
+ DNI PROPN B-AC
3338
+ , PUNCT B-O
3339
+ delta NOUN B-LF
3340
+ neutrophil NOUN I-LF
3341
+ index NOUN I-LF
3342
+ ; PUNCT B-O
3343
+ SOFA PROPN B-AC
3344
+ , PUNCT B-O
3345
+ sequential ADJ B-LF
3346
+ organ NOUN I-LF
3347
+ failure NOUN I-LF
3348
+ assessment NOUN I-LF
3349
+ ; PUNCT B-O
3350
+ POD1 PROPN B-O
3351
+ , PUNCT B-O
3352
+ postoperative ADJ B-O
3353
+ day NOUN B-O
3354
+ 1 NUM B-O
3355
+ ; PUNCT B-O
3356
+ ICU PROPN B-AC
3357
+ , PUNCT B-O
3358
+ intensive ADJ B-LF
3359
+ care NOUN I-LF
3360
+ unit NOUN I-LF
3361
+ . PUNCT B-O
3362
+
3363
+ It PRON B-O
3364
+ was AUX B-O
3365
+ shown VERB B-O
3366
+ previously ADV B-O
3367
+ that SCONJ B-O
3368
+ antiviral ADJ B-O
3369
+ RNAi NOUN B-AC
3370
+ in ADP B-O
3371
+ honey NOUN B-O
3372
+ bees NOUN B-O
3373
+ could AUX B-O
3374
+ be AUX B-O
3375
+ induced VERB B-O
3376
+ by ADP B-O
3377
+ introduction NOUN B-O
3378
+ of ADP B-O
3379
+ double ADJ B-LF
3380
+ - PUNCT I-LF
3381
+ stranded ADJ I-LF
3382
+ RNA NOUN I-LF
3383
+ ( PUNCT B-O
3384
+ dsRNA NOUN B-AC
3385
+ ) PUNCT B-O
3386
+ molecules NOUN B-O
3387
+ orally ADV B-O
3388
+ [ X B-O
3389
+ 30 NUM B-O
3390
+ ] PUNCT B-O
3391
+ . PUNCT B-O
3392
+
3393
+ In ADP B-O
3394
+ the DET B-O
3395
+ Leiden PROPN B-LF
3396
+ Thrombophilia PROPN I-LF
3397
+ Study PROPN I-LF
3398
+ ( PUNCT B-O
3399
+ LETS PROPN B-AC
3400
+ ) PUNCT B-O
3401
+ , PUNCT B-O
3402
+ both CCONJ B-O
3403
+ cytokines NOUN B-O
3404
+ and CCONJ B-O
3405
+ tumour NOUN B-LF
3406
+ necrosis NOUN I-LF
3407
+ factor NOUN I-LF
3408
+ alpha NOUN I-LF
3409
+ ( PUNCT B-O
3410
+ TNF PROPN B-AC
3411
+ - ADJ B-AC
3412
+ α NOUN B-AC
3413
+ ) PUNCT B-O
3414
+ were AUX B-O
3415
+ associated VERB B-O
3416
+ with ADP B-O
3417
+ a DET B-O
3418
+ 2- NUM B-O
3419
+ to PART B-O
3420
+ 3 NUM B-O
3421
+ - ADJ B-O
3422
+ fold ADJ B-O
3423
+ increased VERB B-O
3424
+ risk NOUN B-O
3425
+ of ADP B-O
3426
+ a DET B-O
3427
+ first ADJ B-O
3428
+ VT PROPN B-AC
3429
+ , PUNCT B-O
3430
+ whereas SCONJ B-O
3431
+ the DET B-O
3432
+ risk NOUN B-O
3433
+ for ADP B-O
3434
+ IL-10 NOUN B-AC
3435
+ seemed VERB B-O
3436
+ to PART B-O
3437
+ be AUX B-O
3438
+ decreased VERB B-O
3439
+ [ PUNCT B-O
3440
+ 17 NUM B-O
3441
+ ] PUNCT B-O
3442
+ . PUNCT B-O
3443
+
3444
+ In ADP B-O
3445
+ 93/255 NUM B-O
3446
+ ( PUNCT B-O
3447
+ 36 NUM B-O
3448
+ % NOUN B-O
3449
+ ) PUNCT B-O
3450
+ non ADJ B-O
3451
+ - ADJ B-O
3452
+ Cochrane PROPN B-O
3453
+ SRs NOUN B-AC
3454
+ , PUNCT B-O
3455
+ authors NOUN B-O
3456
+ reported VERB B-O
3457
+ using VERB B-O
3458
+ Cochrane PROPN B-O
3459
+ methods NOUN B-O
3460
+ ( PUNCT B-O
3461
+ e.g. X B-O
3462
+ , PUNCT B-O
3463
+ cited VERB B-O
3464
+ the DET B-O
3465
+ Cochrane PROPN B-O
3466
+ Handbook PROPN B-O
3467
+ for ADP B-O
3468
+ Systematic PROPN B-LF
3469
+ Reviews PROPN I-LF
3470
+ of ADP B-O
3471
+ Interventions PROPN B-O
3472
+ [ PUNCT B-O
3473
+ 19 NUM B-O
3474
+ ] PUNCT B-O
3475
+ ) PUNCT B-O
3476
+ . PUNCT B-O
3477
+
3478
+ PDB PROPN B-AC
3479
+ , PUNCT B-O
3480
+ Protein PROPN B-LF
3481
+ Data PROPN I-LF
3482
+ Bank PROPN I-LF
3483
+ ; PUNCT B-O
3484
+ RSVF PROPN B-AC
3485
+ , PUNCT B-O
3486
+ respiratory ADJ B-O
3487
+ syncytial ADJ B-O
3488
+ virus NOUN B-O
3489
+ fusion NOUN B-O
3490
+ protein NOUN B-O
3491
+ ; PUNCT B-O
3492
+ SASA PROPN B-O
3493
+ , PUNCT B-O
3494
+ solvent NOUN B-O
3495
+ accessible ADJ B-O
3496
+ surface NOUN B-O
3497
+ area NOUN B-O
3498
+ . PUNCT B-O
3499
+
3500
+ CBA PROPN B-O
3501
+ : PUNCT B-O
3502
+ cytometric ADJ B-O
3503
+ bead NOUN B-O
3504
+ array NOUN B-O
3505
+ ; PUNCT B-O
3506
+ CDS PROPN B-AC
3507
+ : PUNCT B-O
3508
+ clinical ADJ B-LF
3509
+ disease NOUN I-LF
3510
+ score NOUN I-LF
3511
+ ; PUNCT B-O
3512
+ CLP PROPN B-AC
3513
+ : PUNCT B-O
3514
+ caecal NOUN B-LF
3515
+ ligation NOUN I-LF
3516
+ and CCONJ I-LF
3517
+ puncture NOUN I-LF
3518
+ ; PUNCT B-O
3519
+ MLN NOUN B-AC
3520
+ : PUNCT B-O
3521
+ mesenteric ADJ B-LF
3522
+ lymph NOUN I-LF
3523
+ nodes NOUN I-LF
3524
+ ; PUNCT B-O
3525
+ mRNA NOUN B-O
3526
+ : PUNCT B-O
3527
+ messenger NOUN B-O
3528
+ ribonucleic NOUN B-O
3529
+ acid NOUN B-O
3530
+ ; PUNCT B-O
3531
+ RT NOUN B-O
3532
+ - PUNCT B-O
3533
+ PCR PROPN B-O
3534
+ : PUNCT B-O
3535
+ reverse ADJ B-O
3536
+ transcriptase NOUN B-O
3537
+ real ADJ B-O
3538
+ - PUNCT B-O
3539
+ time NOUN B-O
3540
+ polymerase NOUN B-O
3541
+ chain NOUN B-O
3542
+ reaction NOUN B-O
3543
+ . PUNCT B-O
3544
+
3545
+ Recently ADV B-O
3546
+ , PUNCT B-O
3547
+ the DET B-O
3548
+ gene NOUN B-O
3549
+ family NOUN B-O
3550
+ arylamine NOUN B-LF
3551
+ N NOUN I-LF
3552
+ - NOUN I-LF
3553
+ acetyltransferases NOUN I-LF
3554
+ ( PUNCT B-O
3555
+ NATs NOUN B-AC
3556
+ ) PUNCT B-O
3557
+ , PUNCT B-O
3558
+ which PRON B-O
3559
+ is AUX B-O
3560
+ another DET B-O
3561
+ phase NOUN B-O
3562
+ II NUM B-O
3563
+ enzyme NOUN B-O
3564
+ has AUX B-O
3565
+ been AUX B-O
3566
+ shown VERB B-O
3567
+ to PART B-O
3568
+ be AUX B-O
3569
+ phylogenetically ADV B-O
3570
+ unstable ADJ B-O
3571
+ too ADV B-O
3572
+ [ PUNCT B-O
3573
+ 7 NUM B-O
3574
+ ] PUNCT B-O
3575
+ . PUNCT B-O
3576
+
3577
+ microRNAs NOUN B-LF
3578
+ ( PUNCT B-O
3579
+ miRNAs NOUN B-AC
3580
+ ) PUNCT B-O
3581
+ are AUX B-O
3582
+ important ADJ B-O
3583
+ post ADJ B-O
3584
+ - ADJ B-O
3585
+ transcriptional ADJ B-O
3586
+ regulators NOUN B-O
3587
+ , PUNCT B-O
3588
+ but CCONJ B-O
3589
+ the DET B-O
3590
+ extent NOUN B-O
3591
+ of ADP B-O
3592
+ this DET B-O
3593
+ regulation NOUN B-O
3594
+ is AUX B-O
3595
+ uncertain ADJ B-O
3596
+ , PUNCT B-O
3597
+ both PRON B-O
3598
+ with ADP B-O
3599
+ regard NOUN B-O
3600
+ to ADP B-O
3601
+ the DET B-O
3602
+ number NOUN B-O
3603
+ of ADP B-O
3604
+ miRNA NOUN B-AC
3605
+ genes NOUN B-O
3606
+ and CCONJ B-O
3607
+ their PRON B-O
3608
+ targets NOUN B-O
3609
+ . PUNCT B-O
3610
+
3611
+ Top NOUN B-LF
3612
+ of ADP I-LF
3613
+ SF NOUN I-LF
3614
+ or CCONJ I-LF
3615
+ AS NOUN I-LF
3616
+
3617
+ To ADP B-O
3618
+ our PRON B-O
3619
+ knowledge NOUN B-O
3620
+ , PUNCT B-O
3621
+ this PRON B-O
3622
+ is AUX B-O
3623
+ the DET B-O
3624
+ most ADV B-O
3625
+ diversified ADJ B-O
3626
+ and CCONJ B-O
3627
+ comprehensive ADJ B-O
3628
+ panel NOUN B-O
3629
+ of ADP B-O
3630
+ clinical ADJ B-O
3631
+ and CCONJ B-O
3632
+ genotype NOUN B-O
3633
+ specimens NOUN B-O
3634
+ used VERB B-O
3635
+ in ADP B-O
3636
+ HCV NOUN B-AC
3637
+ nucleic NOUN B-LF
3638
+ acid NOUN I-LF
3639
+ testing NOUN I-LF
3640
+ ( PUNCT B-O
3641
+ NAT PROPN B-AC
3642
+ ) PUNCT B-O
3643
+ validation NOUN B-O
3644
+ to ADP B-O
3645
+ date NOUN B-O
3646
+ . PUNCT B-O
3647
+
3648
+ Parents NOUN B-O
3649
+ completed VERB B-O
3650
+ the DET B-O
3651
+ Behavior PROPN B-LF
3652
+ Assessment PROPN I-LF
3653
+ System PROPN I-LF
3654
+ for ADP I-LF
3655
+ Children PROPN I-LF
3656
+ , PUNCT I-LF
3657
+ Second PROPN I-LF
3658
+ Edition PROPN I-LF
3659
+ ( PUNCT B-O
3660
+ BASC-2 PROPN B-AC
3661
+ ) PUNCT B-O
3662
+ [ PUNCT B-O
3663
+ 27 NUM B-O
3664
+ ] PUNCT B-O
3665
+ , PUNCT B-O
3666
+ and CCONJ B-O
3667
+ the DET B-O
3668
+ Behavior PROPN B-LF
3669
+ Rating PROPN I-LF
3670
+ Inventory PROPN I-LF
3671
+ of ADP I-LF
3672
+ Executive PROPN I-LF
3673
+ Function PROPN I-LF
3674
+ ( PUNCT B-O
3675
+ BRIEF PROPN B-AC
3676
+ ) PUNCT B-O
3677
+ [ PUNCT B-O
3678
+ 28 NUM B-O
3679
+ ] PUNCT B-O
3680
+ . PUNCT B-O
3681
+
3682
+ Interestingly ADV B-O
3683
+ , PUNCT B-O
3684
+ one NUM B-O
3685
+ group NOUN B-O
3686
+ reported VERB B-O
3687
+ that SCONJ B-O
3688
+ the DET B-O
3689
+ prostate NOUN B-LF
3690
+ apoptosis NOUN I-LF
3691
+ response NOUN I-LF
3692
+ 4 NUM I-LF
3693
+ ( PUNCT B-O
3694
+ PAR-4 NOUN B-AC
3695
+ ) PUNCT B-O
3696
+ , PUNCT B-O
3697
+ a DET B-O
3698
+ substrate NOUN B-O
3699
+ of ADP B-O
3700
+ ZIPK PROPN B-AC
3701
+ , PUNCT B-O
3702
+ is AUX B-O
3703
+ capable ADJ B-O
3704
+ of ADP B-O
3705
+ translocating VERB B-O
3706
+ ZIPK PROPN B-AC
3707
+ from ADP B-O
3708
+ the DET B-O
3709
+ PODs NOUN B-AC
3710
+ to ADP B-O
3711
+ the DET B-O
3712
+ actin NOUN B-O
3713
+ microfilaments NOUN B-O
3714
+ [ X B-O
3715
+ 4,12,13 NUM B-O
3716
+ ] PUNCT B-O
3717
+ . PUNCT B-O
3718
+
3719
+ BFP PROPN B-AC
3720
+ , PUNCT B-O
3721
+ body NOUN B-LF
3722
+ fat NOUN I-LF
3723
+ percentage NOUN I-LF
3724
+ ; PUNCT B-O
3725
+ CE PROPN B-AC
3726
+ , PUNCT B-O
3727
+ cholesteryl NOUN B-LF
3728
+ ester NOUN I-LF
3729
+ ; PUNCT B-O
3730
+ Chol PROPN B-AC
3731
+ , PUNCT B-O
3732
+ cholesterol NOUN B-LF
3733
+ ; PUNCT B-O
3734
+ DAG PROPN B-AC
3735
+ , PUNCT B-O
3736
+ diacylglyceride NOUN B-LF
3737
+ ; PUNCT B-O
3738
+ LPC PROPN B-AC
3739
+ , PUNCT B-O
3740
+ lysophosphatidylcholine NOUN B-LF
3741
+ ; PUNCT B-O
3742
+ MAE PROPN B-AC
3743
+ , PUNCT B-O
3744
+ mean ADJ B-LF
3745
+ absolute ADJ I-LF
3746
+ error NOUN I-LF
3747
+ ; PUNCT B-O
3748
+ PC PROPN B-AC
3749
+ , PUNCT B-O
3750
+ phosphatidylcholine NOUN B-LF
3751
+ ; PUNCT B-O
3752
+ PE PROPN B-AC
3753
+ , PUNCT B-O
3754
+ phosphatidylethanolamine NOUN B-LF
3755
+ ; PUNCT B-O
3756
+ PI PROPN B-O
3757
+ , PUNCT B-O
3758
+ phosphatidylinositol NOUN B-O
3759
+ ; PUNCT B-O
3760
+ SM PROPN B-AC
3761
+ , PUNCT B-O
3762
+ sphingomyelin NOUN B-LF
3763
+ ; PUNCT B-O
3764
+ TAG PROPN B-AC
3765
+ , PUNCT B-O
3766
+ triacylglyceride NOUN B-LF
3767
+ . PUNCT B-O
3768
+
3769
+ Expression NOUN B-O
3770
+ levels NOUN B-O
3771
+ of ADP B-O
3772
+ frizzled ADJ B-O
3773
+ homolog NOUN B-O
3774
+ 9 NUM B-O
3775
+ ( PUNCT B-O
3776
+ Fzd9 PROPN B-O
3777
+ ) PUNCT B-O
3778
+ , PUNCT B-O
3779
+ calsequestrin NOUN B-LF
3780
+ 2 NUM I-LF
3781
+ ( PUNCT B-O
3782
+ Casq2 PROPN B-AC
3783
+ ) PUNCT B-O
3784
+ , PUNCT B-O
3785
+ potassium NOUN B-O
3786
+ large ADJ B-O
3787
+ conductance NOUN B-O
3788
+ calcium NOUN B-O
3789
+ - PUNCT B-O
3790
+ activated VERB B-O
3791
+ channel NOUN B-O
3792
+ , PUNCT B-O
3793
+ subfamily NOUN B-O
3794
+ M PROPN B-O
3795
+ , PUNCT B-O
3796
+ alpha NOUN B-O
3797
+ member NOUN B-O
3798
+ 1 NUM B-O
3799
+ ( PUNCT B-O
3800
+ Kcnma1 PROPN B-O
3801
+ ) PUNCT B-O
3802
+ , PUNCT B-O
3803
+ peroxisome NOUN B-O
3804
+ proliferator NOUN B-O
3805
+ activated VERB B-O
3806
+ receptor NOUN B-O
3807
+ alpha NOUN B-O
3808
+ ( PUNCT B-O
3809
+ Ppara PROPN B-O
3810
+ ) PUNCT B-O
3811
+ , PUNCT B-O
3812
+ actinin NOUN B-O
3813
+ alpha NOUN B-O
3814
+ 3 NUM B-O
3815
+ ( PUNCT B-O
3816
+ Actn3 PROPN B-O
3817
+ ) PUNCT B-O
3818
+ , PUNCT B-O
3819
+ myogenic NOUN B-O
3820
+ factor NOUN B-O
3821
+ 6 NUM B-O
3822
+ ( PUNCT B-O
3823
+ Myf6 PROPN B-O
3824
+ ) PUNCT B-O
3825
+ , PUNCT B-O
3826
+ myostatin NOUN B-O
3827
+ ( PUNCT B-O
3828
+ Mstn PROPN B-O
3829
+ ) PUNCT B-O
3830
+ and CCONJ B-O
3831
+ Muscle PROPN B-O
3832
+ RING PROPN B-O
3833
+ Finger PROPN B-O
3834
+ 1 NUM B-O
3835
+ ( PUNCT B-O
3836
+ MuRF1 PROPN B-O
3837
+ ) PUNCT B-O
3838
+ were AUX B-O
3839
+ evaluated VERB B-O
3840
+ by ADP B-O
3841
+ real ADJ B-O
3842
+ - PUNCT B-O
3843
+ time NOUN B-O
3844
+ quantitative ADJ B-O
3845
+ PCR NOUN B-O
3846
+ in ADP B-O
3847
+ soleus NOUN B-O
3848
+ of ADP B-O
3849
+ flown VERB B-O
3850
+ ( PUNCT B-O
3851
+ BF PROPN B-AC
3852
+ ) PUNCT B-O
3853
+ and CCONJ B-O
3854
+ ground NOUN B-O
3855
+ control NOUN B-O
3856
+ mice NOUN B-O
3857
+ ( PUNCT B-O
3858
+ BG PROPN B-AC
3859
+ ) PUNCT B-O
3860
+ . PUNCT B-O
3861
+ Actb PROPN B-O
3862
+ ( PUNCT B-O
3863
+ beta NOUN B-O
3864
+ actin NOUN B-O
3865
+ ) PUNCT B-O
3866
+ was AUX B-O
3867
+ used VERB B-O
3868
+ as ADP B-O
3869
+ housekeeping NOUN B-O
3870
+ to PART B-O
3871
+ calculate VERB B-O
3872
+ the DET B-O
3873
+ delta NOUN B-O
3874
+ Ct NOUN B-O
3875
+ of ADP B-O
3876
+ the DET B-O
3877
+ selected VERB B-O
3878
+ genes NOUN B-O
3879
+ . PUNCT B-O
3880
+
3881
+ BCI PROPN B-AC
3882
+ , PUNCT B-O
3883
+ brain NOUN B-LF
3884
+ – PUNCT I-LF
3885
+ computer NOUN I-LF
3886
+ interface NOUN I-LF
3887
+ . PUNCT B-O
3888
+
3889
+ During ADP B-O
3890
+ stimulus NOUN B-O
3891
+ presentation NOUN B-O
3892
+ , PUNCT B-O
3893
+ one NUM B-O
3894
+ of ADP B-O
3895
+ the DET B-O
3896
+ following ADJ B-O
3897
+ gestures NOUN B-O
3898
+ was AUX B-O
3899
+ performed VERB B-O
3900
+ by ADP B-O
3901
+ the DET B-O
3902
+ experimenter NOUN B-O
3903
+ : PUNCT B-O
3904
+ TP NOUN B-AC
3905
+ , PUNCT B-O
3906
+ MO NOUN B-AC
3907
+ , PUNCT B-O
3908
+ LPS NOUN B-AC
3909
+ , PUNCT B-O
3910
+ HO NOUN B-AC
3911
+ , PUNCT B-O
3912
+ or CCONJ B-O
3913
+ eyes NOUN B-LF
3914
+ opening NOUN I-LF
3915
+ ( PUNCT B-O
3916
+ EYE NOUN B-AC
3917
+ , PUNCT B-O
3918
+ biological ADJ B-O
3919
+ control NOUN B-O
3920
+ condition NOUN B-O
3921
+ ) PUNCT B-O
3922
+ . PUNCT B-O
3923
+
3924
+ The DET B-O
3925
+ study NOUN B-O
3926
+ pharmacist NOUN B-O
3927
+ reviewed VERB B-O
3928
+ drug NOUN B-LF
3929
+ - PUNCT I-LF
3930
+ drug NOUN I-LF
3931
+ interactions NOUN I-LF
3932
+ ( PUNCT B-O
3933
+ DDIs NOUN B-AC
3934
+ ) PUNCT B-O
3935
+ , PUNCT B-O
3936
+ DGIs NOUN B-AC
3937
+ , PUNCT B-O
3938
+ and CCONJ B-O
3939
+ cumulative ADJ B-O
3940
+ drug NOUN B-O
3941
+ and/or CCONJ B-O
3942
+ gene NOUN B-O
3943
+ interactions NOUN B-O
3944
+ in ADP B-O
3945
+ the DET B-O
3946
+ tested VERB B-O
3947
+ group NOUN B-O
3948
+ using VERB B-O
3949
+ the DET B-O
3950
+ YouScript PROPN B-O
3951
+ ® NUM B-O
3952
+ generated VERB B-O
3953
+ reports NOUN B-O
3954
+ and CCONJ B-O
3955
+ CDST NOUN B-AC
3956
+ to ADP B-O
3957
+ provide VERB B-O
3958
+ drug NOUN B-O
3959
+ therapy NOUN B-O
3960
+ recommendations NOUN B-O
3961
+ to ADP B-O
3962
+ clinicians NOUN B-O
3963
+ , PUNCT B-O
3964
+ after ADP B-O
3965
+ which PRON B-O
3966
+ prescriptions NOUN B-O
3967
+ were AUX B-O
3968
+ altered VERB B-O
3969
+ at ADP B-O
3970
+ clinician NOUN B-O
3971
+ discretion NOUN B-O
3972
+ . PUNCT B-O
3973
+
3974
+ This DET B-O
3975
+ discovery NOUN B-O
3976
+ dataset NOUN B-O
3977
+ was AUX B-O
3978
+ collected VERB B-O
3979
+ by ADP B-O
3980
+ a DET B-O
3981
+ Japanese ADJ B-O
3982
+ nationwide ADJ B-O
3983
+ database NOUN B-O
3984
+ project NOUN B-O
3985
+ called VERB B-O
3986
+ the DET B-O
3987
+ Strategic PROPN B-LF
3988
+ Research PROPN I-LF
3989
+ Program PROPN I-LF
3990
+ for ADP I-LF
3991
+ Brain PROPN I-LF
3992
+ Science PROPN I-LF
3993
+ ( PUNCT B-O
3994
+ SRPBS PROPN B-AC
3995
+ , PUNCT B-O
3996
+ https://bicr.atr.jp/decnefpro/ X B-O
3997
+ ) PUNCT B-O
3998
+ since SCONJ B-O
3999
+ 2014 NUM B-O
4000
+ . PUNCT B-O
4001
+
4002
+ The DET B-O
4003
+ ability NOUN B-O
4004
+ of ADP B-O
4005
+ glycine NOUN B-O
4006
+ to PART B-O
4007
+ hyperpolarize VERB B-O
4008
+ cells NOUN B-O
4009
+ depends VERB B-O
4010
+ on ADP B-O
4011
+ the DET B-O
4012
+ co NOUN B-O
4013
+ - NOUN B-O
4014
+ expression NOUN B-O
4015
+ of ADP B-O
4016
+ the DET B-O
4017
+ ion NOUN B-O
4018
+ channel NOUN B-O
4019
+ solute NOUN B-LF
4020
+ carrier NOUN I-LF
4021
+ family NOUN I-LF
4022
+ 12 NUM I-LF
4023
+ ( PUNCT I-LF
4024
+ potassium NOUN I-LF
4025
+ / SYM I-LF
4026
+ chloride NOUN I-LF
4027
+ transporter NOUN I-LF
4028
+ ) PUNCT I-LF
4029
+ , PUNCT I-LF
4030
+ member NOUN I-LF
4031
+ 5b NOUN I-LF
4032
+ ( PUNCT B-O
4033
+ KCC2 NOUN B-AC
4034
+ ) PUNCT B-O
4035
+ and CCONJ B-O
4036
+ the DET B-O
4037
+ glycine NOUN B-O
4038
+ receptor NOUN B-O
4039
+ . PUNCT B-O
4040
+
4041
+ Two NUM B-O
4042
+ randomised ADJ B-LF
4043
+ controlled VERB I-LF
4044
+ trials NOUN I-LF
4045
+ ( PUNCT B-O
4046
+ RCTs NOUN B-AC
4047
+ ) PUNCT B-O
4048
+ recently ADV B-O
4049
+ evaluated VERB B-O
4050
+ the DET B-O
4051
+ risk NOUN B-O
4052
+ of ADP B-O
4053
+ adverse ADJ B-O
4054
+ perinatal ADJ B-O
4055
+ outcome NOUN B-O
4056
+ after ADP B-O
4057
+ a DET B-O
4058
+ policy NOUN B-O
4059
+ of ADP B-O
4060
+ induction NOUN B-LF
4061
+ of ADP I-LF
4062
+ labour NOUN I-LF
4063
+ ( PUNCT B-O
4064
+ IOL PROPN B-AC
4065
+ ) PUNCT B-O
4066
+ at ADP B-O
4067
+ 41 NUM B-O
4068
+ weeks NOUN B-O
4069
+ as SCONJ B-O
4070
+ compared VERB B-O
4071
+ with ADP B-O
4072
+ expectant ADJ B-O
4073
+ management NOUN B-O
4074
+ until ADP B-O
4075
+ 42 NUM B-O
4076
+ weeks NOUN B-O
4077
+ [ PUNCT B-O
4078
+ 6,7 NUM B-O
4079
+ ] PUNCT B-O
4080
+ . PUNCT B-O
4081
+
4082
+ HR NOUN B-O
4083
+ , PUNCT B-O
4084
+ hazard NOUN B-O
4085
+ ratio NOUN B-O
4086
+ ; PUNCT B-O
4087
+ CI PROPN B-O
4088
+ , PUNCT B-O
4089
+ confidence NOUN B-O
4090
+ interval NOUN B-O
4091
+ ; PUNCT B-O
4092
+ ECOG PROPN B-AC
4093
+ , PUNCT B-O
4094
+ Eastern PROPN B-LF
4095
+ Cooperative PROPN I-LF
4096
+ Oncology PROPN I-LF
4097
+ Group PROPN I-LF
4098
+ ; PUNCT B-O
4099
+ DM NOUN B-O
4100
+ , PUNCT B-O
4101
+ diabetes NOUN B-O
4102
+ mellitus NOUN B-O
4103
+ ; PUNCT B-O
4104
+ HTN PROPN B-O
4105
+ , PUNCT B-O
4106
+ hypertension NOUN B-O
4107
+ . PUNCT B-O
4108
+
4109
+ The DET B-O
4110
+ transition NOUN B-O
4111
+ from ADP B-O
4112
+ ln(1 NOUN B-O
4113
+ ) PUNCT B-O
4114
+ to ADP B-O
4115
+ ln(2.62 NOUN B-O
4116
+ ) PUNCT B-O
4117
+ over ADP B-O
4118
+ 130 NUM B-O
4119
+ million NUM B-LF
4120
+ years NOUN I-LF
4121
+ implies VERB B-O
4122
+ a DET B-O
4123
+ Paleozoic ADJ B-O
4124
+ long ADJ B-O
4125
+ - ADJ B-O
4126
+ term NOUN B-O
4127
+ net ADJ B-O
4128
+ diversification NOUN B-O
4129
+ rate NOUN B-O
4130
+ of ADP B-O
4131
+ 0.0202 NUM B-O
4132
+ ln(species)/Myr NOUN B-AC
4133
+ , PUNCT B-O
4134
+ which PRON B-O
4135
+ would AUX B-O
4136
+ generate VERB B-O
4137
+ more ADJ B-O
4138
+ than ADP B-O
4139
+ a DET B-O
4140
+ 40 ADJ B-O
4141
+ - ADJ B-O
4142
+ fold ADJ B-O
4143
+ increase NOUN B-O
4144
+ in ADP B-O
4145
+ diversity NOUN B-O
4146
+ over ADP B-O
4147
+ 190 NUM B-O
4148
+ Myr NOUN B-AC
4149
+ of ADP B-O
4150
+ Mesozoic ADJ B-O
4151
+ time NOUN B-O
4152
+ . PUNCT B-O
4153
+
4154
+ Acetaminophen NOUN B-LF
4155
+ ( PUNCT B-O
4156
+ APAP PROPN B-AC
4157
+ ) PUNCT B-O
4158
+ is AUX B-O
4159
+ a DET B-O
4160
+ commonly ADV B-O
4161
+ used VERB B-O
4162
+ analgesic NOUN B-O
4163
+ and CCONJ B-O
4164
+ antipyretic NOUN B-O
4165
+ that PRON B-O
4166
+ can AUX B-O
4167
+ cause VERB B-O
4168
+ hepatotoxicity NOUN B-O
4169
+ due ADP B-O
4170
+ to ADP B-O
4171
+ production NOUN B-O
4172
+ of ADP B-O
4173
+ toxic ADJ B-O
4174
+ metabolites NOUN B-O
4175
+ via ADP B-O
4176
+ cytochrome NOUN B-LF
4177
+ P450 PROPN I-LF
4178
+ ( PUNCT B-O
4179
+ Cyp PROPN B-AC
4180
+ ) PUNCT B-O
4181
+ 1a2 NUM B-O
4182
+ and CCONJ B-O
4183
+ Cyp2e1 PROPN B-O
4184
+ . PUNCT B-O
4185
+
4186
+ Publication NOUN B-O
4187
+ bias NOUN B-O
4188
+ was AUX B-O
4189
+ suspected VERB B-O
4190
+ in ADP B-O
4191
+ both CCONJ B-O
4192
+ the DET B-O
4193
+ PCS PROPN B-AC
4194
+ ( PUNCT B-O
4195
+ A NOUN B-O
4196
+ ) PUNCT B-O
4197
+ and CCONJ B-O
4198
+ MCS PROPN B-AC
4199
+ ( PUNCT B-O
4200
+ B NOUN B-O
4201
+ ) PUNCT B-O
4202
+ . PUNCT B-O
4203
+ MCS PROPN B-AC
4204
+ : PUNCT B-O
4205
+ mental ADJ B-LF
4206
+ component NOUN I-LF
4207
+ summary NOUN I-LF
4208
+ score NOUN I-LF
4209
+ ; PUNCT B-O
4210
+ PCS PROPN B-AC
4211
+ : PUNCT B-O
4212
+ physical ADJ B-LF
4213
+ component NOUN I-LF
4214
+ summary NOUN I-LF
4215
+ score NOUN I-LF
4216
+ ; PUNCT B-O
4217
+ RFCA PROPN B-AC
4218
+ : PUNCT B-O
4219
+ radiofrequency NOUN B-LF
4220
+ catheter NOUN I-LF
4221
+ ablation NOUN I-LF
4222
+ ; PUNCT B-O
4223
+ WMD PROPN B-AC
4224
+ : PUNCT B-O
4225
+ weighted VERB B-O
4226
+ mean ADJ B-O
4227
+ difference NOUN B-O
4228
+ . PUNCT B-O
4229
+
4230
+ In ADP B-O
4231
+ Saccharomyces PROPN B-O
4232
+ cerevisiae NOUN B-O
4233
+ , PUNCT B-O
4234
+ replication NOUN B-O
4235
+ origins NOUN B-O
4236
+ isolated VERB B-O
4237
+ in ADP B-O
4238
+ DNA PROPN B-O
4239
+ fragments NOUN B-O
4240
+ are AUX B-O
4241
+ known VERB B-O
4242
+ as ADP B-O
4243
+ autonomously ADV B-LF
4244
+ replicating VERB I-LF
4245
+ sequences NOUN I-LF
4246
+ ( PUNCT B-O
4247
+ ARSs PROPN B-AC
4248
+ ) PUNCT B-O
4249
+ . PUNCT B-O
4250
+
4251
+ The DET B-O
4252
+ additional ADJ B-O
4253
+ advantage NOUN B-O
4254
+ of ADP B-O
4255
+ NAATs PROPN B-AC
4256
+ is AUX B-O
4257
+ that SCONJ B-O
4258
+ they PRON B-O
4259
+ have VERB B-O
4260
+ a DET B-O
4261
+ real ADJ B-O
4262
+ - PUNCT B-O
4263
+ world NOUN B-O
4264
+ sensitivity NOUN B-O
4265
+ of ADP B-O
4266
+ 90%–96 NUM B-O
4267
+ % NOUN B-O
4268
+ , NOUN B-O
4269
+ which PRON B-O
4270
+ leads VERB B-O
4271
+ to ADP B-O
4272
+ a DET B-O
4273
+ lower ADJ B-O
4274
+ proportion NOUN B-O
4275
+ of ADP B-O
4276
+ untreated ADJ B-O
4277
+ infections NOUN B-O
4278
+ ( PUNCT B-O
4279
+ false ADJ B-O
4280
+ negative ADJ B-O
4281
+ tests NOUN B-O
4282
+ ) PUNCT B-O
4283
+ compared VERB B-O
4284
+ to ADP B-O
4285
+ antigen NOUN B-O
4286
+ - PUNCT B-O
4287
+ based VERB B-O
4288
+ methods NOUN B-O
4289
+ ( PUNCT B-O
4290
+ direct ADJ B-O
4291
+ immunofluorescence NOUN B-LF
4292
+ ( PUNCT B-O
4293
+ IF PROPN B-AC
4294
+ ) PUNCT B-O
4295
+ or CCONJ B-O
4296
+ direct ADJ B-LF
4297
+ fluorescent ADJ I-LF
4298
+ antibody NOUN I-LF
4299
+ ( PUNCT B-O
4300
+ DFA PROPN B-AC
4301
+ ) PUNCT B-O
4302
+ and CCONJ B-O
4303
+ enzyme NOUN B-O
4304
+ - PUNCT B-O
4305
+ linked VERB B-O
4306
+ immunosorbent NOUN B-O
4307
+ assay NOUN B-O
4308
+ ( PUNCT B-O
4309
+ ELISA PROPN B-AC
4310
+ ) PUNCT B-O
4311
+ or CCONJ B-O
4312
+ enzyme NOUN B-LF
4313
+ immunoassay NOUN I-LF
4314
+ ( PUNCT B-O
4315
+ EIA PROPN B-AC
4316
+ ) PUNCT B-O
4317
+ sensitivity NOUN B-O
4318
+ 65%–75 NUM B-O
4319
+ % NOUN B-O
4320
+ compared VERB B-O
4321
+ to ADP B-O
4322
+ NAAT PROPN B-AC
4323
+ ) PUNCT B-O
4324
+ [ PUNCT B-O
4325
+ 5,6 NUM B-O
4326
+ ] PUNCT B-O
4327
+ . PUNCT B-O
4328
+
4329
+ According VERB B-O
4330
+ to ADP B-O
4331
+ the DET B-O
4332
+ United PROPN B-LF
4333
+ Nations PROPN I-LF
4334
+ Children PROPN I-LF
4335
+ ’s PART I-LF
4336
+ Fund PROPN I-LF
4337
+ ( PUNCT B-O
4338
+ UNICEF PROPN B-AC
4339
+ ) PUNCT B-O
4340
+ , PUNCT B-O
4341
+ with ADP B-O
4342
+ respect NOUN B-O
4343
+ to ADP B-O
4344
+ breastfeeding NOUN B-O
4345
+ , PUNCT B-O
4346
+ every DET B-O
4347
+ second NOUN B-O
4348
+ counts VERB B-O
4349
+ in ADP B-O
4350
+ an DET B-O
4351
+ infant NOUN B-O
4352
+ ’s PART B-O
4353
+ life NOUN B-O
4354
+ . PUNCT B-O
4355
+
4356
+ We PRON B-O
4357
+ established VERB B-O
4358
+ a DET B-O
4359
+ working VERB B-O
4360
+ group NOUN B-O
4361
+ , PUNCT B-O
4362
+ the DET B-O
4363
+ Global PROPN B-LF
4364
+ Respiratory PROPN I-LF
4365
+ Hospitalizations PROPN I-LF
4366
+ – PUNCT I-LF
4367
+ Influenza PROPN I-LF
4368
+ Proportion PROPN I-LF
4369
+ Positive PROPN I-LF
4370
+ ( PUNCT B-O
4371
+ GRIPP PROPN B-AC
4372
+ ) PUNCT B-O
4373
+ Working PROPN B-O
4374
+ Group PROPN B-O
4375
+ . PUNCT B-O
4376
+
4377
+ Please AUX B-O
4378
+ note VERB B-O
4379
+ : PUNCT B-O
4380
+ fixed VERB B-O
4381
+ - PUNCT B-O
4382
+ dose NOUN B-O
4383
+ regimens NOUN B-O
4384
+ are AUX B-O
4385
+ in ADP B-O
4386
+ square ADJ B-O
4387
+ brackets NOUN B-O
4388
+ . PUNCT B-O
4389
+ 3TC PROPN B-O
4390
+ , PUNCT B-O
4391
+ lamivudine NOUN B-O
4392
+ ; PUNCT B-O
4393
+ ABC PROPN B-O
4394
+ , PUNCT B-O
4395
+ abacavir NOUN B-O
4396
+ ; PUNCT B-O
4397
+ d4 PROPN B-AC
4398
+ T PROPN B-AC
4399
+ , PUNCT B-O
4400
+ stavudine NOUN B-LF
4401
+ ; PUNCT B-O
4402
+ EFV PROPN B-AC
4403
+ , PUNCT B-O
4404
+ efavirenz NOUN B-LF
4405
+ ; PUNCT B-O
4406
+ FTC PROPN B-O
4407
+ , PUNCT B-O
4408
+ emtricitabine NOUN B-O
4409
+ ; PUNCT B-O
4410
+ LPV PROPN B-O
4411
+ / SYM B-O
4412
+ r NOUN B-O
4413
+ , PUNCT B-O
4414
+ lopinavir NOUN B-O
4415
+ / SYM B-O
4416
+ ritonavir NOUN B-O
4417
+ ; PUNCT B-O
4418
+ NVP PROPN B-AC
4419
+ , PUNCT B-O
4420
+ nevirapine NOUN B-LF
4421
+ ; PUNCT B-O
4422
+ TDF PROPN B-AC
4423
+ , PUNCT B-O
4424
+ tenofovir NOUN B-LF
4425
+ ; PUNCT B-O
4426
+ ZDV PROPN B-AC
4427
+ , PUNCT B-O
4428
+ zidovudine NOUN B-LF
4429
+ . PUNCT B-O
4430
+
4431
+ To PART B-O
4432
+ account VERB B-O
4433
+ for ADP B-O
4434
+ the DET B-O
4435
+ phenotypic ADJ B-O
4436
+ drug NOUN B-O
4437
+ tolerance NOUN B-O
4438
+ of ADP B-O
4439
+ Mycobacterium NOUN B-O
4440
+ tuberculosis NOUN B-O
4441
+ ( PUNCT B-O
4442
+ Mtb PROPN B-O
4443
+ ) PUNCT B-O
4444
+ bacilli NOUN B-O
4445
+ in ADP B-O
4446
+ nodule NOUN B-O
4447
+ and CCONJ B-O
4448
+ cavity NOUN B-O
4449
+ caseum NOUN B-O
4450
+ [ PUNCT B-O
4451
+ 29 NUM B-O
4452
+ ] PUNCT B-O
4453
+ , PUNCT B-O
4454
+ additional ADJ B-O
4455
+ population NOUN B-O
4456
+ PK NOUN B-AC
4457
+ / SYM B-O
4458
+ PD NOUN B-AC
4459
+ distributions NOUN B-O
4460
+ were AUX B-O
4461
+ simulated ADJ B-O
4462
+ using VERB B-O
4463
+ caseum NOUN B-LF
4464
+ - PUNCT I-LF
4465
+ specific ADJ I-LF
4466
+ minimum ADJ I-LF
4467
+ bactericidal ADJ I-LF
4468
+ concentration NOUN I-LF
4469
+ MBC90 PROPN B-O
4470
+ ( PUNCT B-O
4471
+ CasMBC90 PROPN B-AC
4472
+ ) PUNCT B-O
4473
+ as ADP B-O
4474
+ the DET B-O
4475
+ PD NOUN B-AC
4476
+ parameter NOUN B-O
4477
+ to PART B-O
4478
+ capture VERB B-O
4479
+ the DET B-O
4480
+ drugs NOUN B-O
4481
+ ’ PART B-O
4482
+ killing VERB B-O
4483
+ potential NOUN B-O
4484
+ in ADP B-O
4485
+ the DET B-O
4486
+ caseous ADJ B-O
4487
+ core NOUN B-O
4488
+ of ADP B-O
4489
+ necrotic ADJ B-O
4490
+ lesions NOUN B-O
4491
+ ( PUNCT B-O
4492
+ Fig PROPN B-O
4493
+ 9B NUM B-O
4494
+ ) PUNCT B-O
4495
+ . PUNCT B-O
4496
+ None NOUN B-O
4497
+ of ADP B-O
4498
+ the DET B-O
4499
+ drugs NOUN B-O
4500
+ were AUX B-O
4501
+ able ADJ B-O
4502
+ to PART B-O
4503
+ reach VERB B-O
4504
+ full ADJ B-O
4505
+ efficacy NOUN B-O
4506
+ in ADP B-O
4507
+ this DET B-O
4508
+ hard ADJ B-O
4509
+ - PUNCT B-O
4510
+ to PART B-O
4511
+ - PUNCT B-O
4512
+ treat VERB B-O
4513
+ lesion NOUN B-O
4514
+ , PUNCT B-O
4515
+ and CCONJ B-O
4516
+ MFX PROPN B-AC
4517
+ was AUX B-O
4518
+ the DET B-O
4519
+ only ADJ B-O
4520
+ drug NOUN B-O
4521
+ to PART B-O
4522
+ show VERB B-O
4523
+ efficacy NOUN B-O
4524
+ for ADP B-O
4525
+ 31 NUM B-O
4526
+ % NOUN B-O
4527
+ of ADP B-O
4528
+ the DET B-O
4529
+ simulated ADJ B-O
4530
+ population NOUN B-O
4531
+ . PUNCT B-O
4532
+
4533
+ Postnatal ADJ B-O
4534
+ weight NOUN B-O
4535
+ gain NOUN B-O
4536
+ in ADP B-O
4537
+ extremely ADV B-LF
4538
+ low ADJ I-LF
4539
+ birth NOUN I-LF
4540
+ weight NOUN I-LF
4541
+ infants NOUN I-LF
4542
+ ( PUNCT B-O
4543
+ ELBWIs PROPN B-AC
4544
+ ) PUNCT B-O
4545
+ is AUX B-O
4546
+ a DET B-O
4547
+ critical ADJ B-O
4548
+ issue NOUN B-O
4549
+ for ADP B-O
4550
+ neurodevelopment NOUN B-O
4551
+ outcomes NOUN B-O
4552
+ [ PUNCT B-O
4553
+ 1 NUM B-O
4554
+ ] PUNCT B-O
4555
+ . PUNCT B-O
4556
+
4557
+ MVC NOUN B-AC
4558
+ maximal ADJ B-O
4559
+ voluntary ADJ B-O
4560
+ contraction NOUN B-O
4561
+ , PUNCT B-O
4562
+ VA NOUN B-AC
4563
+ voluntary ADJ B-LF
4564
+ activation NOUN I-LF
4565
+ , PUNCT B-O
4566
+ LFF NOUN B-AC
4567
+ low ADJ B-LF
4568
+ frequency NOUN I-LF
4569
+ fatigue NOUN I-LF
4570
+ index NOUN B-O
4571
+ Db100Hz NOUN B-O
4572
+ double ADJ B-O
4573
+ electrical ADJ B-O
4574
+ pulse NOUN B-O
4575
+ at ADP B-O
4576
+ 100Hz NUM B-O
4577
+ , PUNCT B-O
4578
+ Db10Hz NOUN B-O
4579
+ double ADJ B-O
4580
+ electrical ADJ B-O
4581
+ pulse NOUN B-O
4582
+ at ADP B-O
4583
+ 10Hz NUM B-O
4584
+ , PUNCT B-O
4585
+ Single ADJ B-LF
4586
+ Twitch NOUN I-LF
4587
+ single ADJ B-O
4588
+ electrical ADJ B-O
4589
+ pulse NOUN B-O
4590
+ , PUNCT B-O
4591
+ ST PROPN B-AC
4592
+ - PUNCT B-O
4593
+ RFD PROPN B-AC
4594
+ Rate NOUN B-LF
4595
+ of ADP I-LF
4596
+ force NOUN I-LF
4597
+ development NOUN I-LF
4598
+ of ADP B-O
4599
+ single ADJ B-LF
4600
+ twitch NOUN I-LF
4601
+ , PUNCT B-O
4602
+ ST-½RRT PROPN B-AC
4603
+ Rate NOUN B-O
4604
+ of ADP B-O
4605
+ relaxation NOUN B-O
4606
+ of ADP B-O
4607
+ single ADJ B-LF
4608
+ twitch NOUN I-LF
4609
+ , PUNCT B-O
4610
+ ISR NOUN B-AC
4611
+ intra ADJ B-LF
4612
+ set NOUN I-LF
4613
+ rest NOUN I-LF
4614
+ configuration NOUN B-O
4615
+ , PUNCT B-O
4616
+ TS NOUN B-AC
4617
+ traditional ADJ B-LF
4618
+ set NOUN I-LF
4619
+ configuration NOUN B-O
4620
+ . PUNCT B-O
4621
+
4622
+ GDM NOUN B-AC
4623
+ , PUNCT B-O
4624
+ gestational ADJ B-LF
4625
+ diabetes NOUN I-LF
4626
+ mellitus NOUN I-LF
4627
+ ; PUNCT B-O
4628
+ PUFA NOUN B-AC
4629
+ , PUNCT B-O
4630
+ polyunsaturated ADJ B-LF
4631
+ fatty ADJ I-LF
4632
+ acid NOUN I-LF
4633
+ . PUNCT B-O
4634
+
4635
+ This DET B-O
4636
+ instrument NOUN B-O
4637
+ has VERB B-O
4638
+ the DET B-O
4639
+ advantage NOUN B-O
4640
+ of ADP B-O
4641
+ very ADV B-O
4642
+ sensitive ADJ B-LF
4643
+ avalanche NOUN I-LF
4644
+ photodiode NOUN I-LF
4645
+ detectors NOUN I-LF
4646
+ ( PUNCT B-O
4647
+ SPADs PROPN B-AC
4648
+ ) PUNCT B-O
4649
+ that PRON B-O
4650
+ are AUX B-O
4651
+ capable ADJ B-O
4652
+ at ADP B-O
4653
+ detecting VERB B-O
4654
+ nM NOUN B-O
4655
+ concentrations NOUN B-O
4656
+ of ADP B-O
4657
+ protein NOUN B-O
4658
+ . PUNCT B-O
4659
+
4660
+ uCTXII PROPN B-AC
4661
+ : PUNCT B-O
4662
+ C PROPN B-LF
4663
+ - PROPN I-LF
4664
+ Terminal PROPN I-LF
4665
+ Telopeptide NOUN I-LF
4666
+ type NOUN I-LF
4667
+ II NUM I-LF
4668
+
4669
+ DAPI PROPN B-AC
4670
+ ( PUNCT B-O
4671
+ 4′ NUM B-LF
4672
+ , PUNCT I-LF
4673
+ 6 NUM I-LF
4674
+ - PUNCT I-LF
4675
+ diamidino-2 NOUN I-LF
4676
+ - PUNCT I-LF
4677
+ phenylindole NOUN I-LF
4678
+ dihydrochloride NOUN I-LF
4679
+ ) PUNCT B-O
4680
+ was AUX B-O
4681
+ from ADP B-O
4682
+ Invitrogen PROPN B-O
4683
+ . PUNCT B-O
4684
+
4685
+ As ADP B-O
4686
+ with ADP B-O
4687
+ all DET B-O
4688
+ noncoding NOUN B-O
4689
+ sequences NOUN B-O
4690
+ , PUNCT B-O
4691
+ small ADJ B-O
4692
+ insertion NOUN B-LF
4693
+ or CCONJ I-LF
4694
+ deletion NOUN I-LF
4695
+ ( PUNCT B-O
4696
+ indel NOUN B-AC
4697
+ ) PUNCT B-O
4698
+ events NOUN B-O
4699
+ can AUX B-O
4700
+ also ADV B-O
4701
+ play VERB B-O
4702
+ important ADJ B-O
4703
+ roles NOUN B-O
4704
+ . PUNCT B-O
4705
+
4706
+ ( PUNCT B-O
4707
+ E NOUN B-O
4708
+ , PUNCT B-O
4709
+ F NOUN B-O
4710
+ , PUNCT B-O
4711
+ H NOUN B-O
4712
+ , PUNCT B-O
4713
+ and CCONJ B-O
4714
+ I NOUN B-O
4715
+ ) PUNCT B-O
4716
+ Red ADJ B-O
4717
+ and CCONJ B-O
4718
+ green ADJ B-O
4719
+ cholera NOUN B-LF
4720
+ toxin NOUN I-LF
4721
+ ( PUNCT B-O
4722
+ CT NOUN B-AC
4723
+ ) PUNCT B-O
4724
+ was AUX B-O
4725
+ injected VERB B-O
4726
+ into ADP B-O
4727
+ the DET B-O
4728
+ visual ADJ B-O
4729
+ ( PUNCT B-O
4730
+ V1 NOUN B-AC
4731
+ , PUNCT B-O
4732
+ open ADJ B-O
4733
+ arrowhead NOUN B-O
4734
+ in ADP B-O
4735
+ [ X B-O
4736
+ H NOUN B-O
4737
+ ] PUNCT B-O
4738
+ ) PUNCT B-O
4739
+ and CCONJ B-O
4740
+ somatosensory ADJ B-O
4741
+ ( PUNCT B-O
4742
+ S1 NOUN B-AC
4743
+ , PUNCT B-O
4744
+ open ADJ B-O
4745
+ arrowhead NOUN B-O
4746
+ in ADP B-O
4747
+ [ X B-O
4748
+ E NOUN B-O
4749
+ ] PUNCT B-O
4750
+ ) PUNCT B-O
4751
+ cortex NOUN B-O
4752
+ , PUNCT B-O
4753
+ respectively ADV B-O
4754
+ , PUNCT B-O
4755
+ of ADP B-O
4756
+ wild ADJ B-O
4757
+ - PUNCT B-O
4758
+ type NOUN B-O
4759
+ and CCONJ B-O
4760
+ Sema6A−/− NOUN B-O
4761
+ adult NOUN B-O
4762
+ mice NOUN B-O
4763
+ . PUNCT B-O
4764
+
4765
+ BCC PROPN B-AC
4766
+ , PUNCT B-O
4767
+ behavior NOUN B-LF
4768
+ change NOUN I-LF
4769
+ communication NOUN I-LF
4770
+ ; PUNCT B-O
4771
+ CNS PROPN B-AC
4772
+ , PUNCT B-O
4773
+ well ADJ B-O
4774
+ - PUNCT B-O
4775
+ baby NOUN B-O
4776
+ consultation PROPN B-O
4777
+ ( PUNCT B-O
4778
+ consultation PROPN B-O
4779
+ du X B-O
4780
+ nourrisson X B-O
4781
+ sain PROPN B-O
4782
+ ) PUNCT B-O
4783
+
4784
+ Subcortical ADJ B-O
4785
+ beta NOUN B-O
4786
+ bursting NOUN B-O
4787
+ is AUX B-O
4788
+ now ADV B-O
4789
+ a DET B-O
4790
+ target NOUN B-O
4791
+ for ADP B-O
4792
+ developing VERB B-O
4793
+ adaptive ADJ B-O
4794
+ deep ADJ B-LF
4795
+ brain NOUN I-LF
4796
+ stimulation NOUN I-LF
4797
+ ( PUNCT B-O
4798
+ DBS PROPN B-AC
4799
+ ) PUNCT B-O
4800
+ technologies NOUN B-O
4801
+ that PRON B-O
4802
+ seek VERB B-O
4803
+ to PART B-O
4804
+ directly ADV B-O
4805
+ reshape VERB B-O
4806
+ the DET B-O
4807
+ temporal ADJ B-O
4808
+ profile NOUN B-O
4809
+ of ADP B-O
4810
+ beta NOUN B-O
4811
+ events NOUN B-O
4812
+ and CCONJ B-O
4813
+ thereby ADV B-O
4814
+ provide VERB B-O
4815
+ evidence NOUN B-O
4816
+ for ADP B-O
4817
+ their PRON B-O
4818
+ causal ADJ B-O
4819
+ role NOUN B-O
4820
+ [ X B-O
4821
+ 70,74,86–88 NUM B-O
4822
+ ] PUNCT B-O
4823
+ . PUNCT B-O
4824
+
4825
+ Clinacanthus NOUN B-LF
4826
+ nutans NOUN I-LF
4827
+ ( PUNCT B-O
4828
+ CN PROPN B-AC
4829
+ ) PUNCT B-O
4830
+ has AUX B-O
4831
+ gained VERB B-O
4832
+ much ADJ B-O
4833
+ attention NOUN B-O
4834
+ because SCONJ B-O
4835
+ of ADP B-O
4836
+ its PRON B-O
4837
+ anticancer NOUN B-O
4838
+ properties NOUN B-O
4839
+ , PUNCT B-O
4840
+ but CCONJ B-O
4841
+ its PRON B-O
4842
+ mechanism NOUN B-O
4843
+ remains VERB B-O
4844
+ unclear ADJ B-O
4845
+ . PUNCT B-O
4846
+
4847
+ ILP1 PROPN B-AC
4848
+ also ADV B-O
4849
+ contains VERB B-O
4850
+ two NUM B-O
4851
+ cysteine NOUN B-O
4852
+ – PUNCT B-O
4853
+ cysteine NOUN B-O
4854
+ motifs NOUN B-O
4855
+ that PRON B-O
4856
+ are AUX B-O
4857
+ weakly ADV B-O
4858
+ predicted VERB B-O
4859
+ to PART B-O
4860
+ be AUX B-O
4861
+ palmitoylated VERB B-O
4862
+ by ADP B-O
4863
+ CSS PROPN B-O
4864
+ - PUNCT B-O
4865
+ PALM PROPN B-O
4866
+ [ PUNCT B-O
4867
+ 30 NUM B-O
4868
+ ] NOUN B-O
4869
+ , PUNCT B-O
4870
+ and CCONJ B-O
4871
+ thus ADV B-O
4872
+ a DET B-O
4873
+ quadruple ADJ B-LF
4874
+ C95S NOUN I-LF
4875
+ , PUNCT I-LF
4876
+ C96S PROPN I-LF
4877
+ , PUNCT I-LF
4878
+ C273S PROPN I-LF
4879
+ , PUNCT I-LF
4880
+ C274S PROPN I-LF
4881
+ mutant NOUN I-LF
4882
+ ( PUNCT B-O
4883
+ 4Cys NOUN B-AC
4884
+ ) PUNCT B-O
4885
+ was AUX B-O
4886
+ also ADV B-O
4887
+ generated VERB B-O
4888
+ . PUNCT B-O
4889
+
4890
+ CEA PROPN B-AC
4891
+ , PUNCT B-O
4892
+ carcinoembryonic ADJ B-LF
4893
+ antigen NOUN I-LF
4894
+ ; PUNCT B-O
4895
+ DD PROPN B-O
4896
+ , PUNCT B-O
4897
+ dedifferentiated VERB B-O
4898
+ ; PUNCT B-O
4899
+ FEV1 PROPN B-AC
4900
+ , PUNCT B-O
4901
+ forced VERB B-LF
4902
+ expiratory ADJ I-LF
4903
+ volume NOUN I-LF
4904
+ in ADP I-LF
4905
+ a DET I-LF
4906
+ second ADJ I-LF
4907
+ ; PUNCT B-O
4908
+ FVC PROPN B-AC
4909
+ , PUNCT B-O
4910
+ forced VERB B-LF
4911
+ vital ADJ I-LF
4912
+ capacity NOUN I-LF
4913
+ ; PUNCT B-O
4914
+ MD PROPN B-O
4915
+ , PUNCT B-O
4916
+ moderately ADV B-O
4917
+ differentiated VERB B-O
4918
+ ; PUNCT B-O
4919
+ PD PROPN B-O
4920
+ , PUNCT B-O
4921
+ poorly ADV B-O
4922
+ differentiated VERB B-O
4923
+ ; PUNCT B-O
4924
+ WD PROPN B-O
4925
+ , PUNCT B-O
4926
+ well ADV B-O
4927
+ - PUNCT B-O
4928
+ differentiated VERB B-O
4929
+ . PUNCT B-O
4930
+
4931
+ It PRON B-O
4932
+ is AUX B-O
4933
+ a DET B-O
4934
+ gelatine NOUN B-O
4935
+ based VERB B-O
4936
+ biodegradable ADJ B-O
4937
+ slow ADV B-O
4938
+ - PUNCT B-O
4939
+ releasing VERB B-O
4940
+ - PUNCT B-O
4941
+ device NOUN B-O
4942
+ containing VERB B-O
4943
+ 33 NUM B-O
4944
+ % NOUN B-O
4945
+ ( PUNCT B-O
4946
+ 2.5 NUM B-O
4947
+ mg NOUN B-O
4948
+ ) PUNCT B-O
4949
+ CHX PROPN B-AC
4950
+ . PUNCT B-O
4951
+ This DET B-O
4952
+ small ADJ B-O
4953
+ chip NOUN B-O
4954
+ ( PUNCT B-O
4955
+ 5 NUM B-O
4956
+ mm NOUN B-O
4957
+ x SYM B-O
4958
+ 4 NUM B-O
4959
+ mm NOUN B-O
4960
+ x SYM B-O
4961
+ 0.35 NUM B-O
4962
+ mm NOUN B-O
4963
+ , PUNCT B-O
4964
+ 7 NUM B-O
4965
+ mg NOUN B-O
4966
+ ) PUNCT B-O
4967
+ is AUX B-O
4968
+ placed VERB B-O
4969
+ in ADP B-O
4970
+ periodontal ADJ B-O
4971
+ pockets NOUN B-O
4972
+ and CCONJ B-O
4973
+ releases VERB B-O
4974
+ CHX PROPN B-AC
4975
+ for ADP B-O
4976
+ over ADP B-O
4977
+ 7 NUM B-O
4978
+ days NOUN B-O
4979
+ in ADP B-O
4980
+ clinical ADJ B-O
4981
+ settings NOUN B-O
4982
+ . PUNCT B-O
4983
+ [ X B-O
4984
+ 15 X B-O
4985
+ ] X B-O
4986
+ The DET B-O
4987
+ second ADJ B-O
4988
+ is AUX B-O
4989
+ a DET B-O
4990
+ xanthan NOUN B-O
4991
+ based VERB B-O
4992
+ gel NOUN B-O
4993
+ , PUNCT B-O
4994
+ called VERB B-O
4995
+ Chlosite PROPN B-O
4996
+ , PUNCT B-O
4997
+ containing VERB B-O
4998
+ 0.5 NUM B-O
4999
+ % NOUN B-O
5000
+ chlorhexidine- NOUN B-LF
5001
+ digluconate NOUN B-O
5002
+ and CCONJ B-O
5003
+ 1.0 NUM B-O
5004
+ % NOUN B-O
5005
+ of ADP B-O
5006
+ – PUNCT B-O
5007
+ dihydrochlorite NOUN B-O
5008
+ . PUNCT B-O
5009
+
5010
+ Viability NOUN B-O
5011
+ of ADP B-O
5012
+ the DET B-O
5013
+ embryos NOUN B-O
5014
+ was AUX B-O
5015
+ checked VERB B-O
5016
+ at ADP B-O
5017
+ the DET B-O
5018
+ indicated VERB B-O
5019
+ time NOUN B-O
5020
+ points NOUN B-O
5021
+ ( PUNCT B-O
5022
+ EDD PROPN B-AC
5023
+ = PUNCT B-O
5024
+ embryonic ADJ B-LF
5025
+ development NOUN I-LF
5026
+ day NOUN I-LF
5027
+ ) PUNCT B-O
5028
+ . PUNCT B-O
5029
+
5030
+ The DET B-O
5031
+ package NOUN B-O
5032
+ of ADP B-O
5033
+ CoC PROPN B-AC
5034
+ interventions NOUN B-O
5035
+ improved VERB B-O
5036
+ CoC PROPN B-AC
5037
+ completion NOUN B-O
5038
+ ( PUNCT B-O
5039
+ adjusted VERB B-LF
5040
+ odds NOUN I-LF
5041
+ ratio NOUN I-LF
5042
+ [ PUNCT B-O
5043
+ AOR NOUN B-AC
5044
+ ] PUNCT B-O
5045
+ for ADP B-O
5046
+ DiD PROPN B-AC
5047
+ = SYM B-O
5048
+ 1.77 NUM B-O
5049
+ ; PUNCT B-O
5050
+ 95 NUM B-O
5051
+ % NOUN B-O
5052
+ confidence NOUN B-LF
5053
+ interval NOUN I-LF
5054
+ [ PUNCT B-O
5055
+ CI NOUN B-AC
5056
+ ] PUNCT B-O
5057
+ : PUNCT B-O
5058
+ 1.08 NUM B-O
5059
+ to PART B-O
5060
+ 2.92 NUM B-O
5061
+ ; PUNCT B-O
5062
+ p NOUN B-O
5063
+ = SYM B-O
5064
+ 0.024 NUM B-O
5065
+ ) PUNCT B-O
5066
+ . PUNCT B-O
5067
+
5068
+ DMT PROPN B-AC
5069
+ , PUNCT B-O
5070
+ disease NOUN B-LF
5071
+ - PUNCT I-LF
5072
+ modifying VERB I-LF
5073
+ therapy NOUN I-LF
5074
+ ; PUNCT B-O
5075
+ ICD PROPN B-AC
5076
+ , PUNCT B-O
5077
+ International PROPN B-LF
5078
+ Classification PROPN I-LF
5079
+ of ADP I-LF
5080
+ Diseases PROPN I-LF
5081
+ ; PUNCT B-O
5082
+ MS PROPN B-AC
5083
+ , PUNCT B-O
5084
+ multiple ADJ B-LF
5085
+ sclerosis NOUN I-LF
5086
+ . PUNCT B-O
5087
+
5088
+ The DET B-O
5089
+ Systolic PROPN B-LF
5090
+ Blood PROPN I-LF
5091
+ Pressure PROPN I-LF
5092
+ Intervention PROPN I-LF
5093
+ Trial PROPN I-LF
5094
+ ( PUNCT B-O
5095
+ SPRINT PROPN B-AC
5096
+ ) PUNCT B-O
5097
+ and CCONJ B-O
5098
+ the DET B-O
5099
+ Heart PROPN B-LF
5100
+ Outcomes PROPN I-LF
5101
+ Prevention PROPN I-LF
5102
+ Evaluation-3 PROPN I-LF
5103
+ ( PUNCT B-O
5104
+ HOPE-3 PROPN B-AC
5105
+ ) PUNCT B-O
5106
+ study NOUN B-O
5107
+ provide VERB B-O
5108
+ data NOUN B-O
5109
+ that PRON B-O
5110
+ complement VERB B-O
5111
+ our PRON B-O
5112
+ analyses NOUN B-O
5113
+ and CCONJ B-O
5114
+ support VERB B-O
5115
+ these DET B-O
5116
+ results NOUN B-O
5117
+ [ PUNCT B-O
5118
+ 32,33 NUM B-O
5119
+ ] PUNCT B-O
5120
+ . PUNCT B-O
5121
+
5122
+ NFATs NOUN B-AC
5123
+ often ADV B-O
5124
+ up ADV B-O
5125
+ - PROPN B-O
5126
+ regulate VERB B-O
5127
+ gene NOUN B-O
5128
+ transcription NOUN B-O
5129
+ in ADP B-O
5130
+ cooperation NOUN B-O
5131
+ with ADP B-O
5132
+ other ADJ B-O
5133
+ transcription NOUN B-O
5134
+ factors NOUN B-O
5135
+ , PUNCT B-O
5136
+ most ADV B-O
5137
+ commonly ADV B-O
5138
+ AP-1 PROPN B-O
5139
+ , PUNCT B-O
5140
+ the DET B-O
5141
+ combination NOUN B-O
5142
+ being AUX B-O
5143
+ required VERB B-O
5144
+ for ADP B-O
5145
+ the DET B-O
5146
+ expression NOUN B-O
5147
+ of ADP B-O
5148
+ interleukin NOUN B-LF
5149
+ ( PUNCT B-O
5150
+ IL)-2 NOUN B-AC
5151
+ [ PUNCT B-O
5152
+ 6 NUM B-O
5153
+ ] PUNCT B-O
5154
+ , PUNCT B-O
5155
+ IL-3 NOUN B-AC
5156
+ [ PUNCT B-O
5157
+ 7 NUM B-O
5158
+ ] PUNCT B-O
5159
+ , PUNCT B-O
5160
+ granulocyte NOUN B-LF
5161
+ - PROPN I-LF
5162
+ macrophage NOUN I-LF
5163
+ colony NOUN I-LF
5164
+ - PROPN I-LF
5165
+ stimulating VERB I-LF
5166
+ factor NOUN I-LF
5167
+ ( PUNCT B-O
5168
+ GM PROPN B-AC
5169
+ - PROPN B-AC
5170
+ CSF PROPN B-AC
5171
+ ) PUNCT B-O
5172
+ [ PUNCT B-O
5173
+ 8 NUM B-O
5174
+ ] PUNCT B-O
5175
+ , PUNCT B-O
5176
+ IL-4 NOUN B-AC
5177
+ [ PUNCT B-O
5178
+ 9 NUM B-O
5179
+ ] PUNCT B-O
5180
+ , PUNCT B-O
5181
+ IL-5 NOUN B-AC
5182
+ [ PUNCT B-O
5183
+ 10 NUM B-O
5184
+ ] PUNCT B-O
5185
+ , PUNCT B-O
5186
+ IL-13 NOUN B-AC
5187
+ [ PUNCT B-O
5188
+ 6 NUM B-O
5189
+ ] PUNCT B-O
5190
+ , PUNCT B-O
5191
+ interferon NOUN B-LF
5192
+ gamma NOUN I-LF
5193
+ ( PUNCT B-O
5194
+ IFN PROPN B-AC
5195
+ - PROPN B-AC
5196
+ γ PROPN B-AC
5197
+ ) PUNCT B-O
5198
+ [ PUNCT B-O
5199
+ 11 NUM B-O
5200
+ ] PUNCT B-O
5201
+ , PUNCT B-O
5202
+ Fas NOUN B-LF
5203
+ ligand NOUN I-LF
5204
+ ( PUNCT B-O
5205
+ FasL PROPN B-AC
5206
+ ) PUNCT B-O
5207
+ [ PUNCT B-O
5208
+ 12 NUM B-O
5209
+ ] PUNCT B-O
5210
+ , PUNCT B-O
5211
+ CD25 NOUN B-O
5212
+ [ PUNCT B-O
5213
+ 13 NUM B-O
5214
+ ] PUNCT B-O
5215
+ , PUNCT B-O
5216
+ Cox2 NOUN B-O
5217
+ [ PUNCT B-O
5218
+ 14 NUM B-O
5219
+ ] PUNCT B-O
5220
+ , PUNCT B-O
5221
+ IL-8 NOUN B-AC
5222
+ , PUNCT B-O
5223
+ and CCONJ B-O
5224
+ migration NOUN B-LF
5225
+ inhibitory ADJ I-LF
5226
+ factor NOUN I-LF
5227
+ 1 NUM I-LF
5228
+ alpha NOUN I-LF
5229
+ ( PUNCT B-O
5230
+ MIF-1α PROPN B-AC
5231
+ ) PUNCT B-O
5232
+ [ PUNCT B-O
5233
+ 11 NUM B-O
5234
+ ] PUNCT B-O
5235
+ . PUNCT B-O
5236
+
5237
+ The DET B-O
5238
+ Pseudomonas PROPN B-O
5239
+ aeruginosa NOUN B-O
5240
+ MvfR PROPN B-O
5241
+ - PUNCT B-O
5242
+ dependent ADJ B-O
5243
+ QS NOUN B-AC
5244
+ regulatory ADJ B-O
5245
+ pathway NOUN B-O
5246
+ controls VERB B-O
5247
+ the DET B-O
5248
+ expression NOUN B-O
5249
+ of ADP B-O
5250
+ key ADJ B-O
5251
+ virulence NOUN B-O
5252
+ genes NOUN B-O
5253
+ ; PUNCT B-O
5254
+ and CCONJ B-O
5255
+ is AUX B-O
5256
+ activated VERB B-O
5257
+ via ADP B-O
5258
+ the DET B-O
5259
+ extracellular ADJ B-O
5260
+ signals NOUN B-O
5261
+ 4 NUM B-LF
5262
+ - PUNCT I-LF
5263
+ hydroxy-2 NOUN I-LF
5264
+ - PUNCT I-LF
5265
+ heptylquinoline NOUN I-LF
5266
+ ( PUNCT B-O
5267
+ HHQ PROPN B-AC
5268
+ ) PUNCT B-O
5269
+ and CCONJ B-O
5270
+ 3,4 NUM B-LF
5271
+ - PUNCT I-LF
5272
+ dihydroxy-2 NOUN I-LF
5273
+ - PUNCT I-LF
5274
+ heptylquinoline NOUN I-LF
5275
+ ( PUNCT B-O
5276
+ PQS PROPN B-AC
5277
+ ) PUNCT B-O
5278
+ , PUNCT B-O
5279
+ whose DET B-O
5280
+ syntheses NOUN B-O
5281
+ depend VERB B-O
5282
+ on ADP B-O
5283
+ anthranilic ADJ B-LF
5284
+ acid NOUN I-LF
5285
+ ( PUNCT B-O
5286
+ AA PROPN B-AC
5287
+ ) PUNCT B-O
5288
+ , PUNCT B-O
5289
+ the DET B-O
5290
+ primary ADJ B-O
5291
+ precursor NOUN B-O
5292
+ of ADP B-O
5293
+ 4 NUM B-LF
5294
+ - PUNCT I-LF
5295
+ hydroxy-2 NOUN I-LF
5296
+ - PUNCT I-LF
5297
+ alkylquinolines NOUN I-LF
5298
+ ( PUNCT B-O
5299
+ HAQs PROPN B-AC
5300
+ ) PUNCT B-O
5301
+ . PUNCT B-O
5302
+
5303
+ The DET B-O
5304
+ various ADJ B-O
5305
+ aminoalcohol NOUN B-O
5306
+ derivatives NOUN B-O
5307
+ , PUNCT B-O
5308
+ including VERB B-O
5309
+ 2-(ethylamino)ethanol NOUN B-O
5310
+ , PUNCT B-O
5311
+ N NOUN B-O
5312
+ - NOUN B-O
5313
+ methylethanolamine NOUN B-O
5314
+ , PUNCT B-O
5315
+ diethanolamine NOUN B-O
5316
+ , PUNCT B-O
5317
+ and CCONJ B-O
5318
+ triethanolamine NOUN B-O
5319
+ , PUNCT B-O
5320
+ have AUX B-O
5321
+ been AUX B-O
5322
+ verified VERB B-O
5323
+ as ADP B-O
5324
+ activators NOUN B-O
5325
+ to PART B-O
5326
+ enhance VERB B-O
5327
+ bovine ADJ B-LF
5328
+ intestine NOUN I-LF
5329
+ ALP NOUN I-LF
5330
+ ( PUNCT B-O
5331
+ BIALP PROPN B-AC
5332
+ ) PUNCT B-O
5333
+ activity NOUN B-O
5334
+ to PART B-O
5335
+ degrade VERB B-O
5336
+ p NOUN B-LF
5337
+ - NOUN I-LF
5338
+ nitrophenyl NOUN I-LF
5339
+ phosphate NOUN I-LF
5340
+ ( PUNCT B-O
5341
+ pNPP NOUN B-AC
5342
+ ) PUNCT B-O
5343
+ [ PUNCT B-O
5344
+ 20 NUM B-O
5345
+ ] PUNCT B-O
5346
+ . PUNCT B-O
5347
+
5348
+ The DET B-O
5349
+ mean ADJ B-O
5350
+ ( PUNCT B-O
5351
+ 95 NUM B-O
5352
+ % NOUN B-O
5353
+ confidence NOUN B-O
5354
+ interval NOUN B-O
5355
+ ) NOUN B-O
5356
+ diagnostic ADJ B-O
5357
+ accuracy NOUN B-O
5358
+ of ADP B-O
5359
+ selected VERB B-O
5360
+ modalities NOUN B-O
5361
+ was AUX B-O
5362
+ as SCONJ B-O
5363
+ follows VERB B-O
5364
+ : PUNCT B-O
5365
+ Meckel PROPN B-AC
5366
+ ’s PART B-AC
5367
+ scan NOUN B-AC
5368
+ , PUNCT B-O
5369
+ 21.4 NUM B-O
5370
+ % NOUN B-O
5371
+ ( PUNCT B-O
5372
+ 5.7%-51.2 NUM B-O
5373
+ % NOUN B-O
5374
+ ) NOUN B-O
5375
+ ; PUNCT B-O
5376
+ capsule NOUN B-O
5377
+ endoscopy NOUN B-O
5378
+ , PUNCT B-O
5379
+ 35.7 NUM B-O
5380
+ % NOUN B-O
5381
+ ( PUNCT B-O
5382
+ 14.0%-64.4 NUM B-O
5383
+ % NOUN B-O
5384
+ ) NOUN B-O
5385
+ ; PUNCT B-O
5386
+ balloon NOUN B-LF
5387
+ - PUNCT I-LF
5388
+ assisted VERB I-LF
5389
+ enteroscopy NOUN I-LF
5390
+ ( PUNCT B-O
5391
+ BAE PROPN B-AC
5392
+ ) NOUN B-O
5393
+ , PUNCT B-O
5394
+ 85.0 NUM B-O
5395
+ % NOUN B-O
5396
+ ( PUNCT B-O
5397
+ 61.1%-96.0 NUM B-O
5398
+ % NOUN B-O
5399
+ ) NOUN B-O
5400
+ ; PUNCT B-O
5401
+ angiography NOUN B-O
5402
+ , PUNCT B-O
5403
+ 0.0 NUM B-O
5404
+ % NOUN B-O
5405
+ ( PUNCT B-O
5406
+ 0.0%-80.2 NUM B-O
5407
+ % NOUN B-O
5408
+ ) NOUN B-O
5409
+ ; PUNCT B-O
5410
+ computed VERB B-O
5411
+ tomography NOUN B-O
5412
+ , PUNCT B-O
5413
+ 31.8 NUM B-O
5414
+ % NOUN B-O
5415
+ ( PUNCT B-O
5416
+ 14.7%-54.9 NUM B-O
5417
+ % NOUN B-O
5418
+ ) NOUN B-O
5419
+ ; PUNCT B-O
5420
+ and CCONJ B-O
5421
+ small ADJ B-O
5422
+ - PUNCT B-O
5423
+ bowel NOUN B-O
5424
+ follow NOUN B-O
5425
+ - PUNCT B-O
5426
+ through NOUN B-O
5427
+ , PUNCT B-O
5428
+ 62.5 NUM B-O
5429
+ % NOUN B-O
5430
+ ( PUNCT B-O
5431
+ 25.9%-90.0 NUM B-O
5432
+ % NOUN B-O
5433
+ ) NOUN B-O
5434
+ . NOUN B-O
5435
+
5436
+ PE PROPN B-AC
5437
+ = PUNCT B-O
5438
+ Patient NOUN B-LF
5439
+ Empowerment NOUN I-LF
5440
+ , PUNCT B-O
5441
+ GSE PROPN B-AC
5442
+ = PUNCT B-O
5443
+ General PROPN B-LF
5444
+ Self PROPN I-LF
5445
+ - PUNCT I-LF
5446
+ Efficacy NOUN I-LF
5447
+ , PUNCT B-O
5448
+ TCS PROPN B-AC
5449
+ = PUNCT B-O
5450
+ Transition PROPN B-LF
5451
+ Competence NOUN I-LF
5452
+ Scale NOUN I-LF
5453
+ , PUNCT B-O
5454
+ PAM PROPN B-AC
5455
+ = PUNCT B-O
5456
+ Patient NOUN B-O
5457
+ Activation PROPN B-O
5458
+ Measurement PROPN B-O
5459
+ – PUNCT B-O
5460
+ German PROPN B-O
5461
+ Youth PROPN B-O
5462
+ Version PROPN B-O
5463
+ . PUNCT B-O
5464
+
5465
+ Developmental ADJ B-O
5466
+ task NOUN B-O
5467
+ - PUNCT B-O
5468
+ based VERB B-O
5469
+ functional ADJ B-LF
5470
+ magnetic ADJ I-LF
5471
+ resonance NOUN I-LF
5472
+ imaging NOUN I-LF
5473
+ ( PUNCT B-O
5474
+ fMRI NOUN B-AC
5475
+ ) PUNCT B-O
5476
+ studies NOUN B-O
5477
+ indicate VERB B-O
5478
+ that SCONJ B-O
5479
+ core NOUN B-O
5480
+ regions NOUN B-O
5481
+ supporting VERB B-O
5482
+ cognitive ADJ B-O
5483
+ control NOUN B-O
5484
+ ( PUNCT B-O
5485
+ e.g. X B-O
5486
+ , PUNCT B-O
5487
+ anterior ADJ B-LF
5488
+ cingulate NOUN I-LF
5489
+ cortex NOUN I-LF
5490
+ [ X B-O
5491
+ ACC PROPN B-AC
5492
+ ] PUNCT B-O
5493
+ and CCONJ B-O
5494
+ anterior ADJ B-LF
5495
+ insula NOUN I-LF
5496
+ [ X B-O
5497
+ aIns NOUN B-AC
5498
+ ] PUNCT B-O
5499
+ ) PUNCT B-O
5500
+ are AUX B-O
5501
+ engaged VERB B-O
5502
+ in ADP B-O
5503
+ adolescence NOUN B-O
5504
+ during ADP B-O
5505
+ cognitive ADJ B-O
5506
+ tasks NOUN B-O
5507
+ , PUNCT B-O
5508
+ but CCONJ B-O
5509
+ their PRON B-O
5510
+ blood NOUN B-LF
5511
+ oxygen NOUN I-LF
5512
+ level NOUN I-LF
5513
+ – PUNCT I-LF
5514
+ dependent ADJ I-LF
5515
+ ( PUNCT B-O
5516
+ BOLD PROPN B-AC
5517
+ ) PUNCT B-O
5518
+ signal NOUN B-O
5519
+ activation NOUN B-O
5520
+ [ X B-O
5521
+ 3,4 NUM B-O
5522
+ ] PUNCT B-O
5523
+ and CCONJ B-O
5524
+ connectivity NOUN B-O
5525
+ with ADP B-O
5526
+ other ADJ B-O
5527
+ brain NOUN B-O
5528
+ regions NOUN B-O
5529
+ continue VERB B-O
5530
+ to PART B-O
5531
+ increase VERB B-O
5532
+ into ADP B-O
5533
+ adulthood NOUN B-O
5534
+ [ X B-O
5535
+ 5–7 NUM B-O
5536
+ ] PUNCT B-O
5537
+ . PUNCT B-O
5538
+
5539
+ A DET B-O
5540
+ candidate NOUN B-O
5541
+ target NOUN B-O
5542
+ pathway NOUN B-O
5543
+ is AUX B-O
5544
+ quorum NOUN B-LF
5545
+ sensing NOUN I-LF
5546
+ ( PUNCT B-O
5547
+ QS PROPN B-AC
5548
+ ) PUNCT B-O
5549
+ , PUNCT B-O
5550
+ which PRON B-O
5551
+ many ADJ B-O
5552
+ bacterial ADJ B-O
5553
+ pathogens NOUN B-O
5554
+ use VERB B-O
5555
+ to PART B-O
5556
+ coordinately ADV B-O
5557
+ regulate VERB B-O
5558
+ virulence NOUN B-O
5559
+ determinants NOUN B-O
5560
+ . PUNCT B-O
5561
+
5562
+ Wall NOUN B-LF
5563
+ - PUNCT I-LF
5564
+ associated VERB I-LF
5565
+ kinases NOUN I-LF
5566
+ ( PUNCT B-O
5567
+ WAKs PROPN B-AC
5568
+ ) PUNCT B-O
5569
+ comprise VERB B-O
5570
+ a DET B-O
5571
+ subfamily NOUN B-O
5572
+ of ADP B-O
5573
+ proteins NOUN B-O
5574
+ within ADP B-O
5575
+ the DET B-O
5576
+ receptor NOUN B-LF
5577
+ - PUNCT I-LF
5578
+ like ADJ I-LF
5579
+ kinase NOUN I-LF
5580
+ ( PUNCT B-O
5581
+ RLK PROPN B-AC
5582
+ ) PUNCT B-O
5583
+ superfamily NOUN B-O
5584
+ . PUNCT B-O
5585
+
5586
+ Early ADJ B-LF
5587
+ repolarization NOUN I-LF
5588
+ pattern NOUN I-LF
5589
+ ( PUNCT B-O
5590
+ ERP NOUN B-AC
5591
+ ) PUNCT B-O
5592
+ on ADP B-O
5593
+ electrocardiogram NOUN B-O
5594
+ was AUX B-O
5595
+ associated VERB B-O
5596
+ with ADP B-O
5597
+ idiopathic ADJ B-O
5598
+ ventricular ADJ B-O
5599
+ fibrillation NOUN B-O
5600
+ and CCONJ B-O
5601
+ sudden ADJ B-O
5602
+ cardiac ADJ B-O
5603
+ arrest NOUN B-O
5604
+ in ADP B-O
5605
+ a DET B-O
5606
+ case NOUN B-O
5607
+ - PUNCT B-O
5608
+ control NOUN B-O
5609
+ study NOUN B-O
5610
+ and CCONJ B-O
5611
+ with ADP B-O
5612
+ cardiovascular ADJ B-O
5613
+ mortality NOUN B-O
5614
+ in ADP B-O
5615
+ a DET B-O
5616
+ Finnish ADJ B-O
5617
+ community NOUN B-O
5618
+ - PUNCT B-O
5619
+ based VERB B-O
5620
+ sample NOUN B-O
5621
+ . PUNCT B-O
5622
+
5623
+ NF54CSA PROPN B-AC
5624
+ , PUNCT B-O
5625
+ Plasmodium NOUN B-O
5626
+ falciparum NOUN B-O
5627
+ isolate NOUN B-O
5628
+ NF54 PROPN B-AC
5629
+ selected VERB B-O
5630
+ for ADP B-O
5631
+ CSA NOUN B-AC
5632
+ adhesion NOUN B-O
5633
+ ; PUNCT B-O
5634
+ VAR2CSA PROPN B-AC
5635
+ , PUNCT B-O
5636
+ variant NOUN B-LF
5637
+ surface NOUN I-LF
5638
+ antigen NOUN I-LF
5639
+ 2 NUM I-LF
5640
+ - PUNCT I-LF
5641
+ CSA NOUN I-LF
5642
+ ; PUNCT B-O
5643
+ T934A PROPN B-O
5644
+ , PUNCT B-O
5645
+ threonine934 NOUN B-O
5646
+ alanine NOUN B-O
5647
+ . PUNCT B-O
5648
+
5649
+ Age NOUN B-O
5650
+ - PUNCT B-O
5651
+ standardized VERB B-O
5652
+ incidence NOUN B-O
5653
+ rates NOUN B-O
5654
+ ( PUNCT B-O
5655
+ per ADP B-O
5656
+ million NUM B-O
5657
+ person NOUN B-O
5658
+ - PUNCT B-O
5659
+ years NOUN B-O
5660
+ ) PUNCT B-O
5661
+ in ADP B-O
5662
+ males NOUN B-O
5663
+ and CCONJ B-O
5664
+ females NOUN B-O
5665
+ were AUX B-O
5666
+ 34.0 NUM B-O
5667
+ ( PUNCT B-O
5668
+ 95 NUM B-LF
5669
+ % NOUN I-LF
5670
+ confidence NOUN I-LF
5671
+ interval NOUN I-LF
5672
+ [ PUNCT B-O
5673
+ CI NOUN B-O
5674
+ ] X B-O
5675
+ 28.9–39.1 NUM B-O
5676
+ ) PUNCT B-O
5677
+ and CCONJ B-O
5678
+ 26.2 NUM B-O
5679
+ ( PUNCT B-O
5680
+ 95 NUM B-AC
5681
+ % NOUN B-AC
5682
+ CI NOUN B-AC
5683
+ 21.5–30.7 NUM B-O
5684
+ ) PUNCT B-O
5685
+ for ADP B-O
5686
+ LL PROPN B-AC
5687
+ , PUNCT B-O
5688
+ 10.5 NUM B-O
5689
+ ( PUNCT B-O
5690
+ 95 NUM B-AC
5691
+ % NOUN B-AC
5692
+ CI NOUN B-AC
5693
+ 7.7–13.3 NUM B-O
5694
+ ) PUNCT B-O
5695
+ and CCONJ B-O
5696
+ 12.5 NUM B-O
5697
+ ( PUNCT B-O
5698
+ 95 NUM B-AC
5699
+ % NOUN B-AC
5700
+ CI NOUN B-AC
5701
+ 9.4–15.7 NUM B-O
5702
+ ) PUNCT B-O
5703
+ for ADP B-O
5704
+ HL PROPN B-AC
5705
+ , PUNCT B-O
5706
+ 12.5 NUM B-O
5707
+ ( PUNCT B-O
5708
+ 95 NUM B-AC
5709
+ % NOUN B-AC
5710
+ CI NOUN B-AC
5711
+ 9.3–15.4 NUM B-O
5712
+ ) PUNCT B-O
5713
+ and CCONJ B-O
5714
+ 7.7 NUM B-O
5715
+ ( PUNCT B-O
5716
+ 95 NUM B-AC
5717
+ % NOUN B-AC
5718
+ CI NOUN B-AC
5719
+ 5.2–10.2 NUM B-O
5720
+ ) PUNCT B-O
5721
+ for ADP B-O
5722
+ NHL PROPN B-AC
5723
+ ( PUNCT B-O
5724
+ except SCONJ B-O
5725
+ for ADP B-O
5726
+ Burkitt PROPN B-O
5727
+ lymphomas NOUN B-O
5728
+ ) PUNCT B-O
5729
+ , PUNCT B-O
5730
+ and CCONJ B-O
5731
+ 3.2 NUM B-O
5732
+ ( PUNCT B-O
5733
+ 95 NUM B-AC
5734
+ % NOUN B-AC
5735
+ CI NOUN B-AC
5736
+ 1.6–4.7 NUM B-O
5737
+ ) PUNCT B-O
5738
+ and CCONJ B-O
5739
+ 1.5 NUM B-O
5740
+ ( PUNCT B-O
5741
+ 95 NUM B-AC
5742
+ % NOUN B-AC
5743
+ CI NOUN B-AC
5744
+ 0.4–2.5 NUM B-O
5745
+ ) PUNCT B-O
5746
+ for ADP B-O
5747
+ Burkitt PROPN B-O
5748
+ lymphomas NOUN B-O
5749
+ . PUNCT B-O
5750
+
5751
+ AMPA PROPN B-AC
5752
+ , PUNCT B-O
5753
+ α NOUN B-LF
5754
+ - PUNCT I-LF
5755
+ amino-3 NOUN I-LF
5756
+ - PUNCT I-LF
5757
+ hydroxy-5 NOUN I-LF
5758
+ - PUNCT I-LF
5759
+ methyl-4 NOUN I-LF
5760
+ - PUNCT I-LF
5761
+ isoxazolepropionic NOUN I-LF
5762
+ acid NOUN I-LF
5763
+ ; PUNCT B-O
5764
+ DiSs PROPN B-AC
5765
+ , PUNCT B-O
5766
+ dually ADV B-LF
5767
+ innervated VERB I-LF
5768
+ spines NOUN I-LF
5769
+ ; PUNCT B-O
5770
+ EPSP PROPN B-AC
5771
+ , PUNCT B-O
5772
+ excitatory ADJ B-LF
5773
+ postsynaptic ADJ I-LF
5774
+ potential NOUN I-LF
5775
+ ; PUNCT B-O
5776
+ IPSP PROPN B-AC
5777
+ , PUNCT B-O
5778
+ inhibitory ADJ B-LF
5779
+ postsynaptic ADJ I-LF
5780
+ potential NOUN I-LF
5781
+ ; PUNCT B-O
5782
+ NMDA PROPN B-AC
5783
+ , PUNCT B-O
5784
+ N NOUN B-LF
5785
+ - PUNCT I-LF
5786
+ Methyl NOUN I-LF
5787
+ - PUNCT I-LF
5788
+ D NOUN I-LF
5789
+ - PUNCT I-LF
5790
+ aspartate NOUN I-LF
5791
+ . PUNCT B-O
5792
+
5793
+ AFP PROPN B-AC
5794
+ , PUNCT B-O
5795
+ α NOUN B-LF
5796
+ - PUNCT I-LF
5797
+ fetoprotein NOUN I-LF
5798
+ ; PUNCT B-O
5799
+ ALT PROPN B-AC
5800
+ , PUNCT B-O
5801
+ alanine NOUN B-LF
5802
+ transaminase NOUN I-LF
5803
+ ; PUNCT B-O
5804
+ CLIP PROPN B-AC
5805
+ , PUNCT B-O
5806
+ Cancer PROPN B-LF
5807
+ of ADP I-LF
5808
+ the DET I-LF
5809
+ Liver PROPN I-LF
5810
+ Italian PROPN I-LF
5811
+ Program PROPN I-LF
5812
+ ; PUNCT B-O
5813
+ CTP PROPN B-AC
5814
+ , PUNCT B-O
5815
+ Child PROPN B-LF
5816
+ - PUNCT I-LF
5817
+ Turcotte PROPN I-LF
5818
+ - PUNCT I-LF
5819
+ Pugh PROPN I-LF
5820
+ ; PUNCT B-O
5821
+ HBsAg PROPN B-AC
5822
+ , PUNCT B-O
5823
+ hepatitis NOUN B-LF
5824
+ B NOUN I-LF
5825
+ surface NOUN I-LF
5826
+ antigen NOUN I-LF
5827
+ ; PUNCT B-O
5828
+ HCV PROPN B-AC
5829
+ , PUNCT B-O
5830
+ hepatitis NOUN B-O
5831
+ C NOUN B-O
5832
+ ; PUNCT B-O
5833
+ INR NOUN B-AC
5834
+ , PUNCT B-O
5835
+ international ADJ B-LF
5836
+ normalized VERB I-LF
5837
+ ratio NOUN I-LF
5838
+ ; PUNCT B-O
5839
+ MELD PROPN B-AC
5840
+ , PUNCT B-O
5841
+ model NOUN B-LF
5842
+ for ADP I-LF
5843
+ end ADJ I-LF
5844
+ - PUNCT I-LF
5845
+ stage NOUN I-LF
5846
+ liver NOUN I-LF
5847
+ disease NOUN I-LF
5848
+ ; PUNCT B-O
5849
+ PT PROPN B-AC
5850
+ , PUNCT B-O
5851
+ prothrombin NOUN B-LF
5852
+ time NOUN I-LF
5853
+ ; PUNCT B-O
5854
+ SD PROPN B-AC
5855
+ , PUNCT B-O
5856
+ standard ADJ B-LF
5857
+ deviation NOUN I-LF
5858
+ ; PUNCT B-O
5859
+ SR PROPN B-AC
5860
+ , PUNCT B-O
5861
+ surgical ADJ B-LF
5862
+ resection NOUN I-LF
5863
+ ; PUNCT B-O
5864
+ TACE PROPN B-AC
5865
+ , PUNCT B-O
5866
+ transarterial ADJ B-LF
5867
+ chemoembolization NOUN I-LF
5868
+ ; PUNCT B-O
5869
+ TIS PROPN B-AC
5870
+ , PUNCT B-O
5871
+ Taipei PROPN B-LF
5872
+ Integrated PROPN I-LF
5873
+ Scoring PROPN I-LF
5874
+ System PROPN I-LF
5875
+
5876
+ GLM PROPN B-AC
5877
+ , PUNCT B-O
5878
+ general ADJ B-LF
5879
+ linear ADJ I-LF
5880
+ model NOUN I-LF
5881
+ ; PUNCT B-O
5882
+ OFC PROPN B-AC
5883
+ , PUNCT B-O
5884
+ orbitofrontal ADJ B-LF
5885
+ cortex NOUN I-LF
5886
+ . PUNCT B-O
5887
+
5888
+ NSAID PROPN B-AC
5889
+ , PUNCT B-O
5890
+ non ADJ B-LF
5891
+ - PUNCT I-LF
5892
+ steroidal ADJ I-LF
5893
+ anti ADJ I-LF
5894
+ - PUNCT I-LF
5895
+ inflammatory ADJ I-LF
5896
+ drug NOUN I-LF
5897
+ ; PUNCT B-O
5898
+ RT PROPN B-O
5899
+ - PUNCT B-O
5900
+ PCR PROPN B-O
5901
+ , PUNCT B-O
5902
+ reverse ADJ B-O
5903
+ transcription NOUN B-O
5904
+ polymerase NOUN B-O
5905
+ chain NOUN B-O
5906
+ reaction NOUN B-O
5907
+ ; PUNCT B-O
5908
+ SARS PROPN B-AC
5909
+ - PUNCT B-AC
5910
+ CoV-2 PROPN B-AC
5911
+ , PUNCT B-O
5912
+ severe ADJ B-LF
5913
+ acute ADJ I-LF
5914
+ respiratory ADJ I-LF
5915
+ syndrome NOUN I-LF
5916
+ coronavirus NOUN I-LF
5917
+ 2 NUM I-LF
5918
+ . PUNCT B-O
5919
+
5920
+ AUD PROPN B-O
5921
+ , PUNCT B-O
5922
+ Australian ADJ B-O
5923
+ dollars NOUN B-O
5924
+ ; PUNCT B-O
5925
+ DALY PROPN B-AC
5926
+ , PUNCT B-O
5927
+ disability NOUN B-LF
5928
+ - PUNCT I-LF
5929
+ adjusted VERB I-LF
5930
+ life NOUN I-LF
5931
+ year NOUN I-LF
5932
+ ; PUNCT B-O
5933
+ NZ PROPN B-O
5934
+ , PUNCT B-O
5935
+ New PROPN B-O
5936
+ Zealand PROPN B-O
5937
+ . PUNCT B-O
5938
+
5939
+ Data PROPN B-O
5940
+ - PUNCT B-O
5941
+ sharing NOUN B-O
5942
+ platforms NOUN B-O
5943
+ such ADJ B-O
5944
+ as ADP B-O
5945
+ Clinical PROPN B-O
5946
+ Study PROPN B-O
5947
+ Data PROPN B-O
5948
+ Request PROPN B-O
5949
+ , PUNCT B-O
5950
+ the DET B-O
5951
+ Yale PROPN B-LF
5952
+ University PROPN I-LF
5953
+ Open PROPN I-LF
5954
+ Data PROPN I-LF
5955
+ Access PROPN I-LF
5956
+ ( PUNCT B-O
5957
+ YODA PROPN B-AC
5958
+ ) PUNCT B-O
5959
+ Project PROPN B-O
5960
+ and CCONJ B-O
5961
+ Vivli PROPN B-O
5962
+ were AUX B-O
5963
+ created VERB B-O
5964
+ to PART B-O
5965
+ facilitate VERB B-O
5966
+ data NOUN B-O
5967
+ - PUNCT B-O
5968
+ sharing NOUN B-O
5969
+ and CCONJ B-O
5970
+ to PART B-O
5971
+ ensure VERB B-O
5972
+ that SCONJ B-O
5973
+ clinical ADJ B-O
5974
+ trial NOUN B-O
5975
+ data NOUN B-O
5976
+ are AUX B-O
5977
+ FAIR PROPN B-AC
5978
+ ( PUNCT B-O
5979
+ Findable ADJ B-LF
5980
+ , PUNCT I-LF
5981
+ Accessible ADJ I-LF
5982
+ , PUNCT I-LF
5983
+ Interoperable ADJ I-LF
5984
+ and CCONJ I-LF
5985
+ Reusable ADJ I-LF
5986
+ ) PUNCT B-O
5987
+ [ PUNCT B-O
5988
+ 5 NUM B-O
5989
+ ] PUNCT B-O
5990
+ . PUNCT B-O
5991
+
5992
+ We PRON B-O
5993
+ further ADV B-O
5994
+ analyzed VERB B-O
5995
+ primary ADJ B-LF
5996
+ human ADJ I-LF
5997
+ monocyte NOUN I-LF
5998
+ - PUNCT I-LF
5999
+ derived VERB I-LF
6000
+ macrophages NOUN I-LF
6001
+ ( PUNCT B-O
6002
+ PHMDMs PROPN B-AC
6003
+ ) PUNCT B-O
6004
+ differentiated VERB B-O
6005
+ from ADP B-O
6006
+ CD14 NOUN B-O
6007
+ + NOUN B-O
6008
+ monocytes NOUN B-O
6009
+ . PUNCT B-O
6010
+
6011
+ ISS PROPN B-O
6012
+ : PUNCT B-O
6013
+ Injury NOUN B-O
6014
+ severity NOUN B-O
6015
+ score NOUN B-O
6016
+ , PUNCT B-O
6017
+ ER NOUN B-AC
6018
+ : PUNCT B-O
6019
+ emergency NOUN B-LF
6020
+ room NOUN I-LF
6021
+ , PUNCT B-O
6022
+ DM NOUN B-O
6023
+ : PUNCT B-O
6024
+ Diabetes NOUN B-O
6025
+ mellitus NOUN B-O
6026
+ , PUNCT B-O
6027
+ SBP NOUN B-O
6028
+ : PUNCT B-O
6029
+ Systolic ADJ B-O
6030
+ blood NOUN B-O
6031
+ pressure NOUN B-O
6032
+ , PUNCT B-O
6033
+ APC NOUN B-AC
6034
+ : PUNCT B-O
6035
+ Anterior ADJ B-O
6036
+ - PUNCT B-O
6037
+ posterior ADJ B-O
6038
+ compression NOUN B-O
6039
+ , PUNCT B-O
6040
+ LC NOUN B-O
6041
+ : PUNCT B-O
6042
+ Lateral ADJ B-O
6043
+ compression NOUN B-O
6044
+ , PUNCT B-O
6045
+ VS NOUN B-O
6046
+ : PUNCT B-O
6047
+ Vertical ADJ B-O
6048
+ shear NOUN B-O
6049
+ . PUNCT B-O
6050
+
6051
+ As SCONJ B-O
6052
+ described VERB B-O
6053
+ below ADV B-O
6054
+ , PUNCT B-O
6055
+ we PRON B-O
6056
+ have AUX B-O
6057
+ tested VERB B-O
6058
+ both CCONJ B-O
6059
+ double ADJ B-O
6060
+ - PUNCT B-O
6061
+ stranded ADJ B-O
6062
+ ( PUNCT B-O
6063
+ dsDNA NOUN B-AC
6064
+ ) PUNCT B-O
6065
+ and CCONJ B-O
6066
+ single ADJ B-LF
6067
+ - PUNCT I-LF
6068
+ stranded ADJ I-LF
6069
+ DNA NOUN I-LF
6070
+ ( PUNCT B-O
6071
+ ssDNA NOUN B-AC
6072
+ ) PUNCT B-O
6073
+ using VERB B-O
6074
+ two NUM B-O
6075
+ methods NOUN B-O
6076
+ of ADP B-O
6077
+ staining VERB B-O
6078
+ with ADP B-O
6079
+ fluorophores NOUN B-O
6080
+ , PUNCT B-O
6081
+ and CCONJ B-O
6082
+ we PRON B-O
6083
+ report VERB B-O
6084
+ here ADV B-O
6085
+ the DET B-O
6086
+ proof NOUN B-O
6087
+ of ADP B-O
6088
+ concept NOUN B-O
6089
+ demonstrating VERB B-O
6090
+ that SCONJ B-O
6091
+ ssDNA NOUN B-AC
6092
+ shows VERB B-O
6093
+ sequence NOUN B-O
6094
+ - PUNCT B-O
6095
+ specific ADJ B-O
6096
+ responses NOUN B-O
6097
+ to ADP B-O
6098
+ a DET B-O
6099
+ variety NOUN B-O
6100
+ of ADP B-O
6101
+ volatile ADJ B-O
6102
+ compounds NOUN B-O
6103
+ and CCONJ B-O
6104
+ that SCONJ B-O
6105
+ libraries NOUN B-O
6106
+ of ADP B-O
6107
+ these DET B-O
6108
+ materials NOUN B-O
6109
+ can AUX B-O
6110
+ be AUX B-O
6111
+ efficiently ADV B-O
6112
+ screened VERB B-O
6113
+ for ADP B-O
6114
+ odor NOUN B-O
6115
+ responses NOUN B-O
6116
+ . PUNCT B-O
6117
+
6118
+ MglA PROPN B-AC
6119
+ is AUX B-O
6120
+ an DET B-O
6121
+ ortholog NOUN B-O
6122
+ of ADP B-O
6123
+ the DET B-O
6124
+ stringent ADJ B-LF
6125
+ starvation NOUN I-LF
6126
+ protein NOUN I-LF
6127
+ A PROPN I-LF
6128
+ ( PUNCT B-O
6129
+ SspA PROPN B-AC
6130
+ ) PUNCT B-O
6131
+ from ADP B-O
6132
+ Escherichia PROPN B-O
6133
+ coli PROPN B-O
6134
+ ( PUNCT B-O
6135
+ the DET B-O
6136
+ two NUM B-O
6137
+ proteins NOUN B-O
6138
+ share VERB B-O
6139
+ 21 NUM B-O
6140
+ % NOUN B-O
6141
+ identity NOUN B-O
6142
+ and CCONJ B-O
6143
+ 34 NUM B-O
6144
+ % NOUN B-O
6145
+ similarity NOUN B-O
6146
+ at ADP B-O
6147
+ the DET B-O
6148
+ primary ADJ B-O
6149
+ amino NOUN B-O
6150
+ acid NOUN B-O
6151
+ level NOUN B-O
6152
+ ) PUNCT B-O
6153
+ . PUNCT B-O
6154
+
PLOD_CW_2025_Val.parquet ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:715aecb3568ca312178df39b585797e5ce41d92606980cd08283898abf25de07
3
+ size 35910